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Abstract
Every year, a large number of skin cancer cases caused by a prolonged ultra-
violet radiation exposure, are diagnosed around the world. Epigallocatechin–3–
gallate (EGCG) derived from green tea leaves, display protective effect against
oxidative stress which reduce the risk of contracting skin cancer. However, fre-
quently, the antioxidant and anti–inflammatory activities of EGCG in are com-
promised because this molecule is extremely unstable and rapidly degraded in
physiological conditions. Considering these issues, the main goal of this thesis
was developed a stable liposomal nanocarrier for topical/transdermal delivery of
EGCG, firstly, to increase its bioavailability and, secondly, to offer an desirable
skin protection against harmful effects of UV radiation. Primarily, the molecu-
lar mechanisms between EGCG and different phospholipids were studied using
Langmuir experiments, revealling the affinity and localization of EGCG on each
lipidic membrane, which according to the results depends on the molecular orga-
nization of lipidic monolayer (functional groups anchored at headgroup) and of
the degree of protonation of EGCG. EGCG establishes electrostatic and hydrogen-
bonding interactions with zwitterionic (DMPC, DPPC) and anionic (DPPG and
DPPS) phospholipids, which condense the monolayers and alter the membrane’s
potential and compressibility. Regarding the irradiation experiments, the results
indicated that EGCG efficiently slows down the oxidant events in monolayers and
in lipid bilayers, which were produced by blue and ultraviolet radiation exposure,
respectively. Lastly, the nanofibers meshes containing EGCG-loaded liposomes
are biocompatible, support human fibroblasts adhesion and scavenge the oxidant
species generated by UV radiation, which guarantees a higher cell survival.
Keywords: skin cancer; oxidative stress; EGCG;liposomes; wound healing
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Resumo
A cada ano, um grande número de casos de cancro da pele, causados por
uma prolongada exposição à radiação ultravioleta, são diagnosticados em todo
o mundo. A Epigalocatequina–3–galato (EGCG) extraída do chá verde, tem um
efeito protector contra o stress oxidativo, o que reduz o risco de desenvolver can-
cro da pele. Contudo, as actividades antioxidantes e anti-inflamatórias da EGCG
ficam comprometidas, uma vez que esta é extremamente instável e rapidamente
degradada em condições fisiológicas. Assim, o principal objectivo desta tese foi
desenvolver um nanotransportador lipossómico estável para entregar a EGCG via
tópica/transdermal na pele, de forma a aumentar a biodisponibilidade e prote-
ger adequadamente a pele dos efeitos nocisos da radiação UV. Inicialmente, os
mecanismos moleculares entre a EGCG e diferentes fosfolípidos foram estudados
usando experiências de Langmuir, revelando a afinidade e a localização da EGCG
em cada monocamada. De acordo com os dados, esta depende da organização
molecular da monocamada lipídica (grupos funcionais ancorados na cabeça do
lípido) e do grau de protonação da EGCG. A EGCG estabelece interações elec-
trostáticas e pontes de hidrogénio com os fosfolípidos neutros (DMPC, DPPC) e
negativos (DPPG e DPPS), condensa e altera o potential e a compressibilidade das
monocamdas. Segundo os ensaios de irradiação, a EGCG retarda eficientemente
os eventos oxidantes tanto nas monocamadas como nas bicamadas lipídicas. Por
fim, concluiu-se que as nanofibras que contêm liposomas com a EGCG encapsu-
lada são biocompatíveis, permitem a adesão de fibroblastos humanos e eliminam
as expécies oxidantes geradas pela radiação UV, o que garante uma maior sobre-
vivência celular.
Palavras-chave: cancro da pele; stress oxidativo; EGCG; lipossomas; cicatrização
de feridas
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General Introduction
Currently, cancer still is a serious health problem globally, despite the tremen-
dous technological advances in the field of diagnosis imaging, immunotherapy,
epigenetics and nanotheranostics. Cancer is basically a disease that arises from
genetic mutations that greatly increase the rate of cell division. Only a small
percentage of these genetic defects are caused by inherited faulty genes, being the
great majority (90-95 %) due to unhealthy lifestyle and exposure to environmen-
tal contaminants. The major cancer risk factors involve a deficient plant-based
diet, sedentarism, smoking habits and a long-term exposure to ionizing radiation
( such as gamma radiation, X-ray and ultraviolet (UV)).
Definitively, there is a causal relationship between the exposure to UV radia-
tion from sunlight and skin cancer, having the Caucasian population and people
living in equatorial regions (greater UV exposure) a higher propensity to get this
type of cancer. Furthermore, the ongoing threats to the ozone layer will eventually
contribute to increasing incidence of skin cancer, since UV rays of shorter wave-
length (UVC rays) will easily start travelling across the ’perturbed’ atmosphere
and, consequently, will reach the Earth’s surface. Several studies shown that
the exposure to UV radiation suddenly increases the production of reactive oxy-
gen species (ROS), which change the chemical structure of deoxyribonucleic acid
(DNA), start off lipid peroxidation phenomenon and often cause unrepaired ab-
normalities in the cellular metabolism. Other worrisome recent studies, showed
that these harmful oxidant species are also produced by the short-wavelength
visible light (blue light) emitted by smartphones and laptops.
In past few decades, a variety of natural molecules like catechins-derived from
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green tea leaves, have been extensively studied considering the anti-inflammatory,
antioxidant and free radical scavenging properties, that alleviate side-effects stem-
ming from radiation exposure and regulate some steps of the carcinogenesis pro-
cess. Despite the clear health benefits, the molecular interactions that regulate
the partitioning of catechins into cellular membranes, the precise location of
catechins within lipid bilayer and their effect on the dynamics and structural
organization of membrane remains an issue controversal and unclear in the liter-
ature.
Another crucial issue towards the clinical use of catechins is given by the long-
term stability of these molecules in bloodstream. Regrettably, most of the time,
catechins are hydrolyzed and oxidized by a vast array of enzymes along their
journey through the systemic circulation, hence resulting in a small number of
catechins therapeutically active and capable of targeting tumor tissues.
At present, several nanotechnology-based drug delivery systems (such as lipo-
somes) hold tremendous potential to enhance the therapeutic effect of catechins,
since these systems improve the in vivo stability of catechins and precisely regu-
late their deliver rate to the target tissue.
Considering this, the main goals of the thesis are to understand catechin-lipid
interactions at molecular level and how radiation disturb them and, ultimately,
develop a stable catechin-loaded liposome that, after topical administration, pre-
vents the oxidative skin damage induced by UV radiation and accelerates the
healing of skin lesions.
The thesis is divided into six major parts. The first is devoted to the state of
the art focused on two promising different strategies to use catechins in cancer
treatment. The first strategy explores the action of flavonoids on epigenetic mech-
anisms to control gene expression in cancer cells (Chapter 2). The second strategy
mostly lies on the antioxidant activity of catechins that balances the production
and elimination of ROS and so, it can prevent UV-induced damage. More pre-
cisely, the peroxidative damage of lipids caused by UV radiation is discussed in
detail. Additionally, current state of liposome-based delivery systems that im-
prove the pharmacokinetic behavior of catechins, as well as, the challenges for
their use in dermal applications, were also revised (Chapter 3).
In the second part, the basic fundamentals of instrumental techniques used
to prepare mixed catechin–lipid monolayer/bilayer systems as well as to identify
molecular details of catechin–lipid interactions and the underlying mechanisms
by which catechin decreases the membrane sensitivity to blue or UV radiation
damage were described. Moreover, the production process of the nanofibers
incorporating catechin-loaded liposomes and, the cell lines used to assess the
2
biocompatibility and the in vitro pharmacologic effects of these nanofibers against
oxidative stress induced either by UVC radiation and H2O2 exposure, are also
explained.
In the third part, experimental results relating to the anionic and zwitterionic
lipid/EGCG monolayers, spread in air/water or air/buffer subphases and exposed
to blue irradiation, are shown and discussed in the context of the surface behavior
and the structural changes (Chapter 5 and 6, respectively). These experiments
explain the role of lipid headgroup composition (size, charge) and also the effect
of subphase pH, on the miscibility and molecular interactions between catechin
and lipid monolayers.
The fourth section addresses the antioxidant potential of catechin by exposing
liposomal systems to UV radiation (Chapter 7) and explores the maximum cate-
chin loading capacity of the liposomes without compromising the integrity of the
vesicles (Chapter 8). The fifth section concerns the in vitro studies performed to
test the efficiency and the antioxidant activity of the EGCG-carrying liposomes
immobilized onto nanofibers mats for promoting skin healing (Chapter 9).
The sixth and final part presents the main conclusions of the thesis and dis-
cusses future challenges in the field of liposomes to improve the administration
of natural antioxidants to the skin.
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Interactions of Flavonoids and DNA
Dietary polyphenols working as epigenetics modulators: impact
on cancer prevention1
Abstract
Carcinogenesis is one of the most fearsome diseases on the whole society, given
the alarming increase of new diagnosed cases every day around the globe. Malig-
nant cellular transformation can be due to the disruption and changes of epige-
netic mechanisms, including DNA methylation patterns, chromatin and histone
remodeling and microRNA expression. These epigenetics abnormalities, in addi-
tion with genetics defects promote the cancer initiation as well its propagation.
Polyphenols (catechins, resveratrol, genistein, curcumin) are molecules present in
fruit and vegetables that can reverse adverse epigenetic markers in cells, modulat-
ing intracellular signaling pathways that regulate cell proliferation and migration
to other tissues (metastasis). In this review we discuss in detail, the role and po-
tential use of flavonoids, as epigallocatechin-3-gallate, major catechin present in
green tea, on the epigenetic regulation of genes opening new approaches to cancer
chemoprevention. A critical review about the impact of changes in lifestyle and
diet supplementation with natural phytochemicals on cancer statistics was done.
This review highlights the new advances in understanding the anticancer activity
of flavonoids based on its ability to damage DNA in cancer cells.
1This chapter is based on the following publication:
Pires, F., Magalhães-Mota, G. and Raposo, M. Dietary polyphenols working as epigenetics mod-
ulators: impact on cancer prevention. Advances in Medicine and Biology, 2018, 127:10, Nova
Science Publishers.
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2.1 Introduction
People of a modern urban society are exposed to high levels of stress and do not
have any time to practice sports or to prepare meals, choosing a rapid solution
when its time to eat. Unfortunately, in the majority of cases, this rapid solution
is related with the practice of bad dietary habits (consumption of fast food and
sweetened drinks). The harmful and hazardous consumption of a wrong decision
has long-term consequences, evidenced by the alarming increase of the number
of cases of colorectal, pancreas, kidney and breast cancers worldwide.
Most of cancer cases (90%) emerge from the regular exposition to risk factors
(cigarette smoking, alcohol, radiation, diet, infectious agents) and from somatic
mutations. Endogenous processes as the upgregulation of oncogenes, radiation-
induced DNA lesions and the overproduction of inflammatory cytokines disrupt
the cellular homeostasis, leading to an abnormal growth of cells with a malignant
phenotype. Cancer cells have an uncontrolled rate of growth and they easily pro-
liferate and spread to other surrounded and distant tissues, due to their sustained
angiogenesis and elevated resistance against growth inhibitors [1, 2]. Accord-
ing with cancer statistics around 1 million of new cancer cases, per year, will be
recorded in United States in 2020, of which germline mutations contributed with
a low percentage for these cancer statistics [3].
A centuries ago, Hippocrates, "Father of Modern Medicine", said "Everyone
has a doctor in him or her; we just have to help it in its work. Our food should be
our medicine". Vegetables and fruits are rich in polyphenols. Polyphenols boosts
the immune system, modulate the activity of enzymes and cell receptors and they
are strong antioxidants that scavenge the reactive oxygen species (ROS), reducing
in this way the risk of chronic diseases (cardiovascular, stroke, cancer, diabetes,
obesity and arthritis) [4, 5].
Nutrition, stress and toxins are factors that govern epigenomes lifetime. In
simplified terms, according to Rigges, epigenetics is a phenomenon that refers to
mitotically and/or meiotically heritable changes in gene expression that does not
involve DNA sequence [6].
Typical hallmarks of cancer cells are their irregularities at level of DNA methy-
lation status, expression pattern of a gene, regulation of miRNA expression ac-
companied by variations in histone organization. In view of all this, epigenomes
can work as biomarkers to detect cancer cells, since "healthy"and cancer cells have,
for example, unequal DNA methylation status. From a clinical point of view, new
therapeutic approaches have been explored based on epigenetics machinery, con-
sidering the efficacy of epigenetic players to control the cell, organ and tissue
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function, by turning genes on ("expressed") and off ("silenced") at specific time
and locations. In cancer thematic, several studies discussed in detail in the next
section, proved that epigenetic regulation of gene expression by histone modifi-
cations or by DNA methylation triggers environmental and intrinsic signals that
suppresses tumorigenesis.
Recently, nutraceuticals compounds (catechins, curcumin, genistein, resver-
atrol, anthocyanins) have been assessed as modulators to reverse the adverse
epigenetic marks in cancer cells in order to sensitize cancer cells to drugs or to
blockage cancer progression and metastasis. In addition, considering the fact that
epigenetic defects are more easily reverse than genetic changes, researchers have
also been focused on the development of epi-drugs based on bioactive dietary
components as epigallocatechin-3-gallate (EGCG) to be used in therapy against
cancer, reviewed in the coming section.
In this review, we focused on the largest family of polyphenolic compounds
(flavonoids class), reviewing the large number of published articles with recent
findings and research in the field, in order to discuss in detail how the failure in
the proper regulation of epigenetic mechanisms promotes carcinogenesis and how
this health problem can be ameliorate by regular intake of flavonoids. We also
discuss the clinical potential of phytochemical based-epigenetic pharmacology as
an efficient strategy for cancer treatment.
2.2 Polyphenolic Molecules
A polyphenolic molecule has several phenolic rings in its structure. Each polyphe-
nol is grouped in a subclasse according with the number of phenol rings, the
structural elements that connects the various rings to each other and the type
of functional group linked to rings. The main subclasses of polyphenols are
flavonoids and non-flavonoids (stilbenes, polyphenolic acids and lignans).
Flavonoid structure has two aromatic rings (A and B) linked by an oxygen con-
taining heterocycle (C). Flavonoids can be grouped in subclasses considering the
number of hydroxyl groups attached to phenol rings as well the glycosylation and
alkylation patterns. Some of the best-known flavonoids subclasses, illustrated
in Figure 2.1, include flavonols (quercetin, kaempferol), flavones (apigenin, lu-
teolin), flavan-3-ol (catechins), flavanones (naringenin), isoflavonoids (genistein)
and anthocyanins. For instance, flavonols (quercetin) are distinguished from fla-
vanols (catechins) by their binding mode between C2 and C3 and by the linkage
of a specific group on C4 position. Flavanols establish a single bond between C2
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and C3 and have a methylene resonance on C4 position, in contrast with flavonols
which form a double bond and has a carbonyl group attached.
The efficacy of a flavonoid to interact with cell membranes is strongly influ-
enced by the structural aspects of flavonoid backbone as the degree of hydroxy-
lation, the binding mode between C2 and C3 or, simply, the linkage of a specific
group on Cx position [7, 8, 9, 10, 11]. For instance, catechins, or flavanol-3-ols,
are antioxidant molecules present in great amount in tea leaves, that regulate
some intracellular signalling pathways showing significant anticancer effects in
a time and concentration dependent-manner. A typical bag of green tea con-
tains the following catechins: (-)-epicatechin (EC), (-)-epigallocatechin (EGC), de-
fined as flavanol monomers, (-)-epicatechin 3-gallate (ECG), (-)-epigallocatechin
3-gallate (EGCG), which are known as flavanol gallates. This division into fla-
vanol monomers and flavanol gallates considers the presence/absence of the gal-
late group into position 3 of C ring and the presence of different side groups into
position 3 and 5’of C and B rings, respectively. Several studies reported that the
cellular uptake of gallate catechins (ECG/EGCG) is higher than EC/EGC. In fact,
the presence of the ester bond connecting gallic acid and C3 renders a non-polar
cis-type EGCG with a higher topological surface area that binds to the surface
of a lipid bilayer through hydrogen-bonding, without change structural confor-
mation. However, several studies highlights the fact that the precise molecular
mechanisms underlying the action mode of catechin remain puzzling, like in
other studies that involved other flavonoids [12, 13].
2.3 Interactions of Flavonoids within cellular
environment
2.3.1 Flavonoids and DNA bases
Studies of the interaction between polyphenols and biological molecules (DNA,
proteins, lipids, enzymes) are crucial to understand the processes that occur in
cells in the presence of polyphenol molecules. However, the number of papers
focused on the analyses of the interactions DNA bases - polyphenol molecules
is reduced, even known that the outcomes from this type of experiments are
significant, bringing clear and important conclusions for this thematic. Some
interesting simple results are described below.
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Figure 2.1: Chemical structures of the main subclasses of flavonoids.
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Recently, Ensafi et al developed a new electrochemical biosensor to demon-
strate the effect of Acridine Orange (AO) on DNA damage and to check the in-
hibitor effect of flavonols antioxidants as myricetin, fisetin and kaempferol on
DNA damage [14]. In fact, AO presents high affinity to nucleic acid and stretch the
double helical structure of DNA, contributing for the reductions of the intensities
of guanine and adenine oxidation signals after the interaction of AO molecules
with DNA. In presence of the myricetin, fisetin and kaempferol molecules the
DNA damage was reduced being the anti-damaging effects of kaempferol and
fisetin better than of myricetin. Theoretical calculations demonstrated that best
conformers of flavonol molecules are docked in binding sites of DNA molecule
[14]. Already previously, a study of the interaction of DNA with the textile
dyes Disperse Orange 1 (DO1) and Disperse Red 1(DR1) have shown signifi-
cant changes in the characteristic oxidation peaks of the guanine and adenine
moieties of immobilized dsDNA while when flavonoids as myricetin and api-
genin are added the oxidation peaks are reduced, allowing to conclude that these
flavonoids were able to protect adenine and guanine from interaction with those
dyes [15]. The interaction of DNA and the flavonoid–transition metal complex
(Cu(II)–naringin complex) was demonstrated using square wave voltammetry
(SWV) electrochemical method which demonstrates changes in the oxidation peak
of the guanine and adenine bases in presence of naringin complex, while the vari-
ations of the spectroscopic characteristics of DNA and Cu(II)–naringin complex
in aqueous medium demonstrated that the predominant interaction mode may
be by intercalation being the guanine site the most adequate for the interaction
[16]. Recently, Bhattacharjee et al. used double stranded (duplex) DNA and
guanine-rich sequences, which have the propensity to fold into a four stranded
DNA structure known as a G-quadruplex (G4), to study the interactions of two
polyphenols (fisetin and naringenin) with DNA. Experimental and theoretical
results demonstrate the differential binding ability of the two flavonoids with G4
and duplex DNA. Naringenin have shown stronger binding affinity to duplex
rather than G4 DNA, while fisetin had shown the opposite behavior. The C-ring
planarity of the flavonoid structure appears to be a crucial factor for preferential
DNA recognition of flavonoids [17].
2.3.2 Flavonoids and DNA damage
Carcinogenesis is a complex and multistep process which is categorized in the
following stages: initiation, promotion and progression [18]. The extensive DNA
damage caused by the exposure to cytotoxic or genotoxic agents (ionizing and
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ultraviolet radiation, environmental agents, therapeutic agents and ROS) attacks
the nitrogen bases and sugar-phosphate backbone of DNA, causing single and
double-stranded DNA breaks [19, 20, 21, 22, 23]. These exogenous and endoge-
nous lesions disrupt and/or impair the DNA replication and transcription, af-
fecting the genetic stability critical for cell function. Genome instability together
with defective DNA repair mechanisms and high frequency of mutations, leads to
cellular transformation, decrease cellular defenses and triggers aberrant inflam-
matory signalling associated with initiation and progression of cancer [24, 25,
26].
Two different strategies are underlying the use of flavonoids in cancer therapy:
the first one is see the flavonoids as killers of cancer cells and, the second one, is
see the flavonoids as biological soldiers that fight progression and metastasis of
cancer cells. Scientific reports demonstrated that flavonoids induce apoptosis in
cancer cells in order to destroy them [27, 28] and protect "healthy"cells against
radiation-induced DNA damage working as scavengers of ROS and enhancers of
DNA repair genes. Under suitable physiological conditions, cellular organelles
produces ROS to mediate phagocytosis, apoptosis and cell signalling to maintain
cell homeostasis. Oppositely, under pathological conditions, serious defects in
scavenging system leads to a high accumulation of ROS, a situation which in-
creases the oxidation rate of biomolecules and worsens inflammation and cancer.
Physiologically, apoptosis is a cellular process extremely sensible to death stim-
ulus as DNA damage, UV radiation, oxidative stress, chemotherapeutic agents
and oncogenic stress. Apoptosis is a normal, well regulated and essential process
of cellular suicide coordinated by caspases to maintain the tissue homeostasis,
surveillance and host defense mechanisms. Apoptosis can be intrinsic and extrin-
sically induced by mitochondrial and death receptor-mediated pathways, respec-
tively. Death receptors are plasma membrane receptors which suffer oligomeriza-
tion upon binding of a specific ligand, resulting in the recruitment of specialized
adaptor proteins and in the activation of caspase cascades to trigger cell suicide
[29, 30, 31, 32, 33]. Failure in proper apoptosis mechanism, coming from epi-
genetic events as downregulation of caspase expression, specific inhibition of
caspase activity either by cysteine nitrosylation or by overexpression of caspase
inhibitors (survinin), promotes tumorigenesis.
Flavonoids induces apoptosis in cancer cells via inhibiting fatty acid synthase
(FASN) activity, increasing DNA fragmentation, regulating the caspase-3 and
p53 transcript expression or by increasing intracellular ROS level. In many
different types of human cancer cells, apigenin showed anti-proliferative and
anti-invasiveness properties by targeting the PI3K/Akt signaling pathway along
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with downregulation of gene expression of matrix metalloproteinases-9, glyco-
gen synthase kinase-3 β and HEF1 [34, 35]. Butin protects lung fibroblast cells
against hydrogen peroxide-induced apoptosis by reducing DNA fragmentation
and caspase-3 activity. Moreover, this molecule reduces intracellular ROS level
by restoring the antioxidant enzymes level, named SOD and catalase [36].
Inflammation is another natural biological response of the host surveillance
mechanisms against harmful stimuli. Several studies points out an association
between the persistence of an inflammatory process and a higher tendency to
develop cancer [2, 37]. Nuclear factor kappa B (NFkB) is one among the many
intracellular signalling pathways which comes into operation as soon as inflam-
matory and immune responses occurs, controlling the expression of various genes
involved, for example, in the interruption of apoptotic biochemical cascades as
well in the steps of initiation and progression of carcinogenesis. The conversion
of a latent form to a biologically active form of NFkB is triggered by the release of
pro-inflammatory cytokines (TNF-α, IL-6, IL-8, IL-1b and IL-1a) from immune or
adjacent stromal cells. The activation of epidermal growth factor (EGF) receptor,
the production of cyclooxygenase 2 (COX-2), the IkB phosphorylation, the eleva-
tion of intracellular calcium levels and the oxidative stress, are also activators of
NFkB [38, 39, 40, 41, 42]. Defects in NFkB signalling pathway up-regulates the
expression of anti-apoptotic genes and down-regulates apoptotic genes, keeping
the cell proliferation rate and guaranteeing resilience against apoptosis. More-
over, the permanent activation of NFkB conferes resistance to tumor cells to the
action of chemotherapeutic agents via inactivation of caspases.
Considering all this, researchers have been studying different classes of drugs
(immunomodulatory drugs, nonsteroidal anti-inflammatory drugs and newly de-
veloped selective IKK inhibitors) to control NFkB activation, since this signalling
pathway is an attractive target for anti-cancer therapy [43, 44, 45, 46, 47, 48].
A detailed study of reports on the anti-inflammatory and apoptotic responses
of different subclass of flavonoids against death stimulus, covering publication
searches between 2010 and 2017, is presented in Table2.1.
The modulation of a particular signalling pathway by a flavonoid is strongly
dose dependent. High concentrations of quercetin (100 µM) inactivates NFkB
activity in intestinal epithelial cells and human hepatoma cells [49, 50], whereas
a concentration of 40 µM increased the translocation of NFkB to the nucleus
of HT29 and HCT15 human colonic cancer cell lines [51]. In addition, another
interesting point reported in this study is the fact that quercetin only induced
apoptosis in HT29 cells via partial inactivation of COX-2, increasing the inter-
cellular ROS level and caused cell cycle arrest at G1 check point. HCT15 cells
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proved to be insensible to quercetin-induced apoptosis since these cells did not
expressed cox-2 RNA transcript, maintaining unaltered the antioxidant status
and a lower intracellular ROS level.
2.4 Flavonoids and epigenetic environment
2.4.1 Flavonoids action in DNA methylation
Epigenetic modifications as DNA methylation associated with histone modifica-
tions alters the chromatin architecture controlling in this way the functioning of
genome and the signalling pathways that control the cell cycle and apoptosis.
DNA methylation is the most studied epigenetic modification since DNA is
stable comparative to proteins and mRNA. DNA methyltransferases (DNMT1,
DNMT3a and DNMT3b) are the enzymes responsible to chemically bind a methyl
group in DNA sequence, specifically, in the region in which a cytosine and
guanine nucleotides are separated by only one phosphate (CpG site), using S-
adenosyl-methionine (SAM) as a substrate [52]. CpG islands has a great amount
of GC (' 55%), in the majority of cases, in unmethylated state. DNA methylation
pathway is maintained by DNMT3a and DNMT3b during development and by
DNMT1 during cell division (mitosis) [53]. Even so, this process can be disturbed
by single nucleotide mutations resulting from, for example, the coupling of 5-
methylcytosine deaminase as well the failure of the thymine DNA glycosylase to
correct them [54].
According with Cheng et al.[55], DNMT has a catalytic core structure simi-
lar to the catechol-O-methyltransferase (COMT), belonging both enzymes to the
same family: SAM-dependent methyltransferases. COMT is an enzyme present in
mammalian tissues (liver, kidney, small intestine) that catalyzes O-methylation of
catechol-structure molecules (catecholamines, catechins, flavonoids). Catechins
and their metabolites are substrates for the COMT-mediated methylation, yielding
significant amounts of the demethylated SAM (S-adenosyl-L-homocysteine, SAH),
a potent noncompetitive inhibitor of DNMTs [56, 57, 58, 59]. COMT methylates
the D-ring of EGCG in vitro and in vivo forming 4-MeEGCG and 4’-4-DiMeEGCG,
which compromises EGCG bioavailability in bloodstream and, consequently, its
therapeutic action [60, 61, 62]. Having in mind, that the presence of gallate
group (D-ring) in EGCG plays an inhibitory effect on COMT-activity, is expect
that EGCG also inhibit DNMT by binding to certain catalytic site [55, 63].
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Table 2.1: Protective mechanisms of flavonoids against death stimulus.
Bioactive Compound Cell Line Death Stimulus Biological Action
Apigenin
HaCaT skin keratinocytes UVB radiation
DNA protection via:
[64]
↑ NER genes expression
↓ CPDs
↓ ROS generation
↓ NFkB and MAPK
T-24 human bladder cancer cells Tumorigenesis
Inhibition cancer cell proliferation via:
[65]
Induction of cell cycle arrest:
↑ p53 phosphorylation
↓ Cyclin A, Cyclin B1, Cyclin E, CDK2, Cdc2, and Cdc25C
Induction of Apoptosis:
↑ cytochrome c release
↑ proapoptotic proteins level ( Bax, Bad, and Bak)
↑ cysteine proteases (caspase-3, -7, and -9)
↑ ROS
Butin V79-4 lung fibroblast cells H2O2
Decrease oxidative damage via:
[66]
↓ H2O2-induced 8-OHdG level
↑ OGG1 mRNA and protein levels
↑ Phosphorylation of Akt
Cyanidin SH-SY5Y neuroblastoma cell Aggregated Aβ
Protection against neuronal injury via:
[67]
↓ ROS
↓ SOD and GSH-Px expression
↓ intracellular [Ca2+]
↓ HO-1, NQO1, and Bcl-2 protein level
EGCG
C57 BL/6 male mice Gamma Radiation
DNA repair via:
[68]
↓ HDAC activity
↑ Chromatin opening
HaCaT human epidermal keratinocyte cells X-rays radiation
Radioresistance to HaCaT via:
[69]
↓ intracellular ROS
↑ anti-apoptotic protein Bcl-2
↓ pro-apoptotic protein Bax
↓ y-H2AX foci number
↓ DSBs
↑ SOD2 and HO-1 expression
Genistein
NHDF and KEL dermal fibroblast cells [70] UV radiation Photoprotection of cell by decreasing concentration of free radicals
Pheochromocytoma (PC12) cells Aggregated amyloid beta Aβ
Cell survival via:
[71]
↓ Cytochrome c and Smac release
↓ caspase-3 activity
↓ phosphorylation of JNK
Albino Sprague-Dawley rats AlCl3
Protection against neuronal injury via:
[72]
↑ GSH and SOD
↓ AChE activity
↓ TNF-α, NF-κβ subunit P65 and COX-2 expression
↑ ER-β mRNA expression
Quercetin
CF1 mice [73] Azoxymethane Decrease precancerous lesions
Rat primary hippocampal neurons
Aggregated Aβ
Protection against neuronal injury via:
[74]
H2O2
↓ ROS
Restoring of the mitochondrial morphology and potential
↓ superoxide anion
Kidney and bladder tissues of Sprague-Dawley rats X-rays radiation
Attenuation of irradiation-induced oxidative damage via:
[75]
↓ TNF- α levels
↓ 8-OH dG levels
↓ caspase-3
↓MPO
↓ ROM-mediated recruitment of neutrophils
↓ pro-inflammatory mediators release
↓ radiation-induced tissue destruction
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According with Zhu et al., EGCG is much stronger inhibitor of DNMT1 com-
pared to other catechins (epicatechin and catechin), forming complexes EGCG-
DNMT1 trough a reaction energetically more favorable in the presence of mag-
nesium ions. Computer modelling showed that D-ring of EGCG (gallate group)
is able to form hydrogen bonds with Glu1265 residue at the catalytic core site of
DNMT1 [76]. Natural products working as inhibitors of DNMTs, in particular
DNMT1, guarantees the re-expression of silenced-genes in daughter cells since
the hypermethylation status was reversed. The therapeutic potential of EGCG in
early studies was assessed in cancer cells. It was shown that treatment of colon
cancer cells with EGCG downregulates the expression of DNMT3b by inhibition
of E3 ubiquitin ligase (UHFR1) which plays a critical role in cancer progression
by gene silencing and DNMTs recruitment [77, 78]. The reduction in DNMT
expression induced by EGCG inhibited promoter methylation of retinoid X recep-
tor alpha ( RXR α), disrupting cancer cell proliferation and promoting cell cycle
arrest in CIMP+ colon cancer cells and in colon tumors of Apc Min/+ mice [79].
In fact, changes in DNA methylation pattern status trigger different biological
actions. For example, hypermethylation causes the inactivation of tumor sup-
pressor genes (p16INK4a, APC, and BRCA1) involved in different cancer type
[80, 81, 82], while hypomethylation disturbs chromosomal stability, increases
the mutations events resulting in cancer development and progression [83, 84].
The accumulation of epigenetic changes in multiple genes and in underlying
intracellular signalling pathways (apoptosis, inflammation), alters the cellular
metabolism, as for example, the acceleration of glucose metabolism in cancer cells.
The DNA methylation pattern is strongly influenced by oxidative stress. The over-
production of ROS overloads the intracellular detoxification system, damaging
the biomolecules (DNA, cell membranes) and affecting the transduction pathways,
promoting apoptosis, inflammation, necrosis and other diseases [85].
The binding of the Nuclear factor-erythroid-2-related factor 2 (Nrf2) to the
cytosolic protein Kelch-like ECH-associated protein 1 (Keap 1) is the major in-
tracellular mechanism against oxidative stress. The dissociation of Nrf2-Keap1
complex, promoted by the oxidation or covalent modifications on the thiols of
the cysteine residues of Keap1, leads to Nrf2 translocation to cell nucleus, where
activates antioxidant and phase II detoxifying enzyme genes. A deficient gene
and protein expression of Nfr2, often coming from the hypermethylation of the
first five CpG residues in Nfr2 promoter, being one of the classical hallmarks of
prostate carcinogenesis [86]. An impairment in Nrf2-Keap1 pathway compro-
mises cellular defence mechanisms against oxidative and electrophilic stress due
15
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to the deregulation of expression of many cytoprotective genes that encodes detox-
ifying proteins such as superoxide dismutase (SOD), glutathione S-transferase
(GST), glutathione peroxidase, catalase, among others , leading to an inevitable
tumor development and chemoresistance [87, 88, 89, 90].
The action of the flavonoids lie in their antioxidant and scavenger power to-
gether with their ability to target some transcription factors (NFkB, estrogen re-
ceptor (ER), hypoxia inducible factor-1 (HIF-1)) involved in the regulation of anti-
inflammatory and antitumor processes [91, 92, 93]. There is a substantial body of
evidence that bioactive drugs, reviewed in Table 2.2a, influence the status of epige-
netic machinery namely, microRNA expression, DNA methylation and chromatin
dynamics in gene and cell line specific, in an exposure time-dependent manner.
In malignant melanocytes, EGCG prevented metastasis and cancer growth, af-
ter directly binds to Gln54, Ile72, Cys73, Gly55, Asp57 and Lys96 residues in
substrate-binding pocket of TRAF6, and after suppress the TRAF6 E3 ubiquitin
ligase activity. Consequently, the IL-1 β -induced activation of the NF-κB pathway
was attenuated [94]. Some of the intermediary signalling pathways targeted by
EGCG responsible for modulating the anti-tumour activities are Wnt/β-Catenin,
MAPK, AKT/STAT3 and p53 [95, 96, 97, 98].
In most of cases, the physiological concentrations used in in vitro experi-
ments might be very difficult to obtain in vivo, considering the complex metabolic
processes as well physical and biochemical barriers (gastrointestinal epitelium,
stomach pH, liver first-pass metabolism, immune system mediated-clearance)
that contributes to a poor absorption and a suboptimal drug delivery. However,
some studies have demonstrated that lower concentrations of apigenin, easily
achieved through dietary sources (∼ 1.5µM), are strong enough to exerts anti-
inflammatory effects in different cell type via modulation of NF-κB activity by
different mechanisms [99]. Apigenin suppresses NF-κB activity through blockage
of pro-inflammatory cytokines and growth factors expression (IL-6, IL-8) and by
controlling the p38MAPK phosphorylation level. Apigenin may compete with
adenosine triphosphate (ATP) for binding to p38MAPK, considering the strong
degree of similarity between the aglycone structure (ABC ring) of apigenin and
the structure of the molecule ATP. The interference of apigenin in ATP binding
and cleavage, prevents the activation of p38MAPK, acting as negative regulator
of invasion and migration of tumor cells [100, 101, 102].
16
2.4. FLAVONOIDS AND EPIGENETIC ENVIRONMENT
2.4.2 Flavonoids action in histone tail modifications
Histones are positively charged small proteins that governs DNA packing allow-
ing the storage of approximately of 2 meters of DNA inside of the microscopic
space of the human diploid cell nucleus. As a curiosity, "human body has 50 tril-
lion cells corresponding to 100 trillion meters of DNA, meaning that each human
has enough DNA to go from earth to the Sun and back more than 300 times"( Sun
is 150 billion meters from Earth) [103].
Histones octamer (two copies of each H2A, H2B, H3, and H4) binds to DNA
via electrostatic interactions (DNA is a negative-charged molecule due to the
presence of phosphate groups), forming DNA-histone complexes called nucleo-
somes. Nucleosome, building block of chromatin, is connected to other nucleo-
some via linker DNA. H1 histones bind to a single nucleosome and to the linker
DNA, exerting a chromatin-condensing action. During cell division, chromatin
fibers fold upon themselves forming higher order chromosome structures[104,
105, 106, 107]. Figure 2.2 illustrates several intracellular reversible processes
as acetylation, phosphorylation, ubiquitylation, glycosylation and sumoylation
that can happens on aminoacid residues of histone tails (that are facing out-
side of nucleosome), which influences chromatin architecture and, consequently,
gene expression. Chromatin in condensed state (Heterochromatin) hampers the
binding of transcription factors and thereby occurs gene silencing. Of course,
specific enzymes are crucial and work during these processes, being their in-
tracellular concentration dependent of nutrients, energy level (ATP/ADP) and
cellular metabolism (glycolysis, mitochondrial respiration rate, ROS/RNS pro-
duction)[108, 109].
Acetylation phenomenon, catalyzed by enzymes of histone acetyltransferases
(HATs), decreases the electrostatic interactions DNA-histones and loosens chro-
matin structure, which facilitates the binding of transcription factors and pro-
motes gene expression.
Histone deacetylases (HDACs) catalyses histone deacetylation. HDACs (HDAC1,
HDAC2, HDAC3) expression levels and activity are epigenetic shutters that re-
press genes and activate signalling pathways (Keap1/Nfr2, NFkB, HO-1, PGC-1
α, HIF-1 α ) involved in the regulation of cellular responses to oxidative stress.
Impairments in N-terminal tails of histones alters gene expression and compro-
mise the functioning of signalling pathways mentioned before, resulting in many
human pathologies which could be inherited in the next generations. Carcinogen-
esis can emerge from the imbalance between HATs and HDACs activity. Cancer
cells have an uncontrolled cell division since cells miss cell cycle checkpoints(G1,
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Figure 2.2: Gene activation status determined by DNA methylation and his-
tone modifications. Histone tails contains residues that are susceptible to trans-
lational covalent modifications as ubiquitylation, isomerization, phosphorylation,
sumoylation, methylation and acetylation. When CpG sites are methylated, a
process catalyzed by DNMT, occurs histone modifications which trigger the acti-
vation or repression of gene depending upon which residue is modified and the
degree of methylation. The recruitment of DNMT turns chromatin more con-
densed, preventing the access of transcription factors to DNA and, consequently,
gene expression.
S, G2, M) due to repression of genes involved in inhibition of cyclins and cyclin-
dependent kinases p21 or in induction of apoptosis (BAX). HDACs inhibitors
(vorinostat, romidepsin, belinostat and panobinostat) are a new class of FDA-
approved anticancer drugs which supress the overexpression of the HDAC en-
zymes and reactivates the expression of p21 in malignant tumors, controlling cell
proliferation rate and blocking angiogenesis and inflammation. Unfortunately,
the dampening of angiogenesis and inflammation decrease drug delivery and
therapeutic response in solid tumors, which compromises the use of HDACs in-
hibitors in cancer clinic. In view of all this, researchers studied the potential of
several nutraceuticals for modifying histones by themselves or by synergism with
HDACs inhibitors, as a suitable way of combating cancer. In a recent study, the
ability of 131 different natural products to regulate HDACs activity was assess,
resulting in eighteen new bioactive compounds working as HDAC inhibitors, able
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to increased the lysine acetylation in rat cardiac cells, showing potential to be
used for treatment of heart failure. [110, 111].
Apigenin prevented the uncontrolled growth rate of breast cancer cells via
suppression of cyclins (cyclin A, cyclin B, and CDK1) and through the induction
of H3 acetylation which, consequently, leads to the activation of p21 promoter. As
a consequence, p21 binds to PCNA (proliferating cell nuclear antigen) inhibiting
the progression of the cells into M phase of the cell cycle [112].In another study,
apigenin inhibited prostate cancer cells progression through the regulation of the
MAPK and PI3K/Akt signaling pathways, inducing G0/G1 cell cycle arrest [113].
Yoon and co-workers showed that different catechins (EGCG, EGC and EC)
induced cell death and prevent growth of androgen-sensitive (LNCaP) human
prostate cancer cell line, in a concentration- dependent manner. Androgen re-
ceptor (AR) is an essential hormone nuclear receptor for normal prostate devel-
opment. Mutations and post-transcriptional modifications (acetylation and phos-
phorylation) on AR receptor have been related with acceleration of prostate cancer
progression. EGCG decreased HAT activity (p300) and, thus the acetylation level
of AR and histone H3, delaying in this way the prostate cancer progression [114].
Modification of histone acetylation by EGCG was also observed in human cervi-
cal cancer cells. EGCG decreased enzymatic activity of DNMT3b and HDAC1 in
HeLa cells in a time-dependent manner. Docking studies suggested that gallate
moiety of EGCG interacts with binding pocket of DNMT3b, in particular, with
residues Arg 832, Arg 731, Arg 733 and Asn 652 [115]. Synergistic effects of
a combination of EGCG and trichostatin A (HDACs inhibitor) in ERα negative
MDA-MB-231 breast cancer cells was reported. Researchers found that EGCG
reactivated ERα expression through alterations in histone acetylation and methy-
lation status [116]. In lung cancer cells, the protein level of HDAC4, -5, and -6
were decreased, due to the synergism coming from the combination of EGCG with
retinoids (Am80). Furthermore, the combination EGCG+Am80 also promoted
acetylation of lysine 382 in p53 (a non-histone protein), enhancing the p21 gene
expression and thus the apoptosis in cancer cells [117].
Medical conditions as hyperglycemia (HG) is a risk factor to develop cancer,
besides additional problems as cardiovascular disease, kidney failure and blind-
ness. The deacethylation of NFkB-p65 at lysine 310 and histone 3 (H3) at lysine
9 position resulting from the sirtuin-1 (SIRT-1) activation induced by resveratrol,
decreased the cardiac oxidative stress and normalized the mRNA expression of
genes (TNF-α, IL-6, COX-2, Bax, NOX1 and NOX4), which are overexpressed in
a diabetic heart [118]. In another study, the combination treatment with fisetin
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and luteolin induced the SIRT-1 activation, increase the FOXO3a expression, de-
creased the activity of histone acetyltransferase, promoted the deacetylation of the
p65 subunit of NF-κB and modulated the release of proinflammatory molecules
in human monocytes under HG conditions, showing their potential to be used as
a therapeutic agent for the treatment of diabetes [119].
2.4.3 Flavonoids action in miRNAs expression
A bulk of literature has suggested that a abnormal expression of MicroRNAs (miR-
NAs) is one of the hallmarks of cancer, leading to a overproduction of oncogenes
and inhibition of tumor suppressor genes [120]. miRNAs are shorter non-conding
sequences of RNAs, which binds to Argonaute protein family leading to mRNA
cleavage and posttranscriptional gene silencing. The analysis of miRNA signa-
tures is a specific and sensitive tool that improves the capability for an early
detection of cancer, based on the differences in miRNA expression in cancer
and cancer-free patients. Recently, effort had been made to improve diagnos-
tic method, through non-invasive procedure as the quantification of the miRNA
expression (miR-10b, miR-1 and miR-30a) in bronchoalveolar lavage, sputum and
plasma of lung cancer patients instead of tissue/biopsy samples [121].
An interesting fact abound miRNAs is that they can work as epigenetics mod-
ulators, but themselves can be regulated through epigenetic modifications. DNA
methylation status and histone modifications are key regulators of miRNAs ex-
pression since a substantial portion of miRNAs are present near of CpG islands.
For instance, in the epithelial tissue of patients with colorectal cancer, the miR-
NAs (hsa-miR-9, hsa-miR-124, hsa-miR-129, hsa-miR-137, hsa-miR-149) are down-
regulated. All of these miRNAS are localized on CpG island, being the DNA
hypermethylation and histone acetylation the phenomenons responsible for the
decrease of miRNAs expression [122].
Flavonoids induce changes in miRNA profile, illustrated in Table 2.3a, as hap-
pens in DNA and histones to trigger anti-cancer effect. In vitro study shown
that the exposure of oral cancer cells to a 5 µM of luteolin for 6 hours, was an
efficient treatment to decreased the rate of angiogenesis and cell proliferation.
Furthermore, a significant decreased in histone acetylation ((H3K9 and H3K14)
and significant global changes in miRNAs expression was observed. Luteolin
decreased the expression of oncogenes (miR-135a) and increased the expression
of tumor suppresor genes (miR-195/215, let7c) [123]. Another in vitro study
revealed that luteolin suppressed survival, proliferation and migration of MDA-
MB-231 breast cancer cells by triggering an decrease in Notch-1 signalling by
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regulating mRNAs expression. Luteolin increased the expression of miR-34a,
miR-139-5p, miR-246,miR-181a, miR-224 and decrease miR-155 in order to in-
hibit Notch pathway. Suppressing effect of luteolin in Notch signalling caused
downregulation of growth factors (VEGF) and metalloproteinases (MMP-2, MMP-
9), which are involved in angiogenesis that sustains cancer survival and migration
[124]. In addition, luteolin also activate ERK and p38 signalling pathways to pro-
mote the nuclear translocation of mitochondrial protein (AIF) to induce breast
cancer cell death [125].
Zarghami et al. encapsulated chrysin, a flavone found in bee pollen, in PLGA-
PEG nanoparticles to improve its bioavailability and efficacy to prevent prolifer-
ation of gastric cancer cell line, through regulation of miRNAs expression. The
dysregulation of miRNA-9 is a fingertip identified in many different types of
cancers, including breast, colon, gastric, lung and neck. The nanoencapsulation
form of chrysin increased the expression of miR-9, Let7-a, miR-22, miR-34a and
miR-126 on human gastric cancer cells compared to free chrysin. The restoration
of tumor suppressor genes (miR-22, miR-34a and miR-126) expression reduced
gastric tumor growth through induction of apoptosis [126, 127].
2.5 Flavonoids: agents for epigenetics
pharmacotherapy
As aformentioned, drug’s journey to cancer site is hampered by physical (vascular
architecture, porosity, natural filtration systems) or chemical constraints (pH,
temperature, oxygen, enzymes and immune systems attack), that decrease drug
concentration in bloodstream (bioavailabilty) and that impair its interaction with
cell membrane as well as its deliver to target specific tissues.
Epigenetic drugs approved by Food and Drug Administration (FDA) modu-
late the DNA methylation and histone acetylation status, acting as inhibitors of
DNMTs (azacitidine and decitabine) and of HDACs (vorinostat, romidespin, tri-
chostatin and belinostat), respectively [128]. However, clinical trials alerts to
toxicity, low efficacy in solid tumors and side-effects associated to several epige-
netic drugs.
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Table 2.2a: Modulation of epigenome by bioactive compounds.
Bioactive
Cancer type Cell Line Epigenetic modifications Cellular Consequences
Compound
Apigenin Breast MDA-MB-231
↓ Cyclin A, cyclin B, and cyclin-dependent kinase-1 (CDK1) expression Inhibition of cell proliferation
[112]
↑ Acetylation of histone H3 in the p21WAF1/CIP1 promoter region G2/M phase cell cycle arrest
Apigenin Breast HCA
↓ IL-1A-stimulated IL-6 secretion
[102]
↓ IP10/CXCL10 ↓ Cell proliferation rate
(10µM) ↓ NF-κB activity Supress SASP to stimulate breast cancer cell proliferation
↓ IRAK1/IRAK4/p38MAPK phosphorylation
EGCG Esophageal
ECa109 cells
↑ p16 gene demethylation G1 phase cell cycle arrest
[63, 129, 130]
↑ p16 mRNA expression Inhibition of proliferation
(50-200mg/L) ↑ protein expression and malignant transformation
Induction of apoptosis
KYSE510
Inhibition of O-6-methylguanine- DNA methyltransferase (MGMT)
Reactivation of methylation-silenced genes ↑ Protein expression
( p16INK4a, RARβ, MGMT, and hMLH1)
(50 µmol/L Reactivation RARβ mRNA ↑ Tumor cell apotosis
for 6d) Inhibition of promoter cytosine (CpG islands) hypermethylation
↑ Alteration of acetylation status of nonhistone proteins (p53 and α-tubulin)
EGCG + AM80 Lung PC-9 ↓ HDAC4, -5 and -6 protein expression through posttranscriptional regulation ↑ Apoptosis
(synthetic retinoid) [117] ↑ GADD153, DR5 and p21waf1 gene expression
EGCG (20 µM) +
Breast ERα-(-) MDA-MB-231
Partial reactivation of ERα re-expression
Inhibition of cancer cell proliferation
SFN from broccoli
[131]
Reduction gene expression of HDAC1 at mRNA level
Re-sensitization of cancer cells to hormonal therapy
sprouts (10 µM) Decrease enzymatic activities of HDACs and DNMTs
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Table 2.2b: Modulation of epigenome by bioactive compounds (continued).
Bioactive
Cancer type Cell Line Epigenetic modifications Cellular Consequences
Compound
↑ Nfr2 mRNA
↑ HO-1 mRNA
FN1 Prostate TRAMP-C1 ↑ NQO1, UGTA1 protein expression Inhibition of cancer growth
(Curcumin Analog) [132] ↓ Keap1 expression ↓ Colony formation
(50-250 nM) ↓ DNMT1, DNMT3a, DNMT3b
↓ HDAC4
Genistein
Prostate
Prostate Specimens Demethylation of ADCY4 promoter ↓ Cell proliferation
[133]
(30 mg capsules Expression of NOTCH3 and JAG1 mRNAs ↓ Cell survival
daily for 3-6 weeks) Promotion of PTEN activity and inhibition of MYC activity
LNCaP, LAPC-4 and PC-3
Reversion of ER-β promotor hypermethylation
(0.5-10 µmol/L)
Induction of phosphorylation, nuclear translocation ↑ Apoptosis
and transcriptional activity ER-β
Lung NSCLC A549
Reversion of Keap1 promoter hypermethylation ↑ Radiosensitivity
[134]
Inhibition of NQO1 protein expression ↑ ROS Level
Inhibition of Nrf2 translocation to the nucleus ↑ Radiation-induced apoptosis
Inhibition of synthesis of GSH
Quercetin Colon
↑ Caspase 3
(10µM) [51]
↑ Cytosolic cytochrome c Apoptosis of HCT15 and HT29 colon cancer cell
HCT15 ↓ pAkt, pGSK-3β and cyclin D1 expression Chromatin cleavage
HT29 ↑ COX-2 Breakdown of chromosomal DNA
↑ TNF-α miRNA Increase of intracellular ROS level
↓ GSH
Resveratrol —- H9C2
Deacetylates NFkB-p65 at Lys 310 and histone 3 (H3) at Lys 9
↓ Cardiac oxidative stress
[118]
↓mRNA expression TNF-α, IL-6, COX-2, Bax, NOX1 and NOX4
↓ NADPH oxidase expression
↑ SIRT-1 activity
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A recent study showed that the combination of EGCG and sulforaphane (SFN),
present in broccoli sprouts, is a green natural strategy that epigenetically mod-
ulates the activation of tumor-related gene expression in a similar way to syn-
thetic epigenetic drugs, but without toxicity signs. In this particular study, EGCG
(amount corresponding to half a cup of green tea) acts on DNA methylation and
SFN on histone acethylation status. The combination EGCG + SFN is strong
enough to reactivate the expression of ER α in MDA-MB-231 breast cancer cells,
re-sensitizing them to hormonal therapy both in vitro as in vivo [131].
Another major problem of the available chemotherapeutic anticancer drugs
is their poor selectivity to cancer cells, being toxic to surrounded "healthy"cells.
Genistein, a natural isoflavone present in soybeans, promotes radiation-induced
apoptosis in non-small cell lung cancer (NSCLC A549 cells) but exerts radiopro-
tective effect on normal lung fibroblast (MRC-5 cells), confirming its selectivity.
In fact, genistein act as epigenetic modulator, inducing the demethylation of
Keap1 promoter which blocked the Nrf2 translocation to nucleus of NSCLC A549
cells, compromising the gene expression involved in Nrf2-dependent antioxidant
system. NSCLC A549 cells have an impaired Nrf2-dependent antioxidant sys-
tem, suffering apoptosis induced by ROS coming from the exposure to X-rays. In
"healthy"cells, genistein did not alters gene promoter region status, maintaining
functional and active the production of antioxidant enzymes (GSH) needed to
protect cells against oxidative stress-induced by X rays [134].
2.6 Conclusion
A healthy balanced diet is the best weapon to fight cancer and other chronic
diseases. The daily consumption of natural compounds, coming from various
sources available on earth, offers health-benefits coming from their anti-oxidant,
anti-inflammatory and anti-cancer properties. The main advantages of flavonoids
is that they can be used over longer periods of time since they have very low toxi-
city. Flavonoids are promising therapeutic drugs for fighting multistage diseases
as cancer, since they regulate the expression of tumor suppressor genes (upreg-
ulation) and of oncogenes (downregulation). These nutraceuticals also have the
ability to modulate some intracellular pathways, namely, the pathways involved
in the activation of apoptosis and cell cycle arrest, thus preventing cancer cell
survival and migration.
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Table 2.3a: Targeting miRNAs by flavonoids.
Bioactive
Cancer type Up-regulated miRNA transcript Down-regulated miRNA transcript Biological Action
Compound
Chrysin
Gastric Cancer
miR-9,Let-7a,miR-34a,miR-22,miR-126 miR-18a, miR-21 and miR-221 Induction of apoptosis
[127, 135, 136]
EGCG
Hepatocellular cancer
miR-467bn,miR-487b,miR-197,miR-805,miR-374n,
Induction of apoptosis
[137]
let-7 f, miR-350,miR-24-1n,miR-137,miR-335-3p,miR-222,
miR-26b,miR-30c-1n,miR-98,miR-30c,miR-30bn,miR-32,
miR-674n,miR-532-5p,let-7g,miR-192,miR-302d,miR-30b,
miR-802,let-7e,miR-322,miR-720,miR-146b,miR-340-3p,
miR-185,miR-425,miR-10a,miR-126-5p,miR-101a,miR-30en,
miR-141,miR-33,miR-29an,miR-199b,miR-450a-5p,miR-21,
miR-23a,miR-101b,miR-148a,miR-193,miR-23b,miR-107,
miR-140,miR-551b,miR-466c-5p,miR-106a,miR-590-3p,
Let-7a, Let-7b, Let-7c, Let-7d, miR-875-3p,miR-224,miR-292-5p,miR-678,miR-469,miR-463n,
miR-16, miR18, miR-20a, miR-32,miR-674n,miR-532-5p,let-7g,miR-192,miR-302d,
miR25, miR-92, miR93, miR-30b,miR-802,let-7e,miR-322,miR-720,miR-146b,miR-340-3p,
miR221, miR-320, miR377 miR-185,miR-425,miR-10a,miR-126-5p,miR-101a,miR-30en,
miR-141,miR-33,miR-29an,miR-199b,miR-450a-5p,miR-21,miR-23a,
miR-101b,miR-148a,miR-193,miR-23b,miR-107,miR-140,miR-551b,
miR-466c-5p,miR-106a,miR-590-3p,miR-875-3p,miR-224,miR-292-5p,
miR-678,miR-469„miR-463n,miR-574-3p,miR-201,miR-290-3p,
miR-181a,miR-302a,miR-429,miR-133a,miR-190b,miR-710,miR-135b,
miR-296-5p,miR-191n,miR-188-5p,miR-298,miR-181a-1n,miR-466 g,
miR-26bn,miR-466 f-3p,miR-29bn,miR-1224,miR-291b-5p,miR-324-5p,
miR-486,miR-128,miR-450b-3p,miR-135an,miR-294,miR-671-5p,
miR-878-3p,miR-801,miR-370,miR-1,miR-494,miR-133b
Colorectal cancer
miR -34a, miR-145, miR-200c Inhibition of self-renewal
[138]
Neuroblastoma
miR-7-1, miR-34a, miR-99a miR-92, miR-93, miR-106b Inhibition of self-renewal
[139, 140]
Lung cancer
miR-210, mmu-miR-2137, mmu-miR-449a, mmu-miR-144, mmu-miR-696, mmu-miR-449c-5p,mmu-miR-7a-5p, mmu-miR-205-5p
Inhibition cell proliferation
[141, 142, 143]
mmu-miR-486, mmu-miR-3107, mmu-miR-5130, mmu-miR-2861 mmu-miR-450a-2-3p, mmu-miR-1199-3p, mmu-miR-374c-5p
Chemotherapy sensitivity
mmu-miR-763, mmu-miR-3473a, hsa-miR-98-5p mmu-miR-218-5p , mmu-let-7b-3p
Breast cancer
miR-16 Inhibition cell proliferation
[144]
Nasopharyngeal cancer
hsa-miR-454,hsa-miR-1202, hsa-miR-1207-5p hsa-miR-205-3p
[145]
hsa-miR-1225-5p, hsa-miR-1246,hsa-miR-1915, hsa-miR-1973
hsa-miR-210, hsa-miR-2861,hsa-miR-29b-1-5p, hsa-miR-3162 Induction of apoptosis
hsa-miR-3196, hsa-miR-34a,hsa-miR-3656, hsa-miR-3665,hsa-miR-4281 hsa-miR-205-3p Inhibition of cell proliferation
hsa-miR-1268, hsa-miR-1290 hsa-miR-186, hsa-miR-193b hsa-miR-21, Inhibition of angiogenesis
hsa-miR-219-5p hsa-miR-22, hsa-miR-22-5p hsa-miR-29a,hsa-miR-365
hsa-miR-4299, hsa-miR-494, hsa-miR-572,hsa-miR-574-5p, hsa-miR-7
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Table 2.3b: Targeting miRNAs by flavonoids (continued).
Bioactive
Cancer type Up-regulated miRNA transcript Down-regulated miRNA transcript Biological Action
Compound
Curcumin
Lymphoma
miR-22, miR-15a, miR-16
↓ Bcl-2 expression
[146, 147] Inhibition tumor progression
Pancreatic Cancer
miR-200, miR-22 miR-21, miR-199 Inhibition tumor progression
[148, 149]
Prostate Cancer
miR-205 miR-21, miR-141, miR-183
↑ Proteins expression
[150, 151] Inhibition tumor progression
Genistein
Breast Cancer
miR-23b miR-155
Induction of apoptosis
[152, 153] Inhibition cell survival
Inhibition cell proliferation
Luteolin Head and neck
hsa-miR-1308, hsa-miR-98, hsa-miR-193b, hsa-miR-122,hsa-miR-576-5p,hsa-miR-609,hsa-miR-147b,
Inhibition of cell proliferation
[123]
hsa-miR-26b,hsa-miR-31,hsa-miR-378,hsa-miR-221, hsa-miR-634,hsa-miR-1284,hsa-miR-15b,hsa-miR-191,
Inhibition of angiogenesishsa-let-7c,hsa-miR-222,hsa-miR-195,hsa-miR-658, hsa-miR-517a,hsa-miR-664,hsa-miR-522,
hsa-miR-484,hsa-miR-223,hsa-miR-484,hsa-miR-144 hsa-miR-933,hsa-miR-377,hsa-let7b
Morin Prostate Cancer miR-155, miR-143, miR-146b
Induction of apoptosis
[154]
Chemosensitivity
Decrease tumor size
GATA3 expression
Proanthocyanidin
Glioblastoma
miR-30e
↑ Induction of apoptosis
[155]
Resveratrol
Pancreatic cancer
miR-663 miR-21, miR-155, miR-27a
↑ Induction of apoptosis
[156, 157]
↓ Cell proliferation
Prostate cancer
miR-328, miR-149, miR-639 miR-17, miR-21, miR-7 ↓Metastasis
[158, 159, 160, 161]
miR-939, miR-572, miR-150 miR-197, miR-129, Let-7c, miR-659 ↑ Tumor suppressor genes
↓ Oncogenes
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A wide array of evidence suggest that flavonoids are epigenetic modulators,
which alter the DNMT and HDACs enzymes activity, turning on or off specific
genes-involved in carcinogenesis, in a concentration and time dependent manner.
Besides their multitargeting capacity, flavonoids also minimizes the side-effects
of radiotherapy and chemotherapy. In addition, flavonoids boosts the effective-
ness of chemotherapy by increasing the chemotherapeutic sensitivity of cancer
cells. Despite these promising findings, a huge obstacle to be solved before im-
plementation of flavonoids in clinic is the improvement of stability, routes of
administration, organ specificity and efficiency delivery to target cancer cells. Of
course, a plenty of different drug delivery approaches as lipossomes, hydrogels,
nanoparticles,cyclodextrins, have already be designed and tested in recent years,
proving be suitable vehicles that improve flavonoid’s stability, half-life and that
facilitate its accumulation at the site of action. Furthermore, another concern in
the field of cancer epigenetics, is the maintenance of the epigenetic changes over
time. Any flavonoid or synthetic drug should maintain epigenetic modifications
in order to preserve cellular identity, cellular processes and to permanently delete
the abnormal cancer epigenome.
Clearly, new combinatorial pharmacological formulations based on the syn-
ergism of natural compounds and hormonal drugs capable of modulating the
epigenome, paves the way to cancer prevention and treatment. Future studies
focus on to better elucidate the molecular mechanisms underlying flavonoids ac-
tion in vitro and in vivo using proper animal models for each cancer can provided
valuable information to design successful strategies to treat solid tumors.
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Post-scriptum: Currently, the protective effect of different EGCG concentra-
tions on calf thymus DNA against UV radiation is being addressed in our labora-
tory, for understanding the binding mechanism and the pharmacological behavior
of EGCG responsible to enhance the susceptibility or resistance of DNA against
oxidative stress, respectively. Afterwards, the idea is to assess the implications
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of the same EGCG concentrations on certain epigenetic targets (non-coding RNA
and DNA-associated proteins). Nonetheless, considering the fact that the thera-
peutic potential of this epigenetic-based strategy will be strongly dependent of
the in vivo EGCG concentration, this thesis work mostly focused on developing
liposome-encapsulated EGCG formulations that will stabilize and protect EGCG
from degradation and therefore, will guarantee an adequate and effective deliver
of EGCG in specific locations such as the cell nucleus.
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EGCG–delivery nanoplatforms to
maximize skin protection against
harmful radiation
Use of catechins in nanotech platforms to control the oxidative
stress in cancer cells 1
Abstract
Oxidative stress arises from an imbalance between oxidative species and an-
tioxidant repair system response, leading to abnormalities in the cellular metabolism
(DNA mutations and cancer). Following this reasoning, medical approaches pro-
viding large doses of dietary antioxidants should decrease the oxidative stress,
and therefore the occurrence of diseases. So, in last decades, the research in
flavonoids area increased owing to their anti–inflammatory and antioxidant prop-
erties. One of the most studied flavonoid subclass are the catechins found in
fruits, chocolate, wine and tea. The potential of catechins for cancer therapy has
been long recognised, but their low therapeutic effectiveness remains an issue.
It appears that catechin action is compromised by their vulnerability to extreme
environmental conditions (pH and temperature changes along gastrointestinal
tract), that hinders their transport and uptake by intracellular targets. Recently,
several nanotechnology–based delivery systems, such as liposomes, have been
1This chapter is based on the publication in preparation for submission:
Pires, F., Oliveira Jr, O. N. and Raposo, M. Use of catechins in nanotech platforms to control the
oxidative stress in cancer cells.
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used to improve catechin’s in vivo stability and pharmacokinetics. Although li-
posome carrying EGCG enhance bioavailability and showed higher antioxidant
efficacy, their use in cosmetics industry can be compromised by their challenging
issues in penetrate skin deeply.
3.1 Introduction
Cell plasma membrane is a complex and semipermeable barrier that surrounds
and shields cell cytoplasm from external cytotoxic insults. This matrix is pri-
marily composed by phospholipids arranged in a double-layered structure (phos-
pholipid bilayer) with the hydrophilic headgroups pointing towards the aque-
ous environment and the hydrophobic tails oriented towards each other.[1] Also,
plasma membrane contains lipid – anchored proteins, glycolipids and cholesterol
that, together with phospholipids, regulate energy storage, cell signalling and as
molecular transport (such as ions, water, drugs, sugars, amino acids) across the
membrane, thus maintaining the integrity and the proper functioning of cell.
Hundreds of different lipids such as glycerophospholipids, sphingolipids and
sterols (such as cholesterol) are present in all eukaryotic cell membranes. For ex-
ample, erythrocytes cells anchor zwitterionic phospholipids as dipalmitoylphos-
phatidylcholine (DPPC) in the outer membrane leaflet and, anionic phospholipids
as dipalmitoylphosphatidylserine (DPPS) in the inner membrane leaflet. [2] Addi-
tionally, DPPC, DPPS and anionic dipalmitoylphosphatidylglycerol (DPPG) phos-
pholipids are present in great amounts in the mammalian lung surfactant which,
together with proteins surfactant, confer resistance to respiratory pathogens and
avoids respiratory infections.[3, 4] Besides saturated phospholipids, cell mem-
branes also possess polyunsaturated lipids (lipids containing double bonds), which
are extremely vulnerable to oxidative damage ( discussed in further detail in the
next section).
At physiological conditions, each organelle membrane of cell has a unique
lipid distribution pattern that regulates membrane structure and mediates the
drug trafficking across the membrane.[5, 6] The problem is that, sometimes, some
pathological changes occur in cells due to certain perturbations in membrane
lipid composition and organization, derived from the sensitivity of the plasma
membrane to environmental factors. For instance, an abrupt change in the phys-
iological level of ROS, which are routinely produced during cellular processes
(cellular respiration and fatty acid β–oxidation), has important implications for
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cell membrane integrity, fluidity, among others.[7, 8] Indeed, several studies re-
ported that the imbalance between ROS production and elimination by antioxi-
dant defence system, phenomenon known as oxidative stress, culminates in an
overproduction of ROS that severely destabilize the lipid bilayer packing, breaks
DNA chain, cause cellular dehydration and, depending on the severity of damage,
culminate in cell death.[9, 10, 11] Apart from ROS generation by normal cellu-
lar metabolism, an exposure to heat, ionizing radiation and as to inflammatory
and chemical toxins (cytokines and transient metals) have also been linked to the
excessive increase in intracellular ROS levels (Figure 3.1).
Considering that one goal of this doctoral thesis is evaluate the antioxidant
effect of catechin on phopholipids against radiation damage, the ROS-mediated
lipid peroxidation phenomenon is discuss in more detail in the next section.
Figure 3.1: Exogenous and endogenous sources of ROS formation involved in cell
damage.
3.2 Radiation-induced lipid peroxidation
In biological systems, radiation track can induce damage either by directly hitting
the cell organelles or indirectly, through the generation of free radicals upon radi-
olysis of water. Since human cells are primarily composed of water (∼ 70%), the
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majority of cellular damage is due to the indirect action of radiation. When water
molecules absorbed radiation they can be excited or become ionized, producing
a significant number of free radicals (hydroxyl (OH•), hydrogen (H•) radicals,
among others), molecular species (hydrogen peroxide) and secondary electrons
(Figure 3.2).
Figure 3.2: By-products of water radiolysis due to ionizing radiation. Image
adapted from [12].
Most of the secondary electrons are stabilized and solvated trough dipolar in-
teractions with water molecules, however, part of them can react with H+ forming
H• radical. Free radicals are highly reactive species, because they carry unpaired
electrons, that easily diffuse across cellular membranes and unspecifically attack
biomolecules to attain stability. Moreover, these radicals can interact with molecu-
lar oxygen yielding ROS radicals such as peroxyl and superoxide (O•−2 ), which are
far stronger oxidizing agents and thus, more troubling in biological system.[13,
14]
One of the major targets of hydroxyl and hydroperoxyl radicals is the lipid
bilayer, where these species promote a cascade of oxidant events known as lipid
peroxidation. Lipid peroxidation is a complex and repetitive process that rear-
ranges the double bonds of unsaturated lipids, due to the hydrogen abstraction
from a carbon that generates a carbon-centered lipid radical (initiation step). Dur-
ing propagation step, the carbon-centered lipid radical reacts with molecular
oxygen yielding lipid peroxyl radicals that attack neighboring polyunsaturated
fatty acids and thus, give rise to new lipid radicals. A radical chain reaction ends
up after an antioxidant molecule (like vitamin E) donate a hydrogen atom to the
lipid peroxy radicals making that nonradical products, such as lipid hydroperox-
ides, are generated (termination step).[15, 16]
In addition to the lipid hydroperoxides, many secondary products such as
aldehyde derivatives (malonyldialdehyde (MDA) and 4-hydroxinonenal (HNE))
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are also formed via a cyclisation reaction during lipid peroxidation, which are also
species extremely toxic to cellular organelles since they inhibit protein synthesis
and enzyme activity [17, 18, 19, 20].
Besides the lipid peroxidation phenomena, the ROS species also decrease the
saturation/unsaturation degree of the phospholipid acyl chains, cleavage the lipid
headgroups, disrupt the lipid bilayer packing and change the mechanical proper-
ties of membranes by often converting a fluid-like membrane into rigid ones. [21,
22, 23, 24, 25].
Again, it is worth mentioning that, a sufficient amount of ROS in cells is re-
quired to activate some signalling pathways involved in normal cellular processes
such as cell growth, differentiation, immune response, among others.[26, 27]
Of course, the presence of an exacerbated amount of ROS in cell, is the driv-
ing force for upregulating the production of endogenous antioxidant molecules
(glutathione peroxidase, superoxide dismutase, catalase) to reduce oxidative in-
jury.[28, 29] Unfortunately, in some pathological conditions, the antioxidant de-
fence system fails in counteracting the ROS toxicity, which compromises the
survival of cell.
3.3 Antioxidant action of catechins
Over the past few decades, the synergistic action between dietary antioxidants and
endogenous antioxidants has been explored as a promising strategy to decrease
the human susceptibility to common ROS-mediated diseases such as neurodegen-
erative diseases and cancer.
As previously discussed in Chapter 2, a green tea bag contains a huge amount
of different catechins, represented in Figure 3.3, that are believed to display in
vitro and in vivo antioxidant and anticarcinogenic activities (for a review see [30]
and references therein). As seen in Figure 3.3, each catechin subclass have distinct
composition and number of functional side groups attached onto backbone that
strongly influence the partitioning of catechin’s into lipidic membrane and their
chemical reactivity underlying the antioxidant activity.[31, 32, 33]
According to Quideau and co-workers[35], the catechins use two essential
mechanisms for free radical scavenging: the hydrogen atom transfer (HAT) and
the single electron transfer (SET), represented by equations 3.1 and 3.2, respec-
tively. Focus on lipid radicals formed during lipid peroxidation, the hydroxyl
groups of catechins (CatOH) dissociate and donate a hydrogen atom to lipid radi-
cal (R•), yielding species more stable and harmless such as lipid hydroperoxide
51
CHAPTER 3. EGCG–DELIVERY NANOPLATFORMS TO MAXIMIZE SKIN
PROTECTION AGAINST HARMFUL RADIATION
Figure 3.3: Structure of the different catechins present in green tea. Image
adapted from [34].
(RH) and phenoxy radical (CatO•). Typically, the phenoxy radical is non-reactive,
since the excited electron is delocalized and shared between aromatic rings, that
provides stabilization. Clearly, the antioxidant efficiency of each type of catechin
involving the HAT mechanism, is correlated with the bond dissociation enthalpy
(BDE) of the phenolic O–H bond, meaning that catechins with lower BDE values
are easily deprotonated and thus much more effective in radical scavenging.[36,
37]
R• +CatOH → RH +CatO• (3.1)
R• +CatOH → R− +CatOH•+ (3.2)
With regard to SET mechanism, the ionization potential of each catechin is
particularly important, since the mechanism involves an electron transfer re-
action from the CatOH to the lipid radical, generating a stable radical cation
CatOH•+ that is deprotonated after reacting with water. So, the reactive func-
tional groups of catechins with lower ionization potential transfer an electron
much more rapidly.[38]
In addition to these two radical scavenging mechanisms, catechins also reduce
oxidative stress in an indirect way by upregulating the expression of the antioxi-
dant enzymes (catalase, superoxide dismutase, glutathione peroxidase) via Nrf2
signalling pathway [39, 40, 41, 42], restoring appropriate vitamins C, E levels
[43, 44] and blocking prooxidant enzymes (xanthine oxidase, lipoxygenase and
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cyclooxygenase).[45, 46] Moreover, catechins have been found to chelate metal
ions such as copper and iron, which frequently react with hydroperoxides to form
the harmful hydroxyl radical via a Fenton-type reaction.[47, 48] In line with these
findings, is expected that medical approaches relying on a large dose of dietary
antioxidants should decrease the oxidative stress and therefore, the occurrence of
diseases. However, there is an ’antioxidant paradox’ since, unlike it was thought,
a high dose of antioxidant are ineffective and brings deleterious effects. Despite
the presence of phenolic hydroxyl groups increases the antioxidant/scavenging
activity of catechins, it is also known that the oxidation of the catechol group on
B-ring of catechins produces catechins by-products (quinones derivatives) that
are toxic and cause adverse effects on biomolecules.[49, 50, 51] So, it is crucial
address the mechanisms involved in catechin’s autoxidation that reduce their in
vivo stability. It is worth mentioning, though, that, some researchers have studied
the prooxidant behavior of these ROS species arising from the autoxidation of
catechins as a potential mechanism to attack the cellular DNA of cancer cells. [52,
53, 54] Nonetheless, in this doctoral thesis one intends to take advantage of the
antioxidant activity of the most abundant catechin in green tea (epigallocatechin-
3-gallate (EGCG)), instead of its prooxidant activity.
3.4 In vivo bioavailability of catechins
The use of catechins for pharmaceutical applications is mostly constrained due to
the vulnerability and instability of these molecules to environmental factors (tem-
perature, pH, radiation) that, consequently, influence the amount of unaltered
catechins that reaches the systemic circulation to be distributed to target organs
(bioavalability).[55, 56, 57, 58]
The in vivo bioavailability of catechins is relatively low because the pheno-
lic hydroxyl groups are commonly oxidized and hydrolyzed by mouth, liver and
small intestine esterases. For instance, the uridine diphosphate glucuronosyl-
transferase (UGTA-1), catechol-O-methyltransferase (COMT) and phenol sulfo-
transferase (SULTA1) are hepatic estereases that glucorinate, methylate and sul-
fonate the hydroxyl groups of catechins, respectively.[59] Consequently, the loss
of hydroxyl groups automatically impairs the HAT and SET mechanisms and
thus, compromises the scavenging activity of catechins. Also, this extensive bio-
transformation and the alkaline milieu of the duodenum (pH ∼ 8.5) increase the
susceptibility of catechin to auto-oxidation and contribute to their poor absorp-
tion in the small intestine. [60, 61, 62, 63].
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Therefore, new strategies are warranted for increasing in vivo bioavailability
of catechins to further enhance their therapeutic action in target organs.
3.5 Liposomal-based EGCG delivery systems
Nanoencapsulation technology based on different formulations ( solid nanopar-
ticles, hydrogels, liposomes, among others) efficiently protect catechins from ex-
treme and hazardous environmental conditions, greatly improve their stability
and absorption and, successfully deliver them in specific cellular targets (for a
review see [64] and references therein).
Here, one intends to focus mainly on the technological advances in the devel-
opment of liposomal formulations to encapsulate EGCG.
Liposomes are sphere-shaped vesicles consisting in monolamellar or mul-
tilamellar phospholipids bilayers surrounding an aqueous nucleus, that spon-
taneously formed in aqueous solutions, known to efficiently entrap lipophilic
molecules in the lipid bilayer and the hydrophilic ones into the aqueous nucleus.
[65, 66] Since organization and distribution of phospholipids in liposomes is quite
like the lipid fraction of natural cell membranes, these systems have been used
as artificial models to evaluate, for instance, how a particular drug protects the
membrane structure and dynamics against free radicals.[67, 68] Liposomes have
been also used as nanocarriers in the pharmaceutical industry, since they offer ad-
vantages in terms of biocompatibility, biodegradability, payloading capacity and
stability of entrapped drug. [69, 70, 71, 72] Also, it is possible to fine-tune the
surface properties of liposomes to avoid their rapid clearance by the the mononu-
clear phagocyte system or reticuloendothelial system (RES) and increase their
circulation time in the bloodstream, simply by coating the outer layer of liposome
with hydrophilic polyethylene glycol (PEG) that shield them from destabilization
(stealth liposomes).[73, 74]
Passive targeting and active targeting are the two mechanisms that mediate
the in vivo liposome’s accumulation in tumour site. In passive targeting, the
drug-loaded nanocarrier accumulates in the tumour by the enhanced permeabil-
ity and retention (EPR) effect, a phenomenon that does not occurs in healthy cells.
EPR effect is reached when the liposomes survive to mononuclear phagocyte sys-
tem and RES systems uptake, allowing their extravasation into tumour due to
high permeability of blood vessels and poor lymphatic drainage.[75] In active
targeting, the surface of liposomes is functionalized with a specific ligand that
recognises and bind to a molecular receptor overexpressed only by cancer cells
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(immunoliposomes) and thus, guarantee a site-specific accumulation of drug.[76,
77] Liposomes can be made by various methods, including film-hydration method
(methodology used in this thesis and further discussed in Chapter 4), detergent
depletion[78, 79], reverse-phase evaporation[80, 81], freeze-dried rehydration
vesicles[82], high pressure homogenization[83, 84], supercritical fluidic technol-
ogy[85, 86], among others. Regarding the vesicle size and number of lamellae,
the resulting liposomes can be divided in: i) smaller unilamellar vesicles, SUVs (
diameter 20–100 nm); ii) large unilamellar vesicles, LUVs (100–1000 nm in diam-
eter) and multilamellar vesicles, MLVs (multiple number of membrane bilayers
with diameter above 1 µm).[87] Some factors such as lipid composition, tempera-
ture, and pH strongly influence vesicle’s characteristics (such as permeability and
stability). Regarding the effect of temperature, each phospholipid has a charac-
teristic phase transition temperature (Tm) that if raised, changes the flexibility
of the hydrocarbon tails, meaning that the well-ordered and packed hydrocarbon
tails of phospholipids (solid-gel phase) acquire a disordered conformation (liquid
phase). Therefore, temperature is a key factor that strongly regulates the fluidity
and permeability of liposomes.[88, 89] Several studies reported that the addition
of cholesterol to liposomal formulation reduces the membrane permeability and
avoids the premature release of entrapped drug.[90, 91, 92]
Liposome encapsulation solve the four major issues that affect the therapeutic
efficacy of EGCG, which are the low water solubility, pH–dependent stability,
poor bioavailability and inability to cross cell membrane. Fang et al. studied the
encapsulation of EGCG in egg phosphatidylcholine:cholesterol:deoxycholic acid
(4:1:0.25 wt%) liposomes and assessed its efficacy against basal cell carcinomas
(BCCs). These liposomes efficiently entrapped EGCG (∼ 99%) and, following
injection in BCCs tumor region, they locally increased EGCG amount (by 20-fold
compared to the free form) that was capable of inducing cell death.[93] Zou et
al. demonstrated that tea polyphenol nanoliposomes improve the stability of the
phenolic compounds in alkaline media and exhibit a sustained release rather than
a burst release (typical of tea polyphenol solution), with minor compromise in
the antioxidant and antibacterial activity.[94]
Cancer strategies based on synergistic effect of EGCG and anticancer drugs
(such as 5-fluorouracil[95, 96], doxorubicin [97, 98], cisplatin [99, 100]) have
gained increasing importance since the antioxidants ameliorates the toxicity and
side-effects associated with anticancer drugs treatment and may also contribute
to attenuation of carcinogenesis. Recently, Sugiyama et al. evaluated the anti-
cancer activity of doxorubicin–loaded EGCG derivative-PEG-modified liposomes
in B16F10 mouse melanoma cells. In this study, an monoamine-modified EGCG
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Figure 3.4: Physicochemical parameters that regulate drug permeation across
skin. Image adapted from [103].
was synthesized for binding to 67-kDa laminin receptors overexpressed in cancer
cells. These liposomes enhance the EGCG accumulation in tumor region, that in
combination with doxorubicin, act synergistically to kill tumor cells by enhancing
the activation of apoptotic activators such as caspase-8.[101]
In the last decades, several different liposomal formations have been designed
to use in cosmetic preparations, especially in formulations that delays the skin
aging and accelerates skin wound repair, however, as we can seen in the following
section, drug permeation through skin is a major challenge in transdermal drug
delivery.
3.6 Challenges in Dermal/Transdermal EGCG
Delivery
The skin is an organ composed by three layers (epidermis, dermis, and subcu-
taneous tissue) that protects body from the external environment (mechanical
injury, UV radiation, microorganisms), maintain water and electrolyte balance
and regulates blood pressure and body temperature.[102] Typically, a drug can
be topically (act on the surface of skin), dermally (drug act on dermal layer) or
transdermally (drug cross dermal layer and enters in bloodstream) administered
in skin, depending on lesion location and severity.
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The Stratum Corneum (SC) is the outermost layer of the epidermis made of ker-
atin, proteolytic enzymes and corneocytes embedded in a lipid matrix (ceramides,
fatty acids, cholesterol), which is recognized as the major barrier that hinders the
penetration of drug through the skin.[104, 105] A drug needs to have appropriate
physicochemical features ( such as a determined size, charge, shape) to overcome
SC layer and achieve deep skin layers (Figure 3.4).[103] Some studies have shown
that conventional liposomes efficiently deliver drugs in the upper layer of SC but
hardly penetrates into deeper skin layers. However, attempts have been made
to manipulate the depth of liposome penetration by adding, for instance, edge
activators (sodium deoxycholate, Tween 80) in liposomal composition, to render
liposomes more flexible and elastic.[106, 107, 108]
Avadhani et al. co-encapsulated hyaluronic acid and EGCG into soy phos-
phatidylcholine:sodium cholate liposomes by using by high-pressure homoge-
nization technique. The liposomes incubated with human skin keratinocytes
HaCaT cells and exposed to 60 J/m2 of UV radiation, exhibited a high free radical-
scavenging action since they lowered the production of by-products of lipid per-
oxidation (such as malondialdehyde) and decreased the activity of the matrix met-
alloproteinase in cells. Furthermore, the liposomes guaranteed a higher enhance-
ment of skin permeation and deposition of EGCG (38.90 ± 1.16 µg/cm2) com-
pared to that observed with EGCG aqueous solution (3.94 ± 0.18 µg/cm2).[109]
In another study, the authors added Tween 20, a edge-activator, in EGCG-loaded
liposome formulation to deliver EGCG in deep skin layers of HaCat cells. One
important finding of this study was that as Tween 20 amount increases in lipo-
somal formulation, the elasticity of vesicles increases but, the vesicle size and
EGCG encapsulation efficiency decrease. Nonetheless, intact liposomes were able
to cross the stratum corneaum, following an osmotic transepidermal gradient,
and promoted an EGCG sustained release in epidermal keratinocytes and dermal
fibroblasts within 2 hours. [110]
Following the line of reasoning of this chapter, a liposomal carrier becomes a
viable approach to improving EGCG stability and assuring a more efficient release
in skin cells, that help protect them from oxidative stress induced by UV radiation.
Hence, to demonstrate that, the developed EGCG-encapsulated liposomes will be
immobilized in nanofibers and their potential to accelerate in vivo wound healing
process will be determined in human fibroblasts cells following UVC exposure.
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Experimental Concepts &
Methodology
In this chapter the general concepts in Langmuir monolayers and liposomes struc-
tures are introduced, in particular, methods of preparation, applied molecular
simulations and spectroscopic techniques used to characterize them. It is worth
mentioning that the detailed description of procedures (details such as concen-
tration, lipid composition, temperature, irradiation time, among others) only was
done in each subsection of the Results section to avoid unnecessary repetition of
information.
4.1 Langmuir Monolayer studies
4.1.1 Surface Pressure - Area Isotherms
The Langmuir monolayers, experimental models used in this work for mimicking
half of a lipid bilayer membrane, are produced in an apparatus similar to that in
Figure 4.1. Briefly, an appropriate concentration of the phospholipid molecules
were dissolved in an appropriate organic solvent (chloroform, methanol) and
spread, drop by drop using a microsyringe, on the water/buffer subphase be-
tween the barriers. The phospholipids are amphiphilic molecules which have the
hydrophilic head (such as choline, carboxylic acid) immersed in the aqueous sub-
phase and the hydrophobic fatty acid chains oriented into the air. Immediately
after evaporation of the solvent, the two lateral symmetric barriers start to move,
bringing the molecules closer to each other, and initiating the compression of the
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monolayer. During monolayer compression, the variations in the surface pressure
as a function of the area per molecule (Am) on the subphase, at a given temper-
ature, were monitored by the Wilhelmy plate method.[1] The Am is calculated
using the equation 4.1:
Am =
ALT ×M
c ×NA ×V (4.1)
where the ALT is the Langmuir trough area, M is the molecular mass, c is the
concentration, NA is the Avogrado number and V is the solution’s volume spread.
Figure 4.1: The Langmuir monolayers at the air-water interface were formed in a
KSV NIMA Langmuir trough.
In these experiments, the Wilhelmy plate consists in a filter paper (10 × 20
mm) attached to a microbalance that was positioned perpendicular and partially
immersed in water subphase to measure the surface pressure. The forces acting
on the filter paper are the gravity and surface tension in a downward direction,
and the buoyancy due to displaced water in an upward direction, that can be
converted into surface tension (mN/m).
The net force downwards (F) in a rectangular plate ( length (L) × width (w) ×
thickness (th), with a specific material density (ρW ) immersed to depth of h in an
aqueous subphase ( density (ρL)) is obtained using the equation 4.2:
F = ρW glwt + 2γ(th +w)cos(θ)− ρLgthwh (4.2)
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where γ is the surface tension of the liquid, g the acceleration of gravity and
θ is the contact angle of the liquid on the solid plate (θ = 0 if plate completely
wetted). So, the surface pressure (pi) is defined as the difference between the
surface tension of water (γ0 = 73 mN/m at 20 ◦ C) and the surface tension upon
lipid monolayer formation at the interface (γ) as shown by equation 4.3:
Π = γ0 −γ = ∆F2(t +w) =
∆F
2w
(4.3)
if the thickness is small compared to the width of the plate (t w).
This technique was used to explore the dynamical structural changes in lipid
membrane that takes places upon mechanical compression and that arise after the
addition of EGCG to the system (for further details about EGCG concentration
used in each lipid monolayer studied, please see Results section). Commonly at
high surface areas, the surface pressure remain unchanged since the monolayer is
in a ’gaseous’ state (G), meaning that the molecules have a long distance between
them and thus they do not interact with each other. Upon compression, the sur-
face pressure increases and the monolayer transits to a ‘liquid-expanded’ state
(LE), where the molecules are closer with their hydrocarbon chains aligned in a
more vertical position, although they still have a great number of gauche defects.
As shown in Figure 4.2, on further compression, firstly a plateau in the isotherm
corresponding to the LE and C coexistence appears and, subsequently, the sur-
face pressure abruptly increases, indicating that the molecular interactions are
maximized forming a closely packed monolayer with the lipid fatty acyl chains
perfectly ordered at the water subphase (condensed state, LC). Moreover, at a
certain threshold, the monolayer cannot be compressed further without become
unstable and collapse, as this may form three-dimensional structures (such as
aggregates), cause crack growth within monolayer and lost of material to the sub-
phase.[2] The minimum area per molecule (A0) at which the monolayer can be
compressed without collapsing, is estimated by extrapolating the LC region of
the isotherm to zero surface pressure on the molecular area axis ( blue dashed
line in Figure 4.2).
Furthermore, a qualitative estimation of the elastic properties of monolayer
(surface compressional modulus, Cs−1) can be obtained from the surface pres-
sure—area isotherms by using Mohwald’ equation[3] (4.4):
C−1s = −Am
(
∂pi
∂Am
)
T
(4.4)
Indeed, the stability, phase behavior and fluidity of a phospholipid monolayer
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Figure 4.2: Surface pressure - area isotherm of DPPC monolayer and schematic
gaseous (G), liquid-expanded (LE) and condensed (LC) phase behavior of the
monolayer during compression.
can changes by the incorporation of a particular molecule. The stability and mis-
cibility of these multicomponent monolayers are analyzed in terms of additivity
rule and the excess Gibbs free energy of mixing (∆G).[4] In theory, the area of a
complete miscible or immiscible multicomponent monolayer is calculated based
on the additive rule (equation 4.5):
Aid = A1X1 +A2X2 (4.5)
where A1 and A2 are the molecular area of each individual component of the
monolayer and the X1 andX2 the mole fraction of each component. Mostly, the ex-
perimental molecular area for a mixed system (A12) deviates from the ideal area,
due to the type of interactions established between the components in the mono-
layer. So, this deviation or excess area per molecule (Aex) can be calculated doing
the difference between the experimental determined and the ideal molecular area
as showed in equation 4.6. Also, if the deviation is positive indicates repulsive
interactions between the two components in the mixed monolayer, whereas a
negative deviation shows attractive interactions.
Aex = A12 −Aid (4.6)
The ∆G for a mixed monolayer at a constant surface pressure is obtained from
the following equation 4.7:
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∆G =Na
∫ pi
0
Aexcdpi (4.7)
where NA is the Avogadro number and pi is the surface pressure. A negative
and positive value of ∆G for the mixed monolayer means that the monolayer
system is stable and unstable, respectively.
In the scope of thesis work, the surface-pressure area isotherms were used to
monitor the adsorption and kinetic movement of EGCG at the air/water interface.
4.1.2 Surface Potential–Area Isotherms
The mechanism of interaction between EGCG and lipid monolayer was also de-
termined by measuring the alterations in the monolayer surface potential. The
monolayer surface potential (∆V) is calculated by subtracting the potential of the
monolayer covered subphase to that for the aqueous subphase (equation 4.8).
In the thesis work, the Kelvin vibrating capacitor technique was used to mea-
sure the potential difference (∆V) between the vibrating plate (placed roughly 1-2
mm above the monolayer) and the reference electrode immersed into the water
subphase.
∆Vmonolayer = ∆Vmonolayer+subphase −∆Vsubphase (4.8)
A Langmuir monolayer at the air–water interface seems to obey the Helmholtz
plate capacitor model (equation 4.9) that shows that is directly proportional to the
intrinsic dipole moment of the molecule (µn) normal to the plane of the monolayer
but, is inversely proportional to the Am, vacuum permittivity (ε0) and dielectric
constant of the membrane interface (ε).
∆V =
µn
Aε0ε
(4.9)
Further improvements in this model resulted when Demchach and Fort[5]
proposed that for a non-ionised monolayer, the µn arises from the three inde-
pendent dipole moment contributions, coming from the polar headgroups (µ1),
hydrophobic tails (µ2) and the dipole reorientation of the water molecules at the
interface (µ3), having each region an effective dielectric constants (ε). Addition-
ally, according to the Gouy–Chapman theory (equation 4.10 ), it should also be
considered the contribution of the counter-ions in the subphase solution (Ψ0) to
∆ V, in those cases where the monolayer is partially ionised (for further details
see [6] and references therein).
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∆V =
1
Aε0
[
µ1
ε1
+
µ2
ε2
+
µ3
ε3
]
+Ψ0 (4.10)
4.1.3 Polarization modulation-infrared reflection-adsorption
spectroscopy
In the thesis work, the Polarization modulation-infrared reflection-adsorption
spectroscopy (PM-IRRAS) was used to study the EGCG-induced conformational
changes in lipid monolayer at molecular-level, such as the EGCG-induced al-
terations in the hydration status of lipid headgroups, lipid phase organization,
hydrocarbon chains packing and also the dynamical changes in the hydrogen
bonding networking. During PM-IRRAS measurements, the polarisation state of
the infrared light that hits the monolayer at an incident angle of 80 ◦, is modu-
lated into two components of radiation whom polarisation is oriented parallel (p
polarisation) or perpendicular (s polarisation) to the plane of incidence, using a
high frequency photoelastic modulator[7]. A portion of the light is reflected and
the resulting differential reflectivity spectrum (∆R/R) correlates the parallel (Rs)
and perpendicular (Rp) reflectances of the sample (equation 4.11).
∆R
R
=
(Rp −Rs)
Rp +Rs
(4.11)
Qualitatively, positive bands in the difference spectra indicate that the molecules
have their dipole moment parallel to the interface (in-plane), whereas negative
bands indicate that the dipoles are perpendicular to the water surface (out-of-
plane).
Also, given that the polarisation state of incident light is modulated and that
the reflection spectra of the lipid- forming surface is normalised to the reference
(aqueous subphase) spectrum, the spectral interference of water vapor and carbon
dioxide significantly decreases, which improves the ’in situ’ PM-IRRAS spectra
quality.
4.1.4 Brewster angle microscopy
The Brewster angle microscopy (BAM) was the technique used in this thesis to
visualize the structural rearrangements in the monolayer that takes place due to
EGCG-lipid interactions and those derived from blue radiation exposure. Shortly,
the BAM technique assumes that when a p–polarised light enters at the air-water
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interface at the Brewster angle (a particular angle of approximately 53 ◦), no re-
flected light returns to the detector (BAM images appear dark). The BAM images
are created considering the differences in the Brewster angle conditions arising
from the presence of a monolayer on the water surface, that has a different re-
fractive index from that of water subphase, and thus some light is reflected (BAM
images became bright)[8, 9].
4.1.5 Blue LED irradiation setup
For assessment of antioxidant activity of EGCG against blue light-induced ox-
idative damage, the lipid monolayers were maintained under irradiation with
blue LED (emission peak, 460 nm, with nominal light intensity of 77.1 mW/cm2)
positioned perpendicularly to the Langmuir through 25 cm above the surface
illuminating the entire trough area for 1 h (Figure 4.3). After irradiation, surface-
pressure area, PM-IRRAS and BAM measurements were carried out to monitor
the structural changes in lipids promoted by irradiation. Control experiments
were performed with the same setup but without the blue LED source. At least
three replicates were performed to ensure reproducible results.
Figure 4.3: Lipid monolayer spread at air-buffer subphase exposed to blue LED
irradiation for 1h.
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4.2 Liposomes studies
4.2.1 Preparation of liposomes
During thesis work, the different liposomal suspensions (chemical composition
and transition temperature of each phospholipid are given in Table 4.1) designed
to carry and deliver EGCG, were prepared using the lipid thin-film hydration
method developed by Alec Bangham and his colleagues (schematic illustration
in Figure 4.4). Liposomes were made by dissolving the phospholipid in an chlo-
roform/methanol solvent mixture into the round-bottomed flask. The solvent is
evaporated under a gentle stream of nitrogen forming a dry film at the bottom of
the flask. The residual traces of solvent were removed by putting the flask into
an exsiccator at high vacuum for overnight. Thereafter, the dry film is hydrated
by the addition of an appropriate aqueous medium for up 2 h under agitation,
forming multiple concentric lipid bilayers (multilamellar vesicles). The structure
of membrane phospholipids studied throughout this thesis is shown in Figure
4.5.
Table 4.1: Chemical composition and transition temperature of each phospholipid
used in thesis work.
Phospholipid
Number
of carbon
Headgroup
Charge
Transition
Temperature (ºC)
Molecular
Weight (g/mol)
DMPC 14:0 Neutral 24 678
DPPC 16:0 Neutral 41 734
DPPG 16:0 Anionic 41 745
DPPS 16:0 Anionic 54 736
The diameter of the multilamellar vesicles was reduced by using the probe
sonication or extrusion (only used in DMPC liposomes, see further details in re-
sults section 8) techniques. Briefly, the tip sonicator is immersed into a liposomal
suspension applying a high energy input that can causes local overheating, and so
the liposomes-containing vessel must be immersed into an ice/water bath during
the procedure. Moreover, the probe tip can also shed metal particles into the lipid
suspension, evidencing a compromise between sonication time and liposomal
vesicle size.
In the extrusion technique, the heterogeneous liposomal suspension is kept
above the phase transition temperature and is forced to pass multiple times
through a polycarbonate membrane filters with defined pore sizes, rendering
unilamellar liposomes with a uniform size distribution.
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Figure 4.4: Preparation of liposomes using the dry-film hydration method.
Figure 4.5: Structure of membrane phospholipids studied throughout this thesis.
4.2.2 Physicochemical characterization of liposomes
Undoubtedly, is mandatory characterize liposomes in terms of their size distri-
bution, physical conformational integrity, drug-liposome interactions, encapsula-
tion efficiency and drug delivery rates, particularly, if these systems are proposed
as therapeutic agents, because these properties regulates the pharmacokinetic
behavior of liposomes. Furthermore, these characterization techniques allow to
analyze the batch to batch reproducibility and thus the quality of liposomes.
79
CHAPTER 4. EXPERIMENTAL CONCEPTS & METHODOLOGY
4.2.2.1 EGCG–liposome interactions analysis: spectroscopy
4.2.2.1.1 UV-visible Spectroscopy (UV-vis) Ultraviolet and visible (UV–vis)
spectroscopy is a technique that determines the concentration of a particular sam-
ple by considering the energy absorbed by this sample at a certain wavelength.
During the procedure, the electromagnetic radiation in the UV-Visible region
passes trough a sample and, when absorbed, it changes the distribution of elec-
trons in the sample and promotes the electron migration from the ground state
to higher energy levels (electronic transitions). This energy absorbed (∆E) can be
calculated using the Planck–Einstein equation:
∆E = hP ν =
hP cL
λ
(4.12)
where hP is the Planck’s constant (6.62607004 × 10-34 m2 kg/s), ν is the fre-
quency, cL the speed of light in vacuum (2.998× 108 m/s) and λ the wavelength,
which depends of the structure of the molecule on its neighborhood. Most of the
polyatomic organic molecules absorb in the near UV and visible region of the
electromagnetic spectrum so, the electronic transitions from a stationary state
orbital to a higher energy orbital involve pi (double bonds) and n (lone pair) elec-
trons and, usually, they appear in the absorption spectrum. According to the
Beer-Lambert Law the absorbance of a given sample, at a certain wavelength, is
proportional to concentration. This relationship is defined by the equation 4.13:
A = εalc = log
(I0
I
)
(4.13)
where A is the absorbance, εa is the molar absorption coefficient (probability
that the photon of that particular wavelength will be absorbed by the material), l
is the optical path length, c is the molar concentration, I0 and I is the intensity of
the light beam before and after passing the cuvette with the sample. Absorption
spectrum is sensitive to minor changes in chemical structure of a molecule and,
sometimes, these are noticeable after occurring shifts in the absorption spectra of
a particular molecule towards lower (hypsochromic shift) or higher (bathochromic
shift) wavelengths.
In thesis work, the UV-Vis spectroscopy was used to verify the possible interac-
tions EGCG-liposomes, or at least, their co-existence in solution after liposomes
preparation. This technique was also used to measure the quantity of EGCG
entrapped inside liposomes following dialysis and to determine the in vitro re-
lease of catechin from liposomes (see further details in results section). Finally,
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UV-Vis spectroscopy was used as a primary technique to verify the effect of UV
irradiation on the antioxidant activity of EGCG on lipid molecules.
4.2.2.1.2 Fourier Transform Infrared Spectroscopy In Fourier transform in-
frared spectroscopy (FTIR) measurements, some of the infrared polychromatic
radiation impinged on the sample is absorbed at a particular energy, indicat-
ing that the incident radiation interacted and displaced the dipole moment of
the molecule leading to a vibrational transition. So, each peak displayed on the
collected absorption infrared spectrum corresponds to the frequency of a charac-
teristic transition in vibrational state of a certain functional group that compose
the molecules. In thesis work, the molecular interaction between liposomes and
EGCG were characterized by using FTIR. The liposomes preparations consist
of encapsulated and unencapsulated EGCG were adsorbed on calcium fluoride
(CaF2) substrates and the FTIR absorption spectrum was collected in the fre-
quency range from 400 to 4000 cm-1, with a resolution of 4 cm-1, at Tensor 27
FTIR spectrometer (Bruker, Germany). The FTIR spectra provide information
concerning the location of EGCG at the liposome structure and its effect on the
membrane polar and nonpolar region. Additionally, the antioxidant action of
EGCG on liposomes against radiation-induced damage was also investigated by
the analysis of FTIR spectrum for all liposomes preparations before and after UV
irradiation for different times. More specifically, the changes in the frequency
and bandwidth of the characteristics bands of lipid such as, the stretching vibra-
tions of phosphate, carbonyl and hydrocarbon chains, are monitored revealling
if the presence of EGCG in the vicinity of these lipid groups decreases sensitiv-
ity to radiation.These results were complemented with data obtained by UV–vis
technique.
4.2.2.1.3 Fluorescence Spectroscopy The intrinsic fluorescence of EGCG was
used in the fluorescence anisotropy measurements in an attempt to determine
the distribution of EGCG in the liposomal bilayer and monitor the implications
of incorporation of the different EGCG concentrations (10-30 mol%) on bilayer
fluidity. Polarization measurements were performed on a Horiba Jobin Yvon
Spex Fluorolog 3-22 spectrofluoremeter (Kyoto, Japan) with excitation at 275 nm
(slit width 5 nm) and emission at 353 nm (slit width 5 nm). Also, ratiometric
fluorescence measurements of di-8-ANEPPS were used to monitor the effect of in-
creasing amounts of EGCG in the bilayer dipole potential. Shortly, after staining
liposomes with di-8-ANEPPS overnight, the changes in membrane dipole poten-
tial are monitored considering the ratio of the fluorescence intensity at 630 nm of
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di-8-ANEPPS excited at 420 nm to that excited at 520 nm (for further detail see
chapter 8).
4.2.2.2 Drug–liposome interactions analysis: molecular simulations
Molecular simulations were used to study the dynamic interactions between
atoms and molecules at specific time periods and the forces acting on each atom.
These forces were determined by solving Newton’s motion equations obtaining
new position coordinates and the velocities for each atom. Furthermore, the in-
teractions between the molecules are modelled by a potential energy function
(known as force field) that considers the sum of individual potentials associated
to bond lengths, bond angles and torsions (covalent contributions) and also those
from the non-bonding van der Waals and Coulomb interactions between atoms
(simplified equation 4.14).
V (−→r ) = Vbonds +Vangle +Vdihe +Vimp +VvdW +VCoulomb (4.14)
All atom molecular dynamics simulations were carried out using the Gromacs
package (version 2016) and the Gromos 54A7 as the atom force field and so, a
general force field can be written as follows (equation 4.15):
V (−→r N ) =
N∑
bonds
1
4
kb
[
b2n − b20
]2
+
N∑
angle
1
2
kθ [cos(θ)− cos(θ0)]2
+
N∑
dihe
1
2
kϕ [1 + cos(δn)cos(mnϕn)] +
N∑
imp
1
2
kξ [ξn − ξ0)]2
+
∑
vdw
4εij
(σijrij
)12
−
(
σij
rij
)6+ N∑
Coulomb
qiqj
4piε0εrrij
(4.15)
where V is the potential energy function,−→r is the position vector for N atoms,
b and rij the inter-particle distance, θ is the bond angle, ϕ is the dihedral angle,mn
is the dihedral multiplicity and δn the phase angle. Also, the ξn is the improper
dihedral angle, the q is the partial charge, εr is the relative permittivity, the σ is a
finite distance where the net electric potential is zero. Finally, the kbonds, kθ, kϕ
and kε represent the respective forces constants.
The specific details for the molecular dynamics simulations are discussed in
respective chapter 8. In the thesis scope, a coarse-grained liposome model was de-
veloped by colleagues from Machuqueiro’ Simulation Group (FCUL institution),
to model the distribution and interactions of EGCG inside of the lipid bilayer at
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molecular level, thus providing the basis for improve the efficiency of experimen-
tally designed liposomes.
4.2.2.3 Liposomes size analysis
In thesis work, the liposome size distribution was determined in the Zetasizer
Nano ZS90 apparatus (Malvern Instruments Inc. He–Ne laser of 633 nm, de-
tection angle of 90 ◦) using the Photon correlation spectroscopy also known as
dynamic light scattering (DLS). During the procedure, a monochromatic laser
beam hits the liposomal suspension and the time-dependent fluctuations of the
light scattered from particles are measured in a photon detector. The light scatter-
ing results from random motion (Brownian motion) of the particles, since they are
continually colliding and interacting with solvent molecules. According to Stokes-
Einstein equation (equation 4.16) the movement (diffusion, DT ) of these particles
is inversely proportional to their size, meaning that larger particles diffuse more
slowly than small ones.
DT =
kBT
6piηRH
(4.16)
In the equation, kB is the Boltzmann constant, DT is the diffusion velocity
of the particle, which depends of the temperature (T ) and the viscosity of the
solution (η), and RH is the hydrodynamic radius of the particle.
4.2.3 UVC irradiation setup
For the UV irradiation experiments, the liposomal suspensions consist of encapsu-
lated and unencapsulated EGCG were placed in closed quartz cells or adsorbed on
CaF2 substrates and then, irradiated with a 254 nm UVC germicid lamp (Philips
TUV PL-S 55W/2P 1CT) at a radiance of 1.9 W/m2. Afterwards, the damage
caused by UV radiation was recorded by measuring the UV–vis and infrared ab-
sorption spectra of the liposomal suspensions and cast films, respectively, over
the irradiation time.
4.2.4 Immobilization of EGCG-loaded liposomes on
nanofibers: electrospinning
Electrospinning was used to incorporate EGCG-loaded liposomes into nanofibers.
During the procedure, a highly viscous synthetic or natural polymeric solution
of choice is placed in a syringe, pumped at a constant flow rate and is injected
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through a needle, due to the high voltage electric field applied to the tip of the
needle (usually between 10 and 30 kV) and the collector. The polymeric solution
is only successfully electrospun into nanofibers when the electric field distort the
polymeric droplet at the tip of the needle into a conical shape (Taylor cone) thus
ejecting a charged jet of fluid towards the collector (for further details see Chapter
9). The surface morphology and size of the nanofibers were evaluated using a
Zeiss Auriga scanning electron microscope (SEM).
4.2.5 Cellular studies
4.2.5.1 Cell lines
Vero cells (monkey kidney epithelial cells) were used for the in vitro cytotoxicity
assays of EGCG and of nanofibers extracts. Human fetal foreskin fibroblasts
(HFFF2, European Collection of Authenticated Cell Cultures, UK), were used
in cell survival assays after cell exposure to H2O2 or UV radiation (for further
details about cell culture conditions used in cytotoxicity and cell viability assays
see Chapter 9).
4.2.6 Statistical Analysis
The Principal Component Analysis (PCA) and 2D–correlation spectroscopy were
two mathematical techniques applied to the UV–vis or the IR spectra of each irra-
diated liposomal suspension, to analyse small changes in measured signals and
then, extract information about the protective role of EGCG against UV damage
(more details are shown in Chapter 7).
For cell-based experiments, one-way or two-way ANOVA with Tukey’s post-
tests were performed to determine significant differences. All the experiments
were performed in triplicate. P values lower than 0.05 (*), 0.01 (**) and 0.001 (***)
indicates that differences are statistically significant. Mean ± SEM was plotted on
all graphs.
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Monolayer Results
Effect of blue light irradiation on the stability of phospholipid
molecules in the presence of epigallocatechin-3-gallate1
Abstract
In this paper, we report on the effects from epigallocatechin-3-gallate (EGCG),
a phytochemical flavonoid present in green tea, on Langmuir monolayers of 1,2-
dipalmitoyl-sn–glycero–3–[phospho–rac–(1–glycerol)] (sodium salt) (DPPG), in-
cluding experiments with blue light irradiation. EGCG was found to interact with
both the DPPG headgroups and hydrophobic tails, thus affecting the lipid packing
according to surface pressure and surface potential isotherms and polarization-
modulated infrared reflection absorption spectroscopy (PM-IRRAS) data. Blue
light irradiation caused considerable changes in the surface pressure isotherms
and PM–IRRAS spectra of DPPG monolayers, but the effects were considerably
less when EGCG was present. For the surface pressure isotherms, for instance,
no irradiation effect could be measured for mixed EGCG-DPPG monolayers. It
is concluded that EGCG protected the DPPG molecules from degrading upon
blue light irradiation, which means that EGCG may be a preventive and thera-
peutic agent to decrease photosensitivity of phospholipids to blue light oxidative
damage, a pathogenic mechanism in skin disorders.
1This chapter is based on the following publication:
Pires, F., Geraldo, V. P., Antunes, A., Marletta, A., Oliveira Jr, O. N., and Raposo,
M.. Effect of blue light irradiation on the stability of phospholipid molecules in the pres-
ence of epigallocatechin-3-gallate. Colloids and Surfaces B: Biointerfaces 2019, 177: 50-57,
DOI:10.1016/j.colsurfb.2019.01.042
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5.1 Introduction
Natural sunlight is photocarcinogenic to human skin owing to its ionizing radia-
tion (UV radiation) as extreme exposure to UVB (290-320 nm) and UVA (320-400
nm) light triggers mutagenic effects on DNA to form cyclobutane pyrimidine
dimers.[1, 2, 3] In recent years, there has been evidence that blue light (400-495
nm) is also phototoxic, causing skin ageing and pigmentation.[4, 5, 6] Kushibiki
et al. reported cytotoxic effects from blue laser irradiation with power density
of 100 mW/cm2 on fibroblasts, lung cancer cells, and human cervix adenocarci-
noma cells, owing to a marked increase in the synthesis of intracellular reactive
oxygen species (ROS). This increment in ROS generation in the cytoplasm was
not observed for cells exposed to red or near-infrared lasers, although some mito-
chondrial ROS could have been produced but not detected with the fluorescent
CM-H2DCFDA probe used.[7] Blue light photons are also absorbed by enzymes
(flavins),flavoproteins,photoreceptors (cryptochrome 2) and cell mitochondrial
respiratory components (cytochrome c oxidase), and therefore prolonged expo-
sure could impair intracellular events and contribute to tumorigenesis.[8, 9, 10]
Furthermore, ROS resulting from blue light-induced mitochondrial oxidative
stress may cause DNA lesions, induce membrane lipid oxidation, increase the
rate of ATP depletion and the membrane permeability, which for retinal pigment
epithelial cells leads to cell dysfunction and retina aging.[11, 12, 13, 14, 15, 16]
Such photoinduced effects can be at least partially mitigated with incorpora-
tion of some herbal drugs into daily diet. For example, the polyphenol flavonoid
catechins, which are present in green tea, protect biomolecules from radiation-
induced damage by acting as antioxidant and free radical scavengers. This ac-
tivity is believed to occur due to the affinity of catechins to lipid bilayers that
make the framework of cell membranes.[17, 18, 19, 20] This activity is believed to
occur due to the affinity of catechins to lipid bilayers that make the framework of
cell membranes.[21] The interaction between catechins and cell membranes has
been investigated with techniques such as Flicker spectroscopy, nuclear magnetic
resonance (NMR), differential scanning calorimetry (DSC), and fluorescence spec-
troscopy. [22, 23, 24, 25, 26] However, to our knowledge the number of studies
on molecular-level interactions with the lipids at the membrane is rather scarce.
Since the cell membrane is complex, with a varied composition of phospholipids
and proteins, this type of investigation is performed with simplified models such
as Langmuir monolayers[27] as it was done by Collado et al.[28] for catechins.
Another possible model involves liposomes made with different types of lipids,
as in recent works from our groups where the lipid electrical charge was found to
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be relevant for incorporation of phytomolecules that affect the level of protection
against oxidizing agents.[29, 30]
In this paper, we report on the interaction between epigallocatechin-3-gallate
(EGCG), the major catechin in green tea leaves, and monolayers of 1,2-dipalmitoyl-
sn-glycero-3-[phospho-rac-(1-glycerol) (sodium salt) (DPPG), with special empha-
sis on effects of blue light irradiation. DPPG is a negatively-charged unsaturated
phospholipid found in the pulmonary surfactant that confers protection to the
surfactant protein B against oxidation, thus decreasing the risk of respiratory dis-
eases.[31, 32] It was chosen for this study to infer possible synergistic effects with
EGCG in protecting cells against irradiation, and because it has fusogenic proper-
ties that seem to increase the liposome uptake into target cells.[33, 34, 35] In order
to probe the intermolecular interactions and the effect from blue light irradiation,
the monolayer properties were evaluated using surface pressure isotherms and
polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS).
5.2 Experimental Details
5.2.1 Chemicals
EGCG (M.W. 458.4 g/mol) and DPPG (M.W. 744.96 g/mol) were purchased from
Sigma-Aldrich and Avanti Polar Lipids, respectively.
5.2.2 Langmuir monolayers
The co-spreading methodology was used to prepare Langmuir monolayers to
study the interaction between EGCG and DPPG. DPPG and EGCG were dissolved
in a chloroform and methanol (4:1) mixture in concentrations of 0.5 mg/mL and
0.3 mg/mL, respectively. These values have been chosen to maintain the same
number of moles in each solution. Aliquots of 50 µL of pure DPPG or DPPG-
EGCG mixtures, namely, DPPG(95%)-EGCG(5%), DPPG(93%)-EGCG(7%) and
DPPG(87%)-EGCG(13%), were spread on an aqueous subphase to obtain Lang-
muir monolayers. Milli-Q water at 24±1◦ C was used as the subphase. After
spreading the solvent was allowed to evaporate for 10 min. The surface activity
of EGCG was assessed without spreading the phospholipids by compressing the
barrier and measuring the surface pressure, pi, using the Wilhelmy plate method.
All experiments were repeated at least three times to ensure reproducibility of
the isotherms. The mean molecular area (Am) is calculated using:
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Am =
ALT ×M
c ×NA ×V (5.1)
where the ALT is the Langmuir trough area, M is the molecular mass, c is the
concentration, NA is the Avogrado number and V is the solution’s volume spread.
In the case of DPPG+EGCG mixtures, the average molar mass (MMA) obtained
with the molar fractions of EGCG and DPPG was used as M value. The experimen-
tal molecular areas were compared with the theoretical molecular areas predicted
by the additivity rule (see later). Surface potential and surface pressure measure-
ments were made with a Langmuir mini trough from KSV Instruments, in a class
10,000 clean room. Film compression was carried out using two symmetrically
movable barriers at a constant barrier speed of 10 mm/min. The stability of the
mixed DPPG-EGCG monolayers at the air-water interface was verified through
hysteresis measurements, which consisted of successive compression/decompres-
sion cycles (11 cycles). Surface potential was measured using the vibrating plate
method (frequency 300 Hz) with a KSV Kelvin probe. Both reference and vibrat-
ing plate electrodes are made of platinum and the probe was located roughly 1-2
mm above the water surface. The irradiation experiments were performed with
the barriers open to promote enhanced ROS via water radiolysis as the number
of solvating water molecules is higher for large areas per lipid. A blue LED (ca.
460 nm, with nominal light intensity of 77.1 mW/cm2) was positioned perpendic-
ularly to the Langmuir through 25 cm above the surface illuminating the entire
trough area during 1 h. After irradiation, film compression was carried out at a
constant barrier speed of 10 mm/min. Control experiments were performed with
the same setup but without the blue LED source. Polarization-modulated infrared
reflection absorption spectra (PM-IRRAS) measurements were performed using
a KSV PMI 550 instrument (KSV Instruments, Finland) at an incidence angle of
80◦. The DPPG-EGCG mixtures were spread on an aqueous subphase, and then
compressed up to 30 mN/m. The spectra were measured for s- and p- polariza-
tions at a high frequency. All the spectra shown were obtained by subtracting the
baseline which corresponded to the spectrum of a pure water subphase.
5.3 Results and Discussion
5.3.1 Surface Pressure Isotherms
The surface pressure isotherms for monolayers containing guest molecules can be
represented either in terms of area per molecule - with the guest molecules being
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assumed to occupy an area at the interface and being therefore considered in the
number of total molecules - or area per lipid molecule. In the latter case, the total
number of molecules used in the calculations is the number of lipid molecules
(hence area per lipid molecule is used in the x-axis of the isotherms), disregard-
ing the number of guest molecules. The isotherms so obtained for monolayers of
DPPG-EGCG mixtures are given in Figure A.1 in the Appendix A . The surface
pressure isotherms with area per molecule are shown in Figure5.1A. The isotherm
for pure DPPG does not display any coexistence region of liquid expanded and
liquid condensed (LE-LC) phases, in contrast to what was observed by Dicko et
al.[36] and Vollhardt et al.[37]. The LE-LC transition is very sensitive to parame-
ters such as temperature and ionic strength. Vollhardt et al. mentioned that the
LE-LC transition plateau is only observed in the temperature range between 26◦
and 37◦C for a pure water subphase. Dicko et al. used 150mM NaCl subphase.
Therefore, the reason why we did not observe the LE-LC transition may be the
use of a pure water subphase at a lower temperature (24◦C) than in other studies.
The incorporation of EGCG causes no appreciable change in the collapse pressure,
typically around 55-57 mN/m. DPPG+EGCG isotherms are shifted to smaller
areas per molecule with increasing EGCG concentration from 5 to 13% in mol,
suggesting that EGCG condenses the monolayer. Effects from the EGCG concen-
tration changes are better seen in the area versus concentration plot in the inset of
Figure5.1A, which deviates from the straight line predicted by the additivity rule
according to which the area per molecule should be: Atheoretical = Xlipid Alipid +
XEGCG AEGCG, where Xlipid and XEGCG are the mole fractions of each component,
and Alipid and AEGCG are the areas occupied by each component in neat Lang-
muir monolayers. Because the measured areas are smaller than predicted from
the additivity rule, one infers there are attractive interactions between EGCG and
DPPG. It is worth mentioning that EGCG did not form a Langmuir film on its own
as it was necessary to spread a large number of molecules to obtain the surface
pressure isotherm. The area per molecule thus calculated as if a true monolayer
had been formed is much smaller than expected for the size of the molecule. The
results of the additivity rule are therefore only useful for the characterization of
the mixed films.
The surface compressional modulus (Cs−1),calculated from the surface pres-
sure isotherms using Cs−1 = −A
(
∂pi
∂A
)
T
, is used to explain qualitatively changes in
the mechanical properties of the monolayer. Differences in lipid phase transitions
(e.g. LE-LC) as well as in monolayer elasticity can be probed. A decrease in Cs−1
means that the monolayer is more compressible/flexible, thus the lipids are not
closely packed. Values of Cs−1 below 100 mN/m indicate that the monolayer is
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Figure 5.1: Surface Pressure for DPPG monolayers with different contents of
EGCG at the water interface. In the inset is shown the additivity rule data ob-
tained from DPPG+EGCG pressure area isotherms, with evidence for the attrac-
tive interactions between EGCG and DPPG with slight deviation from the theo-
retical area. B. Compressional modulus vs surface pressure for DPPG and DPPG
+ EGCG monolayers at the air/water interface. C. Surface Potential isotherms of
DPPG + EGCG monolayers at various concentrations. The top-right inset in C
shows the ratio between the apparent dipole moment of DPPG + EGCG (µ) and
pure DPPG (µ0) vs. EGCG concentration at 1 mN/m and 30 mN/m. The solid
lines in the graph are only to guide the eyes
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in a LE phase. For Cs−1 between 100-250 mN/m the monolayer is considered as
being in a LC phase, while values higher than 250 mN/m denote that the mono-
layer is in a solid state.[38] Figure 5.1B shows that DPPG reaches a Cs−1 value of
500 mN/m, i.e. in the solid state. The introduction of 5 mol% EGCG practically
does not affect Cs−1 at surface pressures below 40 mN/m. Above 40 mN/m, Cs−1
decreases from 524 mN/m for DPPG to 451 mN/m for 5% EGCG cospread. For
the higher concentrations of EGCG (7-13 mol %), Cs−1 at surface pressures above
40 mN/m is higher than for DPPG, indicating that the incorporation of EGCG
turns the monolayer more rigid (less compressible).
The surface potential depends on the charge and orientation of the molecules
on the surface, being more sensitive than pressure for area-dependent effects. The
curve for neat DPPG in Figure 5.1C starts off at a negative surface potential (- 0.1
V) for large areas per molecule due to the electrical double layer, arising from the
negatively-charged DPPG headgroups and the counter-ions in the subphase solu-
tion.[39] It increases abruptly upon packing of the molecules. The introduction
of 5-13 mol% of EGCG into the DPPG monolayer caused an overall decrease in
surface potential. Such a decrease could be caused by additional charge brought
by EGCG[40], as EGCG molecules should be partially charged at the interface
(the pKa for the charged groups of EGCG are 7.6 and 10.7). However, the surface
potential for the monolayer with 13% mol of EGCG is higher than for the smaller
concentrations, and therefore the additional charge cannot be the sole factor to
explain the changes in potential. Additional factors should be taken into account,
and indeed there is a competition of effects to explain the non-monotonic depen-
dence on concentration of the apparent dipole moment in the inset of Figure 5.1C.
These factors may include the intrinsic dipole moment of catechins [41, 42], and
the changes induced by EGCG on the packing of DPPG molecules, as inferred
from the surface pressure isotherms. Furthermore, as we shall see when the PM-
IRRAS spectra are discussed, the incorporation of EGCG affects the hydration and
conformation of DPPG headgroups, which causes the monolayer surface potential
to change.
5.3.2 PM-IRRAS
The PM-IRRAS spectra for neat DPPG and EGCG monolayers and mixed DPPG +
EGCG monolayers at 30 mN/m are shown in Figure 5.2A for distinct wavenumber
regions. These spectra were subtracted from the spectrum of the water interface
obtained without film. In the region between 3000 to 2800 cm−1 (Figure 5.2A),
information is inferred about CH2 groups. Two strong bands appear at 2919
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cm−1 and 2851 cm−1 for DPPG, with the band at 2919 cm−1 being decomposed
into two Gaussian bands at 2947 cm−1 and 2919 cm−1 while the band at 2851
cm−1 can be decomposed into two Gaussian bands at 2880 cm−1 and 2851 cm−1.
The inset in Figure 5.2A shows this decomposition. The positions of these bands
are close to those obtained by Dicko et al.[36] The bands at 2919 cm−1 and 2851
cm−1 are assigned to CH2 antisymmetric and symmetric stretching vibrations,
respectively, while the weak bands at 2947 cm−1 and 2880 cm−1 are assigned to
the antisymmetric and symmetric stretching vibrations, respectively, of terminal
CH3 groups. The changes in wavenumber and width of the methylene infrared
bands provide information about chain conformation.[43] The parameter of order,
calculated from the ratio between the intensity of these bands
(
I2916
I2851
)
[44] , is 1.9,
2.0, 1.7, 1.8 as EGCG concentration increased from 0 to 13%. Therefore, the order
parameter is little influenced by EGCG. However, with increasing percentage of
EGCG the band position for the antisymmetric stretching of methylene groups
was shifted to lower wavenumbers. In addition, the affinity between EGCG and
DPPG phospholipids is also suggested by the changes in intensity and band width
at 2920 cm−1 after incorporation of EGCG, consistent with the change in surface
potential of the DPPG monolayer in Figure 5.1C.
The region of C=O vibrations in Figure 5.2C can be decomposed into two Gaus-
sian bands at 1740 cm−1 and 1760 cm−1, assigned to hydrogen and non-hydrogen
bonded carbonyl groups, respectively.[45, 46] According to the literature [47, 48],
phosphate and carbonyl groups are hydration centers surrounded by a layer of
water molecules at the interface that modulates the thermodynamics and surface
membrane properties such as dipole potential. The carbonyl stretching mode is
strongly affected by EGCG since it is a polyhydroxylated molecule that decreases
the number of water molecules bound to carbonyl groups. As a consequence, the
C=O orientation may change to affect the dipole moment (and surface potential).
In addition, the changes in degree of freedom of carbonyl induced by EGCG mod-
ify the exposure of hydrocarbon chains of phospholipids, which tend to minimize
the area exposed to water since they are hydrophobic.
The spectra region between 1200 and 1300 cm−1 in Figure 5.2C is associated
with the lipid head groups, hydrogen bonds and hydration. The band at 1257
cm−1 in DPPG is decomposed into two Gaussian bands at 1230 cm−1 and 1257
cm−1 corresponding to P=O antisymmetric stretching of PO−4 group and P=O anti-
symmetric stretching of hydrated PO−4 group, respectively. In DPPG cast films
these bands appear at 1222 cm−1 and 1241 cm−1, respectively. For DPPG+EGCG,
the Gaussian decomposition yields two bands at 1235 cm−1 and 1262 cm−1, sug-
gesting that the presence of EGCG shifted the spectra to higher wavenumbers. In
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Figure 5.2: PM-IRRAS spectra of DPPG monolayers with different EGCG percent-
ages in aqueous solutions at a surface pressure of 30 mN/m in the wavelength
region of: A. 3000 to 2600 cm−1; B. 1800 to 1600 cm−1 and C. 1350 to 900
cm−1. The plot shows the degree of hydration of phosphate groups and hydrogen
bonded carbonyl groups fraction ions calculated by fitting the IRRAS spectra (D).
The solid line is a fitting with an exponential function.
DPPG, the presence of the glycerol esterified to phosphate inserts a charge at the
surface which is sufficient to change water organization. Analyzing the bands at
1257 cm−1 (PO−4 hydrated groups) in Figure 5.2C and 1743 cm−1 (C=O) in Figure
5.2B, one notes that EGCG affects hydrogen bonding of PO−4 groups with water
molecules. Note that the band at 1257 cm−1 is shifted from 1236 cm−1 assigned
to the stretching mode of O-C=O group of EGCG. In fact, EGCG has affinity to
phosphate groups creating a hydration stress, since these molecules compete with
water molecules excluded from the surface or replace them nearby the phosphate
groups, affecting the thermodynamic balance of the membrane. The increase in
intensity of the phosphate band of DPPG with increasing EGCG concentration in
Figure 5.2C is due to the absorption of carboxylate groups of EGCG. For DPPG,
this region can be represented by two Gaussian bands, with correlation coefficient
of 0.99976, at 1232.2 ± 0.8 cm−1 and at 1260.4 ± 0.7 cm−1, with width at half max-
imum of 29 ± 1 cm−1 and 28.1 ± 0.6 cm−1. The bands are assigned to the most
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and least hydrated phosphates, respectively. [49] For EGCG, this region is repre-
sented by a Gaussian band, with correlation coefficient of 0.99659, at 1255.8±0.3
cm−1 and with width at half maximum of 55±2 cm−1. The relation between the
most and least hydrated phosphates was obtained by fitting the spectra of the
mixtures of DPPG with EGCG with the three Gaussian bands mentioned above.
From the areas of these bands the ratio
(
A1232
A1232+A1260
)
, where A1232 and A1260 are
the areas under the bands at 1232 cm−1 and 1260 cm−1, respectively. Within the
same rationale, the fraction of hydrogen-bonded carbonyl groups was obtained
by dividing the area under the band at 1740 cm−1 by the total area of the bands
(A1740 + A1760). The ratios representing the degrees of hydration were plotted as
a function of EGCG concentration in Figure 5.2D, where a decrease in phosphate
as well as carbonyl hydration is observed with increasing EGCG concentration.
In summary, the PM-IRRAS results provided significant evidence of struc-
tural rearrangements in the DPPG monolayer induced by EGCG. Differences
appeared in the vibrational modes of carbonyl and phosphate groups, caused by
competition among EGCG and water molecules. This competition alters hydro-
gen bonding between phosphate groups-water molecules and induces structural
rearrangements, e.g. in carbonyl groups (C=O) of DPPG, which may be the reason
for the changes in surface potential shown in Figure 5.1C.
5.3.3 Irradiation of phospholipid monolayers
DPPG monolayers were exposed to a blue LED in the presence and absence of
EGCG. Figure 5.3A shows that this exposure shifted the isotherm of pure DPPG
monolayer to larger molecular areas, e.g. with the minimum phospholipid area
changing from 44 ± 7 Å2 to 50 ± 3 Å2 after 1h of exposure. In contrast, for the
mixed EGCG-containing monolayers in Figure 5.3B, blue light irradiation does
not affect the surface pressure isotherms, for any of the EGCG concentrations
tested. For example, the minimum area for the DPPG+13% EGCG monolayer was
47 ± 2 Å2 and 47 ± 5 Å2 with and without exposure to blue light, respectively.
Significantly, the irradiated mixed monolayers were stable, as confirmed with
hysteresis measurements in compression-decompression cycles and area versus
times measurements in Figure A.2 in the Appendix A.
Because the changes in the surface pressure isotherms owing to blue light
exposure were small for pure DPPG and negligible for the EGCG-containing
mixed monolayers, we investigated the possible role of EGCG with PM-IRRAS
spectroscopy. We selected the composition with the highest EGCG concentration
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Figure 5.3: Irradiation with blue light of pure DPPG (A) and DPPG+13 mol%
EGCG (B) monolayers isotherms. The top-right inset in B shows the blue light-
irradiated DPPG monolayers in the presence of 5 and 7% EGCG. The error bars
represent the standard deviation (SD) of 3 independent experiments.
(13%) as stronger effects are expected. The PM-IRRAS spectra are shown in Fig-
ure 5.4 for monolayers of DPPG and DPPG+EGCG 13%, before and after 1 h
of blue light irradiation. The first thing to be noted in the three regions of the
spectra analysed is that irradiation does affect the monolayers, with effects being
stronger for pure DPPG. In the spectral region corresponding to the hydrocarbon
chains in Figure 5.4A, irradiation induced a decrease in the intensity and a slight
shift in the frequency of the symmetric and antisymmetric stretching of lipid
acyl chains from 2851 ± 3 cm−1 and 2919 ± 1 cm−1 to 2844 ± 1 cm−1 and 2911
± 2 cm−1, respectively. In the absence of EGCG, radiation leads to a disordering
effect on phospholipid fatty acids chains, observed by the decrease in the ratio
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of 2920/2850 band intensity, which reflects the balance between trans-gauche
conformations. Thus, the decrease of this ratio means that the number of gauche
conformers is increasing with radiation exposure. Figure 5.4B shows that even
in the presence of 13 mol% of EGCG, the DPPG acyl chains are affected by ir-
radiation as seen with the appearance of a small shoulder at 2971 cm−1 (CH3
antisymmetric stretching).
The effect of irradiation on the phosphate moiety of DPPG was investigated
by analysing the P=O stretching band in Figure 5.4C, which is decomposed into
three Gaussian bands at 1222 ± 4 cm−1, 1238± 2 cm−1 and 1260 ± 2 cm−1, with
width at half maximum of 21 ± 3 cm−1, 25 ± 6 cm−1 and 28 ± 1 cm−1. These
bands are assigned to dihydrated, monohydrated and dehydrated PO−2 groups, re-
spectively. Upon irradiation, the band assigned to partially hydrated phosphates
(1260 cm−1) shifted to lower wavenumbers (1247 cm−1), meaning that the result-
ing free radicals strongly disturb phosphate-water interactions. The drastic shift
in the band frequency of the PO−2 antisymmetric stretching to lower wavenum-
bers indicates formation of hydrogen bonding between DPPG phosphate groups
and water molecules (increase in the ratio of hydrated phosphate vs dehydrated
phosphate). Also, the exposure to blue light narrowed the bandwidth (bandwidth
= 42.44, breakdown factor = 1.18) suggesting that the released ROS interferes
in the lipid phosphate mobility. The decomposed spectrum of P=O band for the
DPPG+13% EGCG monolayer in Figure 5.4D has two Gaussian bands at 1237.5 ±
1.6 cm−1 and 1261.8 ± 0.9 cm−1, with width at half maximum of 34± 2 cm−1 and
27 ± 1 cm−1. Upon irradiation, this phosphate band changes in shape exhibiting
two well-defined bands at 1262 cm−1 and 1227 cm−1 assigned to dehydrated and
hydrated phosphate groups, respectively. Although the split into two bands sug-
gests a heterogenous population, the population of hydrated phosphates is lower
in the presence of EGCG, even after irradiation, in contrast to what was observed
for the pure DPPG monolayer.
As already mentioned, the presence of EGCG weakens membrane-water inter-
actions by competing with water to bind to the phosphate moiety of the lipids,
dehydrating the lipids. Our results also show that the blue light irradiation is
sufficient to alter the proportion of hydrated and dehydrated phosphate groups,
possibly because some EGCG molecules are damaged and water molecules are
more easily bound to the phosphate.Deconvolution of the carbonyl band of DPPG
monolayer in Figure 5.4E revealed two bands at 1743 cm−1 and 1765 cm−1 cor-
responding to the hydrogen and non-hydrogen bonded carbonyl groups, respec-
tively. Upon irradiation, the bandwidth for the C=O region increases, both in
the absence or presence of EGCG, reflecting a heterogenous carbonyl population
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Figure 5.4: PM-IRRAS spectra of DPPG (A, C, E) and DPPG+13%EGCG (B, D, F)
monolayers, before and after blue light irradiation.
with distinct hydrogen bonding capacity. The appearance of the two well-defined
bands after irradiation for the DPPG+13%EGCG spectrum in Figure 4F corrob-
orates this observation. The spectra in Figures 5.4E and 5.4F obtained after irra-
diation are better explained if each spectrum is fitted with 3 Gaussians, two of
which already used (at 1740 and 1760 cm−1) and another one at ca. 1720 cm−1 as-
sociated with hydrogen bonded carbonyl groups. For pure DPPG, the percentage
of hydrogen-bonded carbonyl groups increases upon irradiation, possibly due to
the attack of light-induced radicals to the water molecules strongly bound to the
carbonyls (one should recall that in the absence of EGCG, DPPG has the highest
degree of hydration (Figure 5.2D). When EGCG is present, the ratio between
hydrated and total C=O bands is not affected by irradiation if we exclude the new
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carbonyl groups associated with the 1720 cm−1 band appearing with the irradia-
tion. This lack of effect can be attributed to three factors: (1) competition between
EGCG and water molecules to bind to the carbonyl group; (2) condensing effect of
EGCG on the DPPG monolayer hampers diffusion of ROS across the monolayer,
and (3) scavenging activity of EGCG eliminates ROS in the vicinity of carbonyl
groups of DPPG lipids.
In conclusion, irradiation affected DPPG in pure monolayers and even in the
presence of EGCG. But the effects were stronger in the absence of EGCG, espe-
cially for the head groups of DPPG. These findings are in line with our previous
work, where we irradiated DPPG liposomes containing EGCG with ultraviolet ra-
diation (254 nm) at fixed times and concluded that EGCG is a good shield against
UV light that slowdowns the cascade of oxidizing events, efficiently protecting
the hydration sites of DPPG lipids (carbonyl and phosphate groups) from degra-
dation. A prolonged exposure to UV light disrupted the integrity of EGCG by
opening the pyrogallol ring, a starting point to initiate lipid damage.[50] The re-
sults presented here are also consistent with previous studies according to which
ROS induced by blue light increases significantly the lipid membrane permeabil-
ity and the level of lipid peroxidation, eventually leading to cell death.[51, 52,
53]
5.4 Conclusions
The effects from catechin EGCG on DPPG Langmuir monolayers have been anal-
ysed from the point of view of interactions and from damage induced by blue light
irradiation. The incorporation of EGCG in DPPG monolayers caused significant
changes in the structuring of the lipid molecules, and this could be confirmed with
PM-IRRAS and surface potential isotherms. The combination of distinct methods
to characterize the monolayers was important to probe the intermolecular inter-
actions. For instance, the decrease in surface potential caused by EGCG is most
likely related to the changes in the dipole moment of C=O groups from DPPG
whose band in the PM-IRRAS spectra was considerably altered. The effects did
not change monotonically with the relative concentration of EGCG, which means
that EGCG cannot be incorporated indefinitely into the DPPG monolayer. Also
relevant for the molecular-level interactions was the competition among EGCG
and water molecules for H-bonding, thus inducing structural rearrangements of
DPPG molecules. As observed with liposomes, EGCG was found to protect the
DPPG monolayer against blue light irradiation.
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Regarding the biological implications, the results presented here point to a
physiological action of EGCG protecting lipids from the free radicals induced by
wavelengths beyond the UV spectrum. In the future, EGCG+DPPG monolayers
should be exposed to a combination of different wavelengths within and beyond
UV, mimicking natural sunlight. This is relevant to improve sunscreen products
in the market. In dermatology, the uncontrolled generation of lipid peroxidation
end products and the depleted level of antioxidants are pathogenic mechanisms
for inflammatory skin diseases such as atopic/photocontact dermatitis and acne.
Therefore, based on the findings of this study, one may envisage EGCG as promis-
ing to control inflammatory diseases related to oxidative stress, by decreasing
the photosensitivity and susceptibility of phospholipids to blue light oxidative
damage. Also, blue light may be beneficial by inactivating and killing bacterial
pathogens, in spite of the damage it may cause to eyes (macular degeneration)
and skin. Since the damage/protection balance depends on the wavelength and
dose used, experiments with EGCG and various blue light wavelengths could
indicate whether the anti-inflammatory and antibacterial action of catechins may
be enhanced by blue light irradiation to treat skin conditions.
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Results
The impact of blue light in monolayers representing tumorigenic
and nontumorigenic cell membranes containing EGCG1
Abstract
Natural products such as epigallocatechin–3–gallate (EGCG) have been sug-
gested for complementary treatments of cancer, since they lower toxic side effects
of anticancer drugs, and possess anti-inflammatory and antioxidant properties
that inhibit carcinogenesis. Their effects on cancer cells depend on interactions
with the membrane, which is the motivation to investigate Langmuir monolay-
ers as simplified membrane models. In this study, EGCG was incorporated in
zwitterionic dipalmitoyl phosphatidyl choline (DPPC) and anionic dipalmitoyl
phosphatidyl serine (DPPS) Langmuir monolayers to simulate healthy and cancer
cells membranes, respectively. EGCG induces condensation in surface pressure
isotherms for both DPPC and DPPS monolayers, interacting mainly via electro-
static forces and hydrogen bonding with the choline and phosphate groups of the
phospholipids, according to data from polarization-modulated infrared reflec-
tion absorption spectroscopy (PM-IRRAS). Both monolayers become more com-
pressible upon interaction with EGCG, which may be correlated to the synergy
between EGCG and anticancer drugs reported in the literature. The interaction
with EGCG is stronger for DPPC, leading to stronger morphological changes in
1This chapter is based on the submitted publication:
Pires, F., Magalhães-Mota, G., Geraldo, V. P., Oliveira Jr, O. N., and Raposo, M.The impact of blue
light in monolayers representing tumorigenic and nontumorigenic cell membranes containing
EGCG.COLSUB,2019.
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Brewster Angle Microscopy (BAM) images and higher degree of condensation in
the surface pressure isotherms. The changes induced by blue irradiation on DPPC
and DPPS monolayers were largely precluded when EGCG was incorporated, thus
confirming its antioxidant capacity for both types of membrane.
6.1 Introduction
Ionizing radiation may ionize biomolecules such as proteins, phospholipids, and
nucleic acids, also impairing the genome stability in cells to yield unrepaired DNA
lesions.[1] A prolonged exposure to ultraviolet radiation (100–400 nm) affects the
homeostasis of cell membranes by altering the ratio of saturated/unsaturated
phospholipids and disturbing packing and the stiffness of lipid membranes.[2, 3]
These cell abnormalities increase with the radiation dose and may be correlated
with cancer progression. Upon long-term exposure, even the blue light (400 -
480 nm) from electronic devices (computers, smartphones) may produce reactive
oxygen species (ROS) that affect the cells metabolic activity, dehydrate the epi-
dermis and accelerate skin ageing, by promoting fragmentation of collagen fibers
and appearance of wrinkles.[4, 5, 6, 7, 8] Since preventing complete exposure is
not possible, strategies have to be sought for reducing or eliminating radiation
damage. This has been attempted with natural products, including antioxidants,
antibacterial and antimutagenic compounds, which may help prevent cellular
injuries from radiation.[9, 10, 11]
One antioxidant that has been suggested to foster protection against irradia-
tion is epigallocatechin –3–gallate (EGCG), found in herb teas. EGCG has hydrox-
yphenol rings (ring B and gallate group) that are chelators to reduce ROS species,
as in the case of hydroxyl radicals to suppress in vitro ’Fenton–like’ reactions.[12]
Since the antioxidant properties of EGCG could be related to their affinity toward
cell membranes, studies have been performed to investigate interaction between
EGCG and Langmuir monolayers, which represent simplified membrane mod-
els.[13, 14] In fact, Langmuir monolayers have long been used to elucidate the
partitioning of several molecules into the cell membrane.[15, 16] For EGCG, in
particular, we have found that it is incorporated in dipalmitoyl phosphatidyl glyc-
erol (DPPG) monolayers spread on an aqueous subphase (pH 6) and is able to
reduce damage caused by blue irradiation in DPPG molecules.[17]
We have decided to extend the study to other phospholipids that could mimic
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healthy and cancerous cell membranes, in addition to verifying if the antioxi-
dant effectiveness of EGCG can be compromised upon oxidation of the pheno-
lic rings, which depends on irradiation, temperature and pH.[18, 19, 20] The
phospholipids chosen were dipalmitoylphosphatidylcholine (DPPC)[21, 22] and
dipalmitoyl phosphatidyl serine (DPPS)[23, 24, 25], representing the healthy and
cancer cell membranes, respectively. We concentrated on probing whether the
partitioning of EGCG in the membrane is conditioned by lipid membrane com-
position (lipid net charge, polar termination, head orientation). Furthermore, we
investigated the effects from blue light irradiation at a neutral subphase (pH 7.4)
to analyse possible changes in EGCG structure that could lead to a conversion of
an antioxidant into a prooxidant behavior, i.e. EGCG could then damage rather
than protect the lipid monolayers.
6.2 Experimental
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dipalmitoyl–sn–
glycero-3–phospho–L–serine (sodium salt) (DPPS) were obtained from Avanti
Polar Lipids. DPPC were dissolved in chloroform to result in a concentration of
0.5 mg/mL. In the case of DPPS, this phospholipid were dissolved in a mixture of
chroform:methanol:water (65:30:5 v/v) to obtain a concentration of 0.5 mg/mL.
The EGCG (M.W. 458.4 g/mol) was purchased from Sigma- Aldrich and dissolved
in chloroform to render a 0.3 mg/mL solution.
Langmuir monolayers were obtained after spreading aliquots of the lipid so-
lutions on the phosphate buffer saline subphase of the Langmuir minitrough
from KSV Instruments. After 10 min the solvent evaporated and two symmetric
barriers start to move at a constant speed of 10 mm.min−1, initiating the sur-
face pressure measurements. All the experiments were carried out in a class
10,000 clean room and they were repeated at least three times to ensure repro-
ducibility of the isotherms. The membrane compressibility modulus (Cs−1) was
obtained from isotherms using the following equation: Cs−1 = −A
(
∂pi
∂A
)
T
, where
A is the average area per lipid and pi is the monolayer surface pressure. The
polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS)
measurements were carried out in a KSV PMI 550 instrument (KSV Instruments,
Finland), operating at a high frequency and at an incidence angle of 80◦, after
compress the monolayer up to 30 mN m−1. All the lipid spectra shown were
obtained by subtracting the spectrum of a phosphate buffer solution subphase at
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the same temperature as that of samples. The morphology of the Langmuir mono-
layers at air/water interface was studied by Brewster angle microscopy (BAM).
Imaging apparatus consists in an ultra-objective BAM 2 Plus microscope (Nano
Film EP4 Technology, Germany) connected to a high quality GigE CCD camera
and to a light source (480 nm laser). The evident contrast in BAM images displays
the clean water surface (no reflection, dark regions) and the monolayer domains
(reflection, bright regions).
In irradiation experiments, the lipid monolayers were exposed to blue led
light (ca. 460 nm, with nominal light intensity of 77.1 mW/cm2) for 1h. The light
source was placed perpendicularly to the Langmuir through (25 cm above the
surface) to irradiate the entire monolayer surface. Control experiments were per-
formed with the same setup but without the blue LED source. Also, the changes
in lipid chemical composition and morphology due to irradiation were analysed
by PM-IRRAS spectroscopy and BAM microscopy, respectively.
6.3 Results
6.3.1 Effect of EGCG on DPPC and DPPS monolayers: analysis
of surface–pressure isotherms
The surface pressure-area isotherm for pure DPPC on a PBS subphase in Fig-
ure 6.1A displays a first-order transition from the liquid expanded to liquid-
condensed (LE/LC) phases, with a plateau at 5-10 mN/m. The DPPC monolayer
collapsed at 62.1±1.5 mN/m, a collapse pressure similar to those reported in
the literature [26, 27]. Regardless of the composition of the mixed DPPC/EGCG
monolayers, the presence of EGCG shifts the surface pressure-area isotherms to
smaller areas. Moreover, the LE/LC transition is less pronounced (although still
present) when large amounts of EGCG were incorporated, consistent with the
condensing effect of EGCG on DPPC monolayers. The compressional modulus
(Cs−1) is a measure of the monolayer elasticity, where values below 100 mN/m
denote the LE state and values ranging from 100 to 250 mN/m are typical of
the LC state [22]. Here, at the surface pressure mimicking the cell membrane
(30 mN/m), Cs−1= 159±16 mN/m for a pure DPPC monolayer (i.e. in the LC
phase), while for DPPC+50%EGCG mixture Cs−1= 97±11 mN/m, which means
that EGCG incorporation turns the DPPC monolayer more compressible. Further-
more, the differences in the compressional modulus indicate that EGCG affects
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the lipid chain packing and modifies the orientation of DPPC headgroups with re-
spect to the membrane plane. Figure 6.1B shows a typical isotherm for DPPS with
a collapse surface pressure of 63.4±1.4 mN/m, consistent with the literature [28,
29, 30]. As observed for DPPC, the presence of EGCG shifted the DPPS isotherms
to smaller molecular areas. The decrease in lipid area with EGCG concentration
in the monolayer at 30 mN/m is plotted in Figure 6.1C, where the condensing
effect of EGCG on the DPPC monolayer is more pronounced than on DPPS mono-
layer. Moreover, the compressibility of DPPC monolayer (inset in Figure 6.1A)
decreased with all the EGCG concentrations studied, whereas the compressibil-
ity of the DPPS monolayer was only significantly affected by the highest EGCG
concentration (50 mol%). Both DPPC and DPPS phospholipids have the same
tail length but their headgroups are distinct, particularly in the surface charge
density. While electrostatic repulsion is expected among the anionic DPPS head-
groups, intermolecular hydrogen bonding may occur between the phosphate and
NH+3 groups of two adjacent DPPS molecules.[31] It seems that the result of these
opposing trends is a decrease in area per molecule induced by EGCG that is larger
for DPPC than for DPPS. The reason why these intermolecular interactions in
DPPC are stronger than in DPPS could be the difference in lipid packing density
as the phase transition temperatures are 41◦ and 54◦ for DPPC[32] and DPPS[33].
Thus, from the analysis of these physical parameters, i.e. area per lipid and
compressional modulus, one infers that EGCG interacts with both neutral and
anionic phospholipids, promoting monolayer condensation. The differences in
the headgroups seem to regulate the strength of the intermolecular interactions
that take place at the monolayer/water interface, which might determine the
degree of monolayer condensation triggered by EGCG (see PM–IRRAS results for
further discussion).
6.3.2 Molecular reorganization of neat and mixed monolayers
upon blue irradiation: PM-IRRAS study
Phospholipids exhibit characteristic vibrational bands at 2920-2850 cm−1, 1710-
1740 cm−1 and 1220-1090 cm−1assigned to the acyl CH2 chains, carbonyl groups
and phosphate groups, respectively. These are very sensitive to the environmental
factors, such as dipolar interactions, protonation state, hydration force changes,
and can thus reflect subtle lipid conformational changes due to blue irradiation
exposure. Table 6.1 shows the assignments of the main vibrational modes of
DPPC monolayer along with the shifts caused by EGCG and upon blue light irra-
diation. In the PM-IRRAS spectrum of neat DPPC monolayer, Figure 6.2A, the
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Figure 6.1: Surface pressure isotherms registered for DPPC (A) and DPPS (B)
monolayers containing different EGCG molar fractions. The compressional mod-
ulus corresponding to each monolayer is shown in inset. At the surface pressure
of 30 mN/m, the lipid molecular area decreases as the amount of EGCG increases
in the monolayer (C).
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bands at 2909 cm−1 and 2852 cm−1 are ascribed to the asymmetric and symmet-
ric CH2 stretching, respectively. The shift of these bands to higher frequencies
( 2919 and 2857 cm−1) upon blue irradiation is clear evidence of the increase in
the number of gauche conformers, and hence of a conformational disordering of
the lipid alkyl chains. In the mixed EGCG/DPPC monolayer, these bands are
located at 2930 and 2828 cm−1. The data suggest that the geometric accommo-
dation of EGCG and the interactions established at the headgroup region seem
to imply conformational changes in the lipid tails, as illustrated schematically in
Figure 6.4B. This is consistent with the compressional modulus measurements,
where the EGCG/DPPC monolayer was more fluid than a neat DPPC monolayer.
Furthermore, these bands shifted to lower frequencies when the monolayer was
submitted to radiation, suggesting a new organization of the hydrocarbon tails,
possibly because radiation affects the EGCG molecules and promotes their mi-
gration towards the water interface. The shift in the asymmetric and symmetric
CH2 stretching bands towards higher frequencies also occurred in DPPS/EGCG
monolayers (Figure 6.2 D), thus indicating that EGCG disturbs the packing of
DPPS alkyl chains similarly to that observed for DPPC. After irradiation, a new
band at 2820 cm−1 appeared in Figure 6.2C for the DPPS monolayer. This band
is assigned to the symmetric CH3 stretching, being indicative of disordering of
the alkyl chains arising from the vulnerability of DPPS lipids to radiation. Table
6.2 shows the assignments of the main vibrational modes of DPPS monolayer
along with the shifts caused by EGCG and upon blue light irradiation. For the
mixed EGCG/DPPS monolayer in Figure 6.2D, a new band appeared at 2959
cm−1 (asymmetric CH3 stretching) and the asymmetric CH2 stretching band was
red-shifted to a wavenumber close to that of pure DPPS monolayer. The relative
intensity of this band increases, possibly because some EGCG molecules are ex-
pelled from the monolayer, which elicits conformational changes in lipid tails.
The interaction between EGCG and DPPC seems to be stronger than with DPPS,
or at least the EGCG seems to be inserted more deeply into the DPPC membrane,
as the CH2 stretching bands in the mixed EGCG/DPPC monolayer did not change
markedly upon irradiation. Finally, our results suggest that the membrane flu-
idity is strongly dependent on EGCG concentration, and therefore EGCG can be
used to enhance the intracellular trafficking of chemotherapeutic drugs across
cell membranes to destroy abnormal DNA.
We also analyzed the vibrational mode assigned to the ester carbonyl C=O
stretching (1736 cm−1), the asymmetrical stretching mode of phosphate group
(1265 cm−1) and of the choline group (+N (CH3)3, 970cm−1). The carbonyl (C=O)
band in neat DPPC monolayer is split into two bands at 1747 cm−1 and 1735 cm−1
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Figure 6.2: PM-IRRAS spectra for neat DPPC, mixed EGCG/DPPC, neat DPPS
and mixed EGCG/DPPS monolayer in the lipid alkyl chains (A-D) and carbonyl
(E-H) region, before and after blue light irradiation.
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Figure 6.3: PM-IRRAS spectra for neat DPPC, mixed EGCG/DPPC, neat DPPS
and mixed EGCG/DPPS monolayer in the phosphate (A-D) and choline (E-H)
region, before and after blue light irradiation.
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assigned to non-hydrated and hydrated carbonyl groups close to the headgroup,
respectively. Upon blue irradiation the carbonyl band in Figure 6.2E becomes
broader and the bands shift to lower frequencies (1740 and 1722 cm−1). The
fraction of hydrated carbonyl groups decreases from 79.4% to 55.3% (1.4 fold
decrease) upon irradiation, indicating disruption in hydrogen bonding between
DPPC lipids. In the presence of EGCG, the bands associated with non-hydrated
and hydrated carbonyl groups are shifted to lower frequencies (1738 and 1720
cm−1), probably due to interactions with the phenolic rings of EGCG. It seems
that such interactions are responsible for protecting carbonyl groups from radia-
tion damage, as indicated by the small change in the fraction of hydrated carbonyl
groups after irradiation (from 68.9% to 61.3%). Furthermore, the well defined
peak at 1435 cm−1 assigned to δCH2 methylene deformation (Appendix B) in-
dicates that EGCG also binds electrostatically to positively charged quaternary
ammonium headgroups of DPPC lipids, in addition to hydrogen bonding with
the carbonyl groups.
The strong intermolecular interactions between the amine hydrogen and ser-
ine carbonyl oxygen groups in DPPS lead to a pronounced aggregation associated
with disordering in the acyl chains, which affects the water movement from the
interface to the lipid tail chains and restricts the headgroup motion.[31] Accord-
ingly, the carbonyl bands of DPPS in Figure 6.2G are located at higher frequencies
(1774 and 1765 cm−1) compared to that in DPPC phospholipids (1747 and 1735
cm−1). Also, the DPPS monolayer has a lower fraction of hydrated carbonyl groups
(35.4 %) than DPPC (79.4%). Regardless of the orientational distribution of the
interfacial water molecules in the lipids, dehydration resulted from irradiation on
the carbonyl groups of each lipid. Figure 6.2H shows that EGCG induces a large
red shift of 36 cm−1 in the carbonyl band owing to hydrogen bonding between
the phenol ring of EGCG and carbonyl groups of DPPS, similarly to that observed
in DPPC monolayer. Again, the anchorage of EGCG on carbonyl groups of DPPS
slows down the rate of oxidation of these groups due to radiation exposure.
The effect of EGCG on the hydration of the phosphate group of both DPPC and
DPPS phospholipids was also addressed. The spectra of neat DPPC monolayer
in Figure 6.3A show an intense band at 1265 cm−1 assigned to the antisymmet-
ric P=O stretching, consisting in two overlapping bands at 1242 cm−1 and 1269
cm−1 corresponding to hydrated and partially hydrated PO−2 groups, respectively.
Blue light irradiation during 1 h on the Langmuir trough led to a slight decrease
(4%) in the area per molecule for DPPC (Figure B.2 of Appendix B). This was
accompanied by a shift to lower frequencies (1227 and 1255 cm−1) in the anti-
symmetric P=O band and broadening of the (CO) ester stretching band (at 1169
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Figure 6.4: Illustrative model for DPPC monolayer (A) and EGCG interaction
with a DPPC monolayer (B). EGCG intercalates among DPPC molecules at the
air/water interface establishing H-bonding between the OH groups of EGCG and
P=O and C=O groups of DPPC (green circle), in addition to ion pairing inter-
actions between the charged oxygen groups of EGCG and the quaternary N+ of
DPPC (orange circle). From the differences in the ordering of acyl chains, it seems
that EGCG can insert into the hydrophobic region of the lipids. C. Illustrative
model for DPPS monolayer. D. Illustrative model for EGCG interaction with
a closely packed DPPS monolayer. The tighter packing of the DPPS monolayer
prevents EGCG penetration to the hydrophobic lipid chains. EGCG binds onto
the DPPS surface at the interface through H-bonding between the OH groups
of EGCG and P=O and C=O groups of DPPS (green circle), in addition to the
electrostatic interactions between the charged oxygen groups of EGCG and the
protonated amine NH3+ of DPPS (orange circle).
cm−1), suggesting some nucleophilic attack to DPPC polar moiety by oxidant
species produced by radiation. The red-shift of the antisymmetric P=O band
points to weakening of the P=O bonds and loss of electron density.[34]
The location of EGCG in the DPPC monolayer may be inferred from a com-
bined analysis of PM-IRRAS data and surface pressure isotherms. One of the
most important physicochemical property of a drug that affects its location and
orientation in a phospholipid monolayer is its ionization state. In an alkaline pH
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Table 6.1: Vibrational assignments and changes in band position of DPPC mono-
layer after blue light irradiation and interaction with EGCG.
Assignment PC PC+Blue PC+EG PC+EG+Blue
Asymmetric CH2 tails 2909 2919 2930 2915
Symmetric CH2 tails 2852 2857 2828 2848
Carbonyl 1747/1735 1740/1722 1738/1720 1736/1713
% Hydrated Carbonyl 79.4% 55.3% 68.8% 61.3%
Phosphate 1269/1242 1255/1227 1265/1236 1263/1236
% Hydrated Phosphate 64.6% 34.4% 44.4% 48.4%
Symmetric Phosphate 1093 1088 1083 1073
Asymmetric Choline 965 974 976 977
Symmetric Choline 935 945 928/963 933/970
environment, some of the phenol hydroxyl groups of EGCG are electron-donors
since they are deprotonated (pKa 7.8-8.7) [35, 36, 37], whereas DPPC molecules
are neutral. Hence, electrostatic interactions may occur: (i) between the hydrogen
of EGCG hydroxyl groups and the negative oxygen of DPPC phosphate groups,
and (ii) between EGCG oxygen groups and the nitrogen of DPPC choline group.
In a previous study[14], the incorporation of EGCG molecules was found to trig-
ger a reorganization of hydration water in the polar sites of dimyristoyl phos-
phatidyl choline (DMPC) due to their ability to form hydrogen bonding with
phosphate groups. Here, such hydrogen bonding is revealed by the slight shift
in the antisymmetric P=O stretching to lower frequencies (1236 and 1265 cm−1)
and the decrease in the fraction of hydrated phosphate groups (44.4%) compared
to neat DPPC monolayer (64.6%). Dehydration of phosphate groups is consistent
with the decrease in area per molecule by incorporating EGCG in Figure 6.1A.
Upon blue irradiation. The antisymmetric P=O and (CO)ester stretching bands
were not affected significantly in position and shape in the mixed EGCG/DPPC
monolayer, in contrast to what was observed in a neat DPPC monolayer. The
percentage of hydrated phosphate groups slightly increases (44.4% to 48.4%) in
the mixed EGCG/DPPC monolayer with irradiation because some EGCG are de-
graded. Upon being degraded, EGCG molecules no longer interact with the DPPC
headgroup, thus giving some space to water molecules to bind.
When examining the hydration status of DPPS phospholipids, the bands as-
signed to the hydrated and non-hydrated phosphate groups of DPPS in Figure
6.3C are seen at lower frequencies, 1196 and 1223 cm−1, respectively, than for
DPPC. Indeed, the orientation of the headgroup in relation to the surface plane is
distinct between zwitterionic and anionic phospholipids, with DPPS headgroup
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oriented perpendicularly whereas the DPPC headgroup is parallel to the mono-
layer plane [38, 39, 40, 41]. Hence, the results in Figure 6.3C suggest that the
phosphate groups of DPPS are oriented more vertically in relation to the interface,
maximizing intermolecular hydrogen bonding with the adjacent water molecules.
After irradiation, the (CO) ester band shifted from 1150 to 1157 cm−1 and the
pattern of the antisymmetric phosphate band changed. In particular, there was
a significant increase in the hydrated phosphate component, thus indicating that
part of the intermolecular H bonds formed between lipids has been disrupted
to generate sufficient space for water molecules to reorganize and bind to the
phosphate groups. Also, irradiation may affect phosphate – sodium counterions
interactions, which are responsible for the decrease in the repulsive headgroup
interactions. This may result in the faster release of counterions and uptake of
water molecules by the phosphate groups of DPPS. Upon EGCG addition, the
phosphate bands shifted to higher wavenumbers ( 1228 and 1260 cm−1), suggest-
ing that the binding of EGCG to phosphate groups involves replacement of water
molecules (Figure 6.3D). These results are consistent with those observed for
EGCG/DPPG and EGCG/DMPC monolayers in an aqueous subphase.[14, 17] It
is worth noting that EGCG molecules hamper the changes induced by blue irra-
diation on the band position in the PM-IRRAS spectra and fraction of hydrated
phosphate groups in mixed EGCG/DPPS monolayers. The protecting effect is
similar to that for EGCG/DPPC monolayers.
The damage induced by irradiation on the charged headgroups of DPPC and
DPPS was analyzed in the presence and absence of EGCG. Blue irradiation in-
duced shifts to higher frequencies on the bands assigned to the choline moiety of
DPPC. The bands at 935 and 965 cm−1, corresponding to the symmetric and
asymmetric (NCH3)
+
3 stretching, shifted to 945 and 974 cm
−1. In the mixed
EGCG/DPPC monolayer, the asymmetric (NCH3)
+
3 band (at 968 cm
−1) was decon-
voluted into two bands at 963 and 975 cm−1 assigned to (NCH3)+3 of DPPC lipids
and CH groups in the aromatic groups of EGCG, respectively. With EGCG, the
symmetric and asymmetric (NCH3)
+
3 bands shifted to 927 and 963 cm
−1 owing to
electrostatic interactions, with the choline group being oriented in a more verti-
cal position than in pure DPPC monolayer, thus reflecting the condensing effect
caused by EGCG. Upon irradiation, the shift in the choline band towards higher
frequencies was slightly smaller in the EGCG/DPPC monolayer (to 933 and 970
cm−1, i.e. a spectral difference ∼ 6 cm−1) than in the neat DPPC monolayer (spec-
tral difference ∼ 10 cm−1). Moreover, blue irradiation did not yield a significant
change in area per molecule for DPPC in the presence of EGCG molecules, given
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the similarity between the surface-pressure isotherms for EGCG/DPPC mono-
layer with and without irradiation (Figure B.2 of Appendix B).
The effect from blue light irradiation is stronger in the surface pressure isotherms
of DPPS than in the DPPC monolayer, according to Figure B.3A of Appendix B.
This can be attributed to the carboxylate and protonated amine NH3+ groups
in DPPS, which are more susceptible to radiation-damage than the (N(CH3)3)
choline group of DPPC. Indeed, the significant shift of 30 cm−1 in the choline
band of the monolayer under irradiation in Figure 6.3G indicates that this func-
tional group in the DPPS headgroup was attacked by irradiation. Nonetheless,
the incorporation of EGCG seems to shield these functional groups from radiation
since no considerable changes in surface pressure isotherms were caused upon
blue light irradiation in Figure B.3B of Appendix B. Accordingly, the wavenum-
ber position of choline bands in the spectra of the DPPS monolayers containing
EGCG were shifted from 958 to 966 cm−1, indicating hydrogen bonding between
the oxygen groups of EGCG and the protons of amine NH3+ of the DPPS head-
group (Figure 6.3H). In this case, the spectral shift in the antisymmetric choline
band induced by irradiation was not so drastic for DPPS monolayers containing
EGCG than for the pure DPPS ones.
In summary, EGCG molecules are incorporated into the headgroup region of
the DPPC monolayer, forming a very condensed monolayer that is more resistant
against oxidative stress-induced by blue irradiation than pure DPPC monolayers.
EGCG also binds onto a DPPS membrane as illustrated in Figure 6.4D and is
capable of scavenging the oxidant species arising from blue irradiation. In this
case, however, the EGCG insertion into the hydrophobic region of DPPS phospho-
lipids is hampered since the DPPS monolayer itself is dense and tightly packed
due to the strong intramolecular interactions between the quaternary ammonium
groups of DPPS and the phosphate or serine carbonyl groups of adjacent lipids.
6.3.3 Morphology and organization of neat and mixed
monolayers: BAM analysis
The BAM images indicate that EGCG affects lateral film organization and vis-
coelastic properties of a DPPC monolayer, consistent with the surface pressure
measurements. At the LE–LC plateau region in the surface pressure-area isotherms
(7 mN/m), the BAM images in Figure 6.5 show large chiral multilobed domains
of pure DPPC that fuse together, forming a homogeneous monolayer at pi= 20
mN/m. Also, blue irradiation causes significant decrease in the number and size
of DPPC domains, which delays the monolayer condensation (pi= 10-15 mN/m).
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Table 6.2: Vibrational assignments and changes in band position of DPPS mono-
layer after blue light irradiation and interaction with EGCG.
Assignment PS PS+Blue PS+EG PS+EG+Blue
Asymmetric CH2 tails 2912 2912 2921 2916
Symmetric CH2 tails 2842 2850 2849 2847
Carbonyl 1774/1765 1778/1769 1738/1724 1744/1719
% Hydrated Carbonyl 35.4% 20.3% 43.3% 38.4%
Phosphate 1223/1196 1221/1200 1260/1228 1262/1233
% Hydrated Phosphate 42.5% 50.4% 31.1% 26.3%
Symmetric Phosphate 1056 1058 1069 1062
Asymmetric Choline 958 988 966 960
Symmetric Choline 934 954 935 919
For instance, upon irradiation the DPPC domains at 10 mN/m are not so con-
densed and have a more rounded contour upon irradiation. The incorporation
of 10 mol% EGCG interferes with the domain formation and shape in the DPPC
monolayer, turning the domains smaller and rounded-shaped. At pi= 10 mN/m,
a different morphology with branched domains was observed for DPPC+10%
EGCG monolayer since EGCG disturbs intermolecular interactions. Upon further
compression, these irregular domains merge and the monolayer becomes com-
pletely homogeneous. After blue irradiation, the BAM images of EGCG/DPPC
monolayer taken at a surface pressure of 10 mN/m suggest that EGCG potentially
increases the stability of the monolayer against radiation, since there are no such
great differences in morphological appearance of the domains as in the neat DPPC
monolayer.
The BAM images of pure DPPS and DPPS+10% EGCG are shown in Figure 6.6,
which illustrate the impact of EGCG on the morphology and fluidity of phospho-
lipids domains at LE (7-10 mN/m) and LC (15-30 mN/m) phases. At 7 mN/m,
DPPS displayed irregular domains (size range: 7-20 ±3 µm ) dispersed within the
LE matrix, resulting from the intermolecular attractions between amine and car-
boxylic groups of DPPS molecules [42, 43]. These domains coalesced and formed
a homogeneous monolayer upon further compression. Morphological changes
were seen in the BAM images upon irradiation, with DPPS domains becoming
more rounded and smaller. After further monolayer compression, it is possible
to distinguish these domains in the irradiated DPPS monolayer. The BAM mi-
crographs of DPPS+10% EGCG monolayer showed condensed domains relatively
large (size range: 78±7 µm) with a distinct circular shape. Blue light does not
seem to affect the domain shape so drastically, although still two domain pop-
ulations can be distinguished at pi= 7 mN/m. It is worth mentioning that the
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Figure 6.5: BAM micrographs of DPPC and DPPC+10% EGCG monolayers at
several surface pressures before and after blue light irradiation.
Figure 6.6: BAM micrographs of DPPS and DPPS+10% EGCG monolayers ob-
tained at several surface pressures before and after blue light irradiation.
domains are much more condensed than for DPPS monolayer, suggesting that
EGCG effectively confers antioxidant protection under stress conditions.
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6.4 Conclusion
The findings from this study indicate that the incorporation of EGCG affects
the physicochemical properties of the zwitterionic (DPPC) and anionic (DPPS)
Langmuir monolayer, causing condensation of the monolayers. According to the
PM-IRRAS spectra, EGCG interacts with the lipid headgroup region, establishing
H-bonding with the phosphate and carbonyl groups of the lipids. The charged
oxygen groups of EGCG interact electrostatically with the protonated amine NH3+
groups of DPPS lipids. EGCG was found to affect the ordering of the DPPC hy-
drocarbon tails considerably, much more than it does with DPPS, which suggest
that EGCG inserts more deeply in the DPPC monolayer, possibily because the
quaternization of the amine group (N(CH3)3) of DPPC reduces the interactions
at the interface. Despite these differences, the blue light irradiation experiments
showed that EGCG has an antioxidant action independently of the phospholipid
headgroup properties, hence protecting the phosphate and carbonyl groups from
radiation in both monolayers. Nonetheless, the EGCG location in the lipid mem-
brane depends on the headgroup hydration and orientation in relation to the
membrane plane. The degree of intermolecular and intramolecular interactions
regulate the EGCG penetration into the hydrophobic region. Taken together, the
results presented here may have important implications for cancer therapy. It has
been shown that the effectiveness of chemotherapeutic agents is higher in cancer
cells when combined with EGCG [44, 45, 46, 47]. From our results we may spec-
ulate that EGCG can enhance the intracellular trafficking of chemotherapeutic
agents across cell membranes to destroy abnormal DNA because it increases mem-
brane fluidity in a concentration-dependent manner. Additionally, some of these
chemotherapeutic agents are inducers of apoptosis, a phenomenon presumably
more intense in the presence of EGCG due to an induced membrane fluidization
and destabilization, thus resulting in much lower survival of cancer cells.
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Results
On the role of epigallocatechin–3–gallate in protecting phospho-
lipid molecules against UV irradiation1
Abstract
Catechin molecules such as epigallocatechin–3–gallate (EGCG) are capable of
attenuating the biomolecular damage induced by UV radiation, possibly through
molecular mechanisms involving the cell membranes. In this study, we con-
firmed the protective role of EGCG against UV of 1,2-dipalmitoyl-sn–glycero–
3–[phospho–rac–(1–glycerol)] (sodium salt) (DPPG) in liposomes and cast films.
The incorporation of EGCG increased the stability of DPPG liposomes as indi-
cated by UV–vis absorption spectra. Using 2D correlation spectroscopy to analyse
the spectra, we found that DPPG and EGCG are co-helpers and complement each
other against degradation induced by UV. At the molecular level, UV irradiation
affects the phosphate and carbonyl groups of DPPG, in addition to triggering
the oxidation and opening of the pyrogallol ring of EGCG. Since EGCG can be
incorporated into liposomes and is a strong shield against UV radiation, one may
envisage its use in anti-ageing and sunscreen creams, and in dermal drug delivery.
1This chapter is based on the following publication:
Pires, F., Geraldo, V. P., Antunes, A., Marletta, A., Oliveira Jr, O. N., and Raposo, M.. On the
role of epigallocatechin-3-gallate in protecting phospholipid molecules against UV irradiation.
Colloids and Surfaces B: Biointerfaces 2019, 173: 312-319, DOI:10.1016/j.colsurfb.2018.09.065
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MOLECULES AGAINST UV IRRADIATION
7.1 Introduction
Excessive exposure to ultraviolet (UV) radiation, either natural (sunlight) or ar-
tificial (tanning beds), is the main driving force for the dramatic increase in
skin cancer cases around the world. The exposure to a high dose of UV radi-
ation produces reactive oxygen species (ROS) through water radiolysis, which
weakens the immune system, affects the integrity and homeostasis of cell mem-
branes, and ultimately causes DNA damage and premature photoaging.[1, 2] Can-
didate – molecules for photoprotection of DNA and lipids may be involved both
in displacing surrounding water, thus reducing production of hydroxyl groups
from collision between secondary radiation/particles (radiation track) and water,
and in local quenching/neutralization of ROS to reduce breaks in DNA strands
caused by radiation exposure. Catechin molecules, such as epigallocatechin–
3–gallate (EGCG), are possible candidates since they are strong antioxidants
present in large quantities in green tea, which attenuate and repair the dam-
age of biomolecules induced by radiation.[3, 4, 5, 6] After 1h of drinking a cup of
green tea, the concentration of catechins in the bloodstream is sufficient to hinder
formation of intracellular ROS, thus reducing the oxidation-induced lesions in
DNA. [7]
The efficiency of catechins, however, depends on the diffusion rate towards the
extracellular medium/cell membrane interface, which is hindered by their vulner-
ability to chemical degradation (dimerization, glycosylation and oxidation) and
by the rapid clearance from the systemic circulation. Therefore, nano–systems
such as liposomes[8], transfersomes [9], nanoethosomes [10, 11] and nanoparti-
cles [12, 13] have been designed to increase the therapeutic efficiency of catechins
on the layer skin (stratum corneum and epidermis) [14, 15, 16] and on the deepest
epidermal layers (stratum basale)[17, 18]. This allows for a localized, controlled
release of catechins to protect skin from UV-induced damage. In addition to oral
administration of EGCG, topical application of EGCG solution minimizes com-
plications such as pain, itching and burning feeling in patients with radiation-
induced dermatitis, a side effect of breast cancer radiotherapy.[19] In Fang et
al.[20], liposomes of egg phosphatidylcholine alone or mixed with anionic species
were prepared to topically deliver EGCG on the skin and locally in the tumour to
treat basal cell carcinoma in female nude mice. They showed that the presence of
the gallate moiety in EGCG, and not in other catechins, increases the lipophilicity
of EGCG and leads to a higher encapsulation efficiency, yielding a higher, faster
uptake in the skin and tumour than for other catechins.
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In this paper, we assess the protective role of EGCG against UV of 1,2 – di-
palmitoyl – sn – glycero – 3 – [phospho – rac – (1 – glycerol)] (sodium salt) (DPPG)
in liposomes in solution, in addition to comparing with cast films. DPPG was
chosen because we wish to test the hypothesis of whether EGCG can be encap-
sulated into DPPG liposomes for pulmonary and skin administration, which can
decrease inflammation and the side – effects of oxidative stress. DPPG liposomes
have fusogenic properties that allow for a direct fusion of liposomes with cell
membranes and act like skin-penetration enhancers for dermal applications.[21,
22] Furthermore, DPPG liposomes may incorporate magnetic nanoparticles that
would be less toxic than if encapsulated in cationic liposomes.[23, 24, 25]
7.2 Experimental details
7.2.1 Materials
EGCG (M.W. 458.4 g/mol) and DPPG (M.W. 744.96 g/mol), whose chemical
structures are shown in the insets of Figure 7.1, were purchased from Sigma-
Aldrich and Avanti Polar Lipids, respectively.
7.2.2 Liposomes Preparation
DPPG liposomes were prepared using the dry film method [23, 26], with a mix-
ture of chloroform and methanol 4:1 (v:v) to dissolve 5mM DPPG. A gentle stream
of nitrogen was used to evaporate the solvent and form a thin lipid film on the
walls of a falcon tube. To remove the residual traces of solvent, the falcon tube
was placed in a primary vacuum system overnight. Then, the lipid films were
hydrated for 2h with ultrapure water or with a 450 µM EGCG aqueous solution
to obtain DPPG or DPPG + EGCG liposomes, respectively, in suspensions with a
lipid concentration of 5mM. All the liposomes were prepared with Milli-Q ultra-
pure water (Millipore GmbH, Billerica, MA). A tip sonicator (UP50H, Hielscher
Ultrasonics, GmbH, Germany) was used to sonicate the vesicle suspensions, in an
ice bath, to obtain small unilamellar vesicles (SUVs). The procedure was repeated
15 times with 1 min interval between sonication cycles of 30 s. For DPPG+EGCG
liposomes, dialysis membranes of regenerated cellulose (Spectra/Pro, Biotech
USA) were used to discard non-bound or non-entrapped EGCG molecules in
the liposomes. DPPG + EGCG suspensions (10 mL) were placed into the dial-
ysis membrane with the cutoff size of 8–10 kDa and dialyzed against 1000 mL
H2O Milli-Q in a water bath at 37 ◦C for 48h. The percentage of encapsulated
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EGCG molecules was determined from the absorbance spectra measured with
a Shimadzu UV–vis spectrometer, model UV 2101, before and after the dialysis
procedure. The encapsulation efficiency of ca. 67% was estimated by calculating
the ratio between the absorbance at 274 nm of the vesicle suspensions DPPG +
EGCG after and before dialysis. The equilibrium dialysis technique was also used
to determine the liposome/water partition coefficient (Kp) for EGCG using the
equation below:
Kp =
nL ×Vwater
nW ×VLipid (7.1)
where nL and nW are the numbers of moles of EGCG in the lipid bilayer and
in the water at the equilibrium, respectively, and VL and VW are the volumes
of liposomes inside the dialysis bag and in water, respectively. The partition
coefficient of EGCG into DPPG liposomes was 1.9, i.e. EGCG is a lipophilic
compound that easily incorporates into the vesicles.
7.2.3 Irradiation of samples
The irradiation studies were performed using aqueous solutions of 15 µM EGCG
and vesicle suspension of 0.5mM DPPG and DPPG + EGCG after dialysis. Cast
films were prepared using the drop casting method, i.e, depositing some drops of
aqueous solutions and vesicle suspensions onto calcium fluoride (CaF2) substrates
that had been cleaned with a 2% mucasol solution, ethanol, ultrapure water and
then dried with a nitrogen flux. The vesicle suspensions placed in closed quartz
cells as well the cast films deposited on CaF2 substrates were irradiated with a
254 nm UVC germicide lamp (Philips TUV PL-S 55W/2P 1CT) at a radiance of
1.9 W/m2. The damage caused by UV radiation was recorded by measuring the
UV–vis and infrared absorption spectra of the solution/vesicle suspension and
cast films, respectively, over the irradiation time. The infrared measurements
were performed with a Fourier transform infrared (FTIR) spectroscope Thermo
Scientific Nicolet–model 530 (Waltham, MA, USA) in the transmittance mode at
a resolution of 4 cm−1 and 128 scans.
7.2.4 Principal component analysis
Principal component analysis (PCA) is a statistical method that converts a set of
data of correlated variables into a set of values of linearly uncorrelated variables
(principal components).[27, 28] PCA was performed using a correlation matrix,
where the original variables are all standardized and the total variance is equal
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to one. The data matrix was built using the UV–vis or the IR spectra for dif-
ferent UV irradiation times. The UV–vis region analysed was between 190–400
nm. For IR, the regions chosen were between 1145–1319 cm−1, 1315–1541 cm−1
and 1700–1760 cm−1, corresponding to absorption bands assigned to phosphate
stretching, CH2 scissoring and carbonyl stretching, respectively. The PCA anal-
ysis was applied to samples of DPPG and DPPG + EGCG to extract information
about the protective role of EGCG against UV damage.
7.2.5 2D–correlation spectroscopy
Since the changes in the UV-–vis spectra induced by irradiation are not straightfor-
ward to analyse, 2D-correlation spectroscopy was also applied. This mathematical
technique is used to analyse small changes in measured signals when a sample is
subjected to an external perturbation. In the present case, the perturbation comes
from irradiation and the measured signals are the UV–vis spectra. This technique
consists in obtaining the 2D correlation spectrum, X(λ1,λ2), which allows for a
quantitative comparison of variation patterns in spectral intensities at two differ-
ent spectral variables, the wavelength λ1 and λ2, along the external variable of
perturbation. Here, this variable is the time, t, represented by the expression:[29]
X(λ1,λ2) =
〈
y˜(λ1, t) · y˜(λ2, t)〉 = Φ(λ1,λ2) + iΨ (λ1,λ2) (7.2)
where the symbol 〈〉 is a cross-correlation function to compare the dependence
patterns of the chosen quantities y˜(λ1, t) and y˜(λ2, t). These are also designated as
dynamic spectra, which can be obtained when a perturbation-induced variation is
observed during a fixed interval of irradiation time t. Considering a perturbation-
induced variation of a spectral intensity, y(λ2, t) measured over a limited range
with minimum time (tmin) and maximum time (tmax), one can calculate the dy-
namic spectra, by:
y˜, (λ,t) = y(λ,t)− 1
(tmax − tmin)
∫ tmax
tmin
(λ,t)dt (7.3)
The 2D correlation spectrum can be also treated as a complex number func-
tion where the real component, Φ(λ1,λ2) corresponds to the synchronous 2D
correlation intensity map and the imaginary part yields the asynchronous 2D
correlation intensity map,Ψ (λ1,λ2). The first represents the similarity or coin-
cidental absorbance changes at a given wavelength when a sample is submitted
to a perturbation-time changing from tmin to tmax. The second part is the asyn-
chronous 2D correlation spectrum, representing absorbance variations out-of
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phase or dissimilarities (the events occur at different irradiation times).[29, 30] It
should be noted that the horizontal and vertical axes of these maps correspond
to the wavelengths (λ) of the UV–vis spectra measured.As for the interpretation,
the synchronous maps are symmetric in respect to a diagonal line correspond-
ing to wavelength coordinates λ1 = λ2. If the UV–vis spectra change with ir-
radiation time, peaks will appear in the diagonal (auto-peaks) and off-diagonal
positions.[31] 2D Shige software for two-dimensional correlation spectroscopy,
a free software by Shigeaki Morita (Osaka Electro-Communication University,
Japan)[29, 31], was employed to verify radiation induced-damage on cast films of
DPPG, EGCG and DPPG + EGCG by using UV–vis spectra.
7.3 Results and discussion
7.3.1 UV radiation influence on EGCG incorporated in
liposomes
7.3.1.1 Analysis of UV damage via UV–vis spectroscopy
UV–vis spectroscopy was used to analyse the damage caused on EGCG solutions
and DPPG and DPPG + EGCG vesicle suspensions exposed to 254 nm UV light.
We recall that EGCG + DPPG vesicle suspension was subjected to dialysis prior
to irradiation to eliminate EGCG molecules that were not interacting with the
liposomes. The encapsulation efficiency for EGCG into the liposomes was 67%.
The absorption spectrum of EGCG in pure water in Figure 7.1a exhibits two
bands at 206 nm and 274 nm, assigned to electronic transitions on aromatic rings
and n-pi∗ transition involving oxygen electrons from the gallic acid group[32, 33],
respectively. Even in the dark at room temperature, EGCG aqueous solutions (not
exposed to UV) are already changed over time, as indicated by the slight decrease
in intensity of the peaks at 206 nm and 274 nm in Figure 7.1a. Such changes
could be attributed to the tendency of EGCG to suffer dimerization in aqueous
solutions owing to its amphipathic nature and the number of hydroxyl groups
in its aromatic rings.[34, 35] As expected, the band intensity decreased sharply
upon exposure to UV radiation, with the EGCG solution being almost entirely
bleached after 2340 min (39 h) of irradiation in Figure 7.1b.
The spectra of DPPG liposomes in Figure 7.1c display an absorption band near
198 nm, consistent with the typical band at 194.4±0.7 nm[36] for DPPG molecules
assigned either to the transition from the lone-pair on the carbonyl oxygen to the
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Figure 7.1: Absorption spectra of EGCG (a,b), DPPG liposomes (c,d) and DPPG
+ EGCG liposomes (e,f). Samples of control group (a,c,e) were maintained in
the dark and the absorbance spectra were recorded over time in order to analyse
the stability of each sample during storage. The remaining samples (b,d,f) were
exposed to 254 nm UV light over time.
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antibonding piCO valence orbital[37, 38], n0→ pi∗CO, or to the valence shell elec-
tronic excitations of hydroxyl groups.[39, 40, 41, 42] The appearance of a new
band at 215 nm shows that during storage the DPPG molecules undergo a possi-
ble oxidation process. This oxidation is enhanced upon exposure to UV radiation,
with the band at 215 nm increasing with irradiation time and shifting to 222 nm
after prolonged irradiation in Figure 7.1d. Hydrolysis and oxidation are the main
degradation pathways of lipids. Ionizing radiation triggers water radiolysis to
form radicals such as hydroxyl (OH), hydrogen peroxide (H2O2) and hydroper-
oxyl. In polyunsaturated lipids, these radicals attack the hydrogen of methylene
groups, with rearrangement of carbon double bonds to form conjugated dienes.
Oxidation of these lipids can be monitored by measuring the absorption band of
conjugated dienes between 215 and 250 nm.[43] In saturated phospholipids, the
ester bonds and hydroxyl groups attached to the polar moiety are attacked by rad-
icals arising from the radiation exposure. For DPPG, irradiation leads to degrada-
tion products such as dipalmitoylphosphatidic acid, 1,2–dipalmitoyl–sn–glycerol–
3–phospho-(1,3-dihydroxyacetone), dipalmitoyl–sn–glycerol–3–phosphoryl, (1,2–
dihydroxypropaldehyde), 1–palmitoyl–sn–propanediol–3–phosphorylglycerol and
1,2–dipalmitoyl–sn–glycerol–3–phosphorylethanol.[44]
The spectra of DPPG + EGCG samples not exposed to radiation in Figure 7.1e
suggest that the addition of EGCG enhanced liposomes stability since there was
no evidence of the peak at 215 nm. In the spectra of irradiated DPPG + EGCG
liposomes in Figure 7.1f, the peak at 215 nm only appeared after the characteristic
peaks of EGCG, now centred at 202 nm and 276 nm, disappeared, indicating that
the EGCG molecules were subjected to damage. From these data, we suggest
that part of EGCG molecule, viz. the gallate group responsible for the peak
at 276 nm, penetrates the phospholipid bilayer leaving the other groups of the
molecule (202 nm) outward facing. These groups act as a protection shield for
the liposomes, being directly exposed to UV radiation instead of DPPG molecules.
After 2340 min, the EGCG protecting shield was disrupted and UV radiation
began to attack the phospholipids (thus causing the 215 nm band to appear).
From the absorbance data we conclude that EGCG has affinity to the lipid bilayer
and this interaction is sufficient to protect DPPG from oxidation during ca. 1860
min (31 h). The absorbance spectra for DPPG and DPPG + EGCG taken before
and after irradiation are displayed in Figure 7.2a for comparison.
The effects from UV irradiation time are more clearly seen by plotting the
absorbance at 206 nm in Figure7.2a, with the following worth observing features:
I) for EGCG solution, absorbance decreases exponentially with the irradiation
time, with a characteristic time of 650 ± 20 min (10.8 ± 0.4h) and correlation of
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Figure 7.2: a. Absorption spectra of DPPG liposomes and DPPG + EGCG lipo-
somes before and after irradiation. b. Absorbance at 206 nm of DPPG (black
square), EGCG (black circle) and of EGCG encapsulated or on DPPG liposomes
(empty triangle) as a function of UV irradiation time. The solid lines represent
the fittings. c. Experimental and calculated absorbance at 206 nm of EGCG en-
capsulated in DPPG liposomes (red circle) versus irradiation time. The lines are
only to guide the eyes. d. PCA for the UV–vis spectra of DPPG and DPPG +
EGCG liposomes, in the region between 190–400 nm, over irradiation time
0.996; II) for DPPG vesicle suspension, absorbance is practically unaffected until
1860 min (31 h) of irradiation, then increased linearly with time at a slope of
(2.3± 0.2)×10−4min−1 and correlation coefficient of 0.986; III) for DPPG + EGCG
vesicle suspension after dialysis the absorbance decreased exponentially until an
irradiation time of 840 min with a characteristic time of 960 ± 60 min (16 ± 1h)
and correlation coefficient of 0.981, followed by a slight increase. The analysis
of the UV effects is complicated by the fact that for EGCG the absorbance always
decreases while for DPPG there is an increase in absorption after long exposure.
If we assume that the damages caused by UV on the two types of molecule were
independent, the absorbance at 206 nm should follow the curve in Figure7.2b la-
belled as DPPG + EGCG calculated data. This latter curve was obtained from the
measured absorbance at 206 nm in Figure 7.2a versus the irradiation time of the
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EGCG and DPPG samples, and then normalized taking into account the respec-
tive concentrations of EGCG and DPPG. The absorbance values for each EGCG
and DPPG samples were then added to yield the calculated curve in Figure7.2c.
The actual dependence (DPPG + EGCG experimental data), also shown in this
figure, indicates that EGCG molecules protect DPPG from being oxidized, as the
increase in absorbance is much less than the predicted based on independent
processes.
Figure7.2d shows the PCA plot for the UV–vis spectra of DPPG and DPPG +
EGCG samples, where each dot represents a sample of DPPG or DPPG + EGCG
liposomes irradiated with UV light over a specific time. The general idea is that
if liposomes are more resistant against UV damage the PCA data should cluster.
In the PCA analysis, clustering results from the transformation of the dataset
to a coordinate two dimensions system: first principal component and second
principal component. So, the dots are spread out along a diagonal line (the two
endpoints of this line represent the maximum variation in the dataset), PC1, but
also, they are spread out above and below this line (representing the second most
variation), PC2. Thus new X and Y axes are created which describe the variation
in the dataset. The negative and positive signs suggest the direction a given vari-
able in that principal component axis is going for along that single dimension
vector. The magnitude gives the strongest/weakest correlation of a variable with
each component axis. Figure7.2d shows the PCA biplot for the UV–vis spectra of
DPPG and DPPG + EGCG samples, where the cumulative variance is 91.15% for
the two first components (PC1 and PC2). There is clear separation of the points
corresponding to DPPG liposomes, indicating dissimilarities in the samples re-
sulting from the lipid-structural changes induced by UV radiation exposure. In
contrast, the points corresponding to the DPPG + EGCG liposomes are closer
to each other, thus suggesting that EGCG molecules slowdown the cascade of
oxidant events responsible for damaging the lipid, at least to a certain extent.
7.3.2 2D-Correlation Spectroscopy applied to UV–vis spectra
Two-dimensional (2D) analysis on 200–400 nm region over radiation time range
0–3120 min was performed and the results are shown in Figure7.3. In the syn-
chronous map of EGCG (Figure7.3 Ia), one autopeak at 206 nm was obtained,
indicating a change in the absorbance. The peak at 206 nm, associated to the
aromatic ring of EGCG, decreased exponentially with the irradiation time. In the
asynchronous map in Figure7.3 Ib, two positive cross-peaks ((206, 225 nm), (206,
276 nm) and one negative correlation peak (198, 206 nm) appear. According to
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Figure 7.3: a) Synchronous and b) asynchronous 2D correlation maps in the wave-
length region between 190 and 300 nm of aqueous solutions of EGCG, vesicle
suspension of DPPG and DPPG + EGCG. All these solutions and vesicle suspen-
sion were irradiated with 254 nm UV during different periods of time. Red and
blue colours mean positive and negative correlation, respectively.
Noda’s rule, the cross-peaks become positive if the absorbance change at 206 nm
(abscissa scale (λ1)) occurs prior to the change in absorbance at 225 and 276 nm
(ordinates scale (λ2)). On the other hand, the negative crosspeak appears when
the change at λ1= 198 nm occurs predominantly after λ2= 206 nm. Based on
these results, it is inferred that the UV light damages the band at 206 nm in the
first place, and then the bands at 225 and 276 nm associated with the gallic acid
ring of EGCG.
The synchronous map for DPPG in Figure7.3 IIa presents two auto-peaks at
193 and 225 nm and a positive crosspeak (193, 226 nm). This indicates that these
141
CHAPTER 7. ON THE ROLE OF EGCG IN PROTECTING PHOSPHOLIPID
MOLECULES AGAINST UV IRRADIATION
bands, assigned to the carbonyl oxygen and hydroxyl groups of DPPG, are af-
fected by UV light simultaneously. The asynchronous maps reveal the sequential
changes of the spectral intensities in response to radiation time showing, in the
case of DPPG, one positive crosspeak at (215, 226 nm) and another negative cross-
peak at (198, 215 nm). According to Noda’s rule, as the crosspeaks (193, 226 nm)
and (198, 215 nm) in the synchronous and asynchronous maps, respectively, have
opposite signs, the change in intensity of the 198 nm absorbance peak occurs after
the change in the 215 nm absorbance peak. The absorbance spectra in Figure 7.1
corroborate this interpretation.
For DPPG + EGCG, the synchronous map in Figure7.3 IIIa) displays one au-
topeak at 203 nm and two positive cross-peaks at (203,232 nm) and (203, 275
nm), indicating that the spectral intensity variation of the 203 nm peak is related
to the changes in the 232 nm and 275 nm peaks. In other words, the change in
the 203 nm peak is correlated to the UV-induced damage on the phospholipid
structure (peak at 232 nm) and gallate ring of EGCG (275 nm). It should also be
mentioned that the notorious absence of the autopeak at 225 nm in the DPPG +
EGCG synchronous maps, previously observed in the DPPG synchronous maps,
indicates that EGCG molecules protect the lipid’s integrity against oxidative stress
to a certain extent. The two positive crosspeaks at (219, 232 nm), (219, 275 nm)
and the negative crosspeak at (203,219 nm) in the asynchronous maps of DPPG
+ EGCG, in Figure7.3 IIIb), indicate that the 219 nm peak changes prior to the
change in the 232 nm and 275 nm peaks, while the change in the 203 nm peak
occurs predominantly after the change in the 219 nm peak. These results show
that DPPG protects EGCG molecules from radiation since the absorbance peaks
of DPPG (219 and 232 nm) were affected before those of EGCG (203 and 275 nm).
In summary, EGCG and DPPG are co-helpers against oxidative stress-induced by
UV radiation.
7.3.3 Analysis of UV damage via infrared spectroscopy
The effects from UV irradiation are seen in the FTIR-spectra of EGCG, DPPG and
DPPG + EGCG cast films in Figure7.4a. The FTIR spectra of EGCG shown in this
Figure are altered considerably by UV irradiation, especially at the 1340 and 3360
cm−1 band assigned to O-C=O of gallic acid and OH-attached to aromatic rings of
EGCG, respectively. Furthermore, in the case of EGCG samples, some molecules
may have come off the solid support during the successive irradiation procedure.
The entire assignment for the bands in Figure7.4a is given in Table 7.1, Table
7.2. The DPPG liposomes deposited onto a solid support are much less affected
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by UV irradiation, though some degradation occurs in hydrophobic hydrocarbon
tails and in phosphate headgroups, as seen by the decrease in intensity of the
peaks at 1093 cm−1 and 1221 cm−1, respectively. Significantly, for the liposomes
containing EGCG, i.e. DPPG + EGCG, there is practically no degradation induced
by UV irradiation, as demonstrated in Figure7.4a.
Since in both DPPG and DPPG + EGCG liposomes the lipid hydrocarbon
chains practically remain unaltered after radiation, the intensity of the symmetric
stretching of CH2 at 2850 cm−1 was assigned a value of 1 and the intensities of the
phosphate and carbonyl groups of phospholipids were normalized to this value.
The objective was to infer if the rate of oxidizing events on these hydration centers
changes in the presence of EGCG. As expected, radiation exposure leads to an
accentuated decrease in absorbance of the peaks corresponding to phosphate and
carbonyl groups of DPPG liposomes. This confirms that these hydration centers
are very sensitive and easily damaged. Such damage seems to be slowed down
when EGCG molecules are present in the lipid bilayer (Fig. C.1).
Table 7.1: Characteristic infrared absorptions of EGCG cast films prepared onto
CaF2 solid supports. The assignments were performed having into account.[45,
46]
EGCG band
Assignment
frequency (cm-1)
975 Stretching of C-H group in the aromatic ring
1016 Stretching C-H group in the aromatic ring
1035
C-O-C group that links the chroman ring
and trihydroxy benzoate ring
1095 Bending of C-OH alcohols
1144 Bending of C-OH alcohols
1238 Carboxylate stretching
1340 Stretching of O-C=O
1458 Stretching of C-H group in chroman ring
1519 C=C aromatic ring
1610
C=CH3 that links the trihydroxybenzoate
group and chroman group
1695
Stretching of C=O of gallic acid that links the
trihydroxybenzoate group and chroman group
3360 Stretching of O-H group attached to aromatic ring
The IR regions between 1145–1319 cm−1, 1315–1541 cm−1 and 1700–1760
cm−1 due to absorption bands of phosphate stretching, CH2 scissoring and car-
bonyl stretching, respectively, were selected to perform the PCA analysis. The plot
in Figure7.4b has a cumulative variance of 84.51% and shows two well-defined
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Figure 7.4: a. FTIR spectra for cast films of EGCG, DPPG and DPPG + EGCG
before and after UV irradiation. The inset shows the FTIR spectra of DPPG and
DPPG + EGCG mixture with similar concentrations, measured using a FTIR spec-
trometer purging high-purity nitrogen, revealing typical bands of EGCG at 1350,
1519 and 1695 cm−1. b. PCA for IR spectra of DPPG (green circle) and DPPG +
EGCG (blue circle) liposomes over irradiation time. The biplot of the first two
principal components showed 84.51% of the cumulative variance. In the inset is
shown the scheme of a possible reaction pathway that leads to oxidation of the
B-ring of EGCG (pyrogallol ring) and to the opening of the ring.
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clusters corresponding to DPPG (left-side) and DPPG + EGCG (right-side) lipo-
somes data. This clear separation indicates that UV radiation induces different
effects on these types of liposomes. Similarly to what was observed in the PCA
analysis of absorbance data, the DPPG + EGCG points are grouped closer than
the DPPG points. Therefore, in the absence of EGCG molecules, UV irradiation
causes more drastic changes in DPPG, mainly in the IR regions assigned to phos-
phate and carbonyl groups. EGCG molecules can act like a shield against UV light
because they can be accommodated below the phosphate groups of DPPG in the
lipids ester region, where the hydroxyl groups (hydrogen bond donors) of EGCG
can interact with the negative oxygen groups of DPPG (hydrogen bond acceptors).
This is possible owing to the liposomal membrane-water partition coefficient for
EGCG (Kp = 1.9) and the hydrophobicity of the molecule.
Table 7.2: Characteristic infrared absorptions of DPPG cast films prepared onto
CaF2 solid supports. The assignments were done having in to account and refer-
ences therein.[46]
DPPG band
Assignment
frequency (cm-1)
1053 Symmetric stretching of C-O-C
1094 Symmetric stretching of CO-O-C
1169 Asymmetric stretching of CO-O-C
1220 P=O antisymmetric stretching of PO−4 group
1240 Anti-symmetric stretching of hydrated PO−4 group
1418 in plane bending of C-O-H group
1468 CH2 Scissoring
1738 Stretching of carbonyl group (C=O)
2851
Symmetric C-H stretching of the
phospholipid hydrocarbon:CH2
2918
Antisymmetric C-H stretching of the
phospholipid hydrocarbon:CH2
3325 OH group of glycerol and H2O retained in liposomes
From the UV–vis absorbance data, one notes that 2340 min is sufficient to
degrade EGCG molecules. Hence, oxidation of the lipids heads is expected (Fig-
ure7.4a) followed by a decrease in CO due to the loss of EGCG molecules that
shield the liposomes, as suggested by the analysis of the UV-vis spectra. But Fig-
ure7.4a shows that the absorbance of CO does not change even after 2340 min.
This may be due to water that would contribute with additional oxygen atoms to
trigger oxidation pathways of the B-ring of EGCG (pyrogallol ring), thus opening
this ring (scheme in Figure7.4b) and creating new CO bonds. Such a hypothesis is
consistent with the scavenging activity of ROS by the gallate group and the B-ring
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of EGCG, which is crucial to prevent lipid peroxidation. [47, 48, 49] According to
Salah et al, the conversion of trihydroxylphenyl B-ring to o-dihydroxylphenyl B-
ring is efficient to decrease the scavenger activity of EGCG.[48] In fact, if UV light
leads to this conversion of EGCG, the intensity of the 1738 cm−1 band comes from
contributions of CO of DPPG and of the opened B-ring of EGCG. One should note
that in the DPPG + EGCG liposomes the decrease in intensity of the phosphate
band at 1221 cm−1 and the increase in CO-O-C band at 1169 cm−1 only occurred
after 2340 min of irradiation, possibly linked to the decrease in the scavenging
activity of EGCG.
The spectra between 2400 and 3800 cm−1 for DPPG and DPPG + EGCG in-
dicate that the CH stretching in CH2 and CH3of DPPG at 2850 and 2915 cm−1,
respectively, was not affected by UV irradiation. Hence, the presence of EGCG
had no appreciable effect on these hydrocarbon groups. However, the changes
in the DPPG spectrum for the region between 3200 and 3600 cm−1, in contrast
to the lack of changes in DPPG + EGCG liposomes, point to DPPG being more
vulnerable to UV light.
We conclude that lipid oxidation is prevented by addition of EGCG, since
the binding of EGCG to lipid molecules through hydrogen bonding decreases
the number of water molecules near the phosphate (P =O) and carbonyl (C =O)
groups of the lipids, thus decreasing the ROS production rate during UV exposure.
In addition, EGCG exerts antioxidant activity, quenching the generated ROS that
induces lipid oxidation.
7.4 Conclusion
The effects from the catechin EGCG on two types of DPPG assemblies have been
investigated, namely in liposomes and cast films from the liposome solutions. In
all systems, EGCG was found to protect DPPG molecules from damage induced
by UV irradiation. The changes observed with UV–vis and FTIR spectroscopies
may be interpreted in terms of molecular-level interactions involving the aromatic
rings (gallic acid moiety) of EGCG and carbonyl and phosphate groups of DPPG.
The presence of a micromolar amount of EGCG is sufficient to decrease the UV-
induced damage in COC, phosphate and carbonyl (C=O) group of DPPG, for
example. After a certain irradiation time (or radiation dose), UV light attacks
and opens the B-ring of EGCG (pyrogallol ring) dismantling this biological shield
against lipid oxidation.
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Within a colloid and interface science context, results from this study con-
tribute to the understanding of how EGCG regulates the physicochemical prop-
erties of the water-lipid interface in the liposome to protect it against radiation
damage. Important issues to address in future studies include a detailed analy-
sis of oxidation index and formation of photoproducts with the radiation dose.
Furthermore, experimental and theoretical work should be performed to inves-
tigate the interaction between EGCG at distinct concentrations and monolayers
at the air/water interfaces, preferably with lipid mixtures to better represent the
complexity of a cell membrane (mixture of saturated/polyunsaturated lipids and
cholesterol). This would provide a framework to understand the antioxidant para-
dox and determine the behavior of EGCG at the water-oil environment in complex
systems. Such basic knowledge is required to correlate molecular-level properties
of EGCG and its possible ability to be used in treating human diseases. Indeed,
liposomal formulations able to encapsulate EGCG may be relevant for cosmetics
(anti-ageing and sunscreen creams) and in dermal drug delivery.
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Evaluation of EGCG loading capacity in DMPC membranes1
Abstract
Catechins are molecules with potential use in different pathologies such as
diabetes and cancer, but their pharmaceutical applications are often hindered
by their instability in the bloodstream. This issue can be circumvented by using
liposomes as their nanocarriers for in vivo delivery. In this work, we studied the
molecular details of (-)-epigallocatechin-3-gallate (EGCG) interacting with 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) monolayer/bilayer systems to
understand the catechin loading ability and liposome stability, using experimen-
tal and computational techniques. The molecular dynamics simulations show the
EGCG molecules deep inside the lipid bilayer, positioned below the lipid ester
groups, generating a concentration-dependent lipid condensation. This effect
was also inferred from the surface pressure isotherms of DMPC monolayers. In
the PM-IRRAS assays, the predominant effect at higher concentrations of EGCG
(e.g. 20 mol%) was an increase in lipid tail disorder. The steady-state fluores-
cence data confirmed this disordered state, indicating that the catechin-induced
liposome aggregation out-weights the condensation effects. Therefore, by adding
more than 10 mol% EGCG to the liposomes, a destabilization of the vesicles oc-
curs with the ensuing release of entrapped catechins. The loading capacity for
1This chapter is based on the following publication:
Pires, F., Geraldo, V. P.N., Rodrigues, B., Granada-Flor, A., Almeida, R.F.M., Oliveira Jr, O. N.,
Victor, B.L., Machuqueiro, M. and Raposo, M.. Evaluation of EGCG loading capacity in DMPC
membranes. Langmuir 2019, 35, 20, 6771:6781, DOI:10.1021/acs.langmuir.9b00372
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DMPC seems to be limited by its disordered lipid arrangements, typical of a fluid
phase. To further increase the liposomes clinical usefulness, lipid bilayers with
more stable and organized assemblies should be employed to avoid aggregation
at large concentrations of catechin.
8.1 Introduction
Epigallocatechin-3-gallate (EGCG; Figure 8.1) is the most abundant catechin in
the Camellia sinensis green tea, whose potential for cancer therapy has been stud-
ied owing to its ability to modulate membrane organization and coordinate intra-
cellular signalling pathways in the various steps of tumorigenesis.[1, 2] EGCG is
known to partition favourably to lipid bilayers,[3, 4, 5] and can even induce mem-
brane disruption at high concentrations.[3] Also, EGCG can lead to aggregation of
phosphatidylcholine (PC) liposomes, rapidly potentiating the cargo release from
the liposome in a concentration–dependent manner [6]. Using phase-contrast
fluorescence microscopy, it has been shown that EGCG can induce calcein leakage
from egg PC giant unilamellar vesicles, where their prolate shape changed to two
spheres connected by a narrow neck. [3, 7] EGCG modulates biological pathways
[8, 9, 10, 11] by altering membrane properties and acting as pan-assay interfer-
ence compounds (PAINS) [12, 13]. Adsorption kinetics studies of different cate-
chins on DMPC phospholipid surface showed that the catechins bearing gallate
moiety bind more strongly to lipid membranes than non-gallolylated catechins,
due to the additional phenolic OH groups. [14] Additionally, the stereochemical
structure also seems to affect the kinetic behaviour of catechins. [15] The cis con-
figurations have more favourable conformations for hydrogen bonding since the
trihydroxyl groups are better oriented and closer to the bilayer surface.
From the clinical point of view, the major limitation in the oral administration
of EGCG is its poor bioavailability in the bloodstream. The susceptibility of its
phenolic groups to deprotonation, oxidation and metabolic reactions within the
living system [16] makes this catechin very unstable. Fortunately, drug carriers
including liposomes [17, 18, 19], nanoparticles [20, 21] and microparticles [22,
23], can be used to overcome this problem, and therefore loading EGCG into
nanocarriers is a promising natural chemopreventive and chemotherapeutic agent
for brain, [24, 25] breast, [26, 27] prostate, [28, 29] lung, [30, 31] and skin[32, 33]
cancers. Many reports have focused on the design of nanocarrier formulations and
the use of new production techniques to improve encapsulation efficiency and
enhance the cellular uptake of liposomes [34, 35, 36, 37]. These developments
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Figure 8.1: Schematic chemical structure of Epigallocatechin-3-gallate (EGCG).
should be guided by molecular–level information regarding the interaction of
EGCG in lipidic model systems. For instance, details on the catechin preferred
location, membrane stability and other monolayer/bilayer structural properties
are useful to evaluate and improve encapsulation efficiency.
This type of information can be obtained by Molecular Dynamics (MD) sim-
ulations, which have been used to investigate interactions between membranes
and small drugs, [38, 39] larger compounds, [40, 41] peptides [42, 43, 44], and
catechins. [4, 15, 45, 46, 47, 48, 49] This in silico technique can provide a detailed
picture of the molecular interactions and allow the prediction of several proper-
ties that are usually very difficult to tackle using experimental techniques. [50]
MD studies on EGCG insertion into lipid bilayers showed that these molecules
adopted a more ordered configuration in membranes composed of phosphatidyl
ethalonamine: phosphatidyl choline (PE:PC) lipids (1:1 ratio), [15, 45, 46] which
is significantly different from pure PC. The molecular interactions of four green
tea catechin compounds, including EGCG, with a POPC pure bilayer have also
been studied, where EGCG was found to establish hydrogen bonds with the lipids
ester region, inducing only a small local condensing effect on the bilayer, prob-
ably due to the presence of only one catechin molecule per leaflet.[4] Recently,
EGCG was observed to insert into two different membrane models, resembling
either a plasma membrane or a late endosome membrane, without a clear ten-
dency to aggregate.[49] Furthermore, the ability of EGCG to insert into neutral
and anionic membrane models was modulated by the presence of salt, especially
divalent Ca++ and Mg++. [47, 48] Despite growing evidence of the health benefits
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of catechins, EGCG has not been thoroughly studied using Langmuir monolayers
models. These experimental membrane models mimic half a liposome/cell mem-
brane, providing valuable information on drug-lipid interactions, particularly its
impact on the physicochemical properties of the system under study (degree of
molecular packing, molecular organization, and surface potential). [51, 52, 53]
In this work, we carried out a detailed study of the molecular interactions be-
tween EGCG and DMPC model membranes. The carrier loading capacity and the
effects of the catechin on the membrane were studied using a multidisciplinary
approach combining Langmuir monolayers, infrared and fluorescence spectro-
scopies, and MD simulations. The results obtained provide an accurate evalua-
tion of liposomes as nanocarriers and catechins encapsulation agents, which is
relevant for future use in food packaging, cosmetics, and cancer therapeutics.
8.2 Experimental
8.2.1 Materials
EGCG (M.W. 458.4 g/mol) and dimyristoylphosphatidylcholine (DMPC) phos-
pholipid (M.W. 677.93 g/mol) were purchased from Sigma–Aldrich and Avanti
Polar Lipids, respectively. 4-(2-[6-(dioctylamino)-2-naphthalenyl]ethyl]- 1-(3-
sulfopropyl)-pyridinium (di-8-ANEPPS) was purchased from Biotium.
8.2.2 Langmuir Monolayers Studies
The Langmuir monolayers were prepared using the co-spreading methodology.
Firstly, DMPC and EGCG were dissolved in chloroform at concentrations of
0.5 mg/ml and 0.3 mg/ml, respectively, leading to the same molar concentra-
tion in each solution. Langmuir monolayers were obtained after spreading the
pure DMPC or EGCG/DMPC mixtures, (1.6, 5, 10, and 20 mol%), on an aqueous
subphase (Milli-Q water at 297 ± 1 K). Surface pressure measurements started
after the solvent was allowed to evaporate for 10 min. The experiments were
carried out in a Langmuir minitrough from KSV Instruments (model 2000, KSV
Nima, Helsinki, Finland), in a class 10,000 clean room and were repeated at least
three times to ensure reproducibility of the isotherms. During film compression,
two symmetric barriers moved at a constant speed of 10 mm.min−1.
In the isotherms analyses, the EGCG molecules were considered to also occupy
an area on the Langmuir monolayer, in addition to the DMPC molecules. There-
fore, the area per lipid (i.e. per DMPC molecule) (Al) was calculated by dividing
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the trough area by the number of DMPC molecules after subtracting the estimated
area occupied by the EGCG molecules. This procedure was necessary because the
area occupied by each EGCG molecule varied with its concentration, since not all
EGCG molecules are expected to be at the interface. We also used the results from
MD simulations to estimate the EGCG area at the interface. Finally, the area of
DMPC was calculated from the total area of the Langmuir minitrough occupied
by the DMPC phospholipid (area of the Langmuir minitrough minus the total
area occupied by EGCG molecules) and the number of DMPC molecules spread
in each condition. The compressional modulus (Cs−1) and the minimum area per
lipid (Al) were estimated from the pi-Al compression isotherms. Cs−1 was calcu-
lated using: Cs−1 = −Al
(
∂pi
∂Al
)
T
, where pi is the monolayer surface pressure. The
minimum area per lipid was derived by extrapolating the tangent to the inflection
point on the condensed region of the isotherm, indicating the area occupied by
one lipid molecule at the air/water interface. The surface potential and surface
pressure-area isotherms were recorded simultaneously in a Langmuir minitrough
equipped with a surface potential sensor (KSV Kelvin probe, Biolin Scientific Oy,
Helsinki, Finland), during the compression of the spread mixed EGCG/DMPC
monolayers with selected ratios. The surface potential sensor measures the po-
tential difference between the vibrating plate (placed roughly 1–2 mm above the
monolayer) and the reference electrode immersed into the water subphase, thus
reflecting the changes in surface potential.[54]
8.2.3 PM-IRRAS Studies
Polarization-modulated infrared reflection absorption spectra (PM-IRRAS) mea-
surements were performed using a KSV PMI 550 instrument (KSV Instruments
Ltd, Helsinki, Finland) at an incidence angle of 80◦. The EGCG/DMPC mixtures
were spread on an aqueous subphase at 297 ± 1 K, and then compressed up to
30 mN m−1. The spectra were measured for s- and p-polarizations at a high fre-
quency. All the spectra were obtained by subtracting the spectrum of a pure water
subphase at the same temperature as that of samples. Spectra of lipid samples
were cut to a frequency range between 3000 and 900 cm−1 and were baseline
corrected with a straight line. Spectra deconvolution using Gaussian lineshape
was used to reveal the components of the phosphate and carbonyl bands as well
as the band position and bandwidth of these components. The phosphate region
of DMPC consists of two bands from the phosphate hydrogen-bonding to wa-
ter (1237 cm−1) and "free"non-bound phosphates (1261 cm−1). The phosphate
hydration degree of DMPC was assessed from the ratio between the area under
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the band at 1237 cm−1 and the total area under the curve. The carbonyl band
was deconvoluted into two Gaussian bands at 1737 cm−1 and 1746 cm−1, which
can be attributed to the hydrogen-bonded ester carbonyl groups and free ester
carbonyl groups, respectively. Within the same rationale, the hydration degree of
the carbonyl groups was calculated from the ratio between the area of the band
at 1737 cm−1 and the total area under the curve. The orientational order parame-
ter of the CH2 lipid hydrocarbon chains was obtained from the band area ratios
A(2920 cm−1)/A(2855 cm−1). [55]
8.2.4 Fluorescence Studies
Steady-state fluorescence anisotropy measurements were performed for EGCG in
DMPC unilamellar vesicles (LUVs) suspensions. Briefly, the required amount of
lipid to obtain a final lipid concentration in the LUVs suspension of 0.25 mM [56]
was dissolved in chloroform and the solvent was evaporated using a gentle stream
of nitrogen, followed by vacuum desiccation for 4h to remove the last traces of
solvent. The dried phospholipid films were dispersed in buffer (10 mM HEPES,
0.1 mM EDTA, 100 mM NaCl, pH 7.4) at 308 K (above the gel to liquid-crystalline
transition temperature of DMPC, which is ca. 297 K [57]) and vortex-mixed. The
resulting multilamellar vesicle suspensions were subjected to five freeze/thaw
cycles and extruded 21 times through polycarbonate membranes with a pore
diameter of 100 nm to form the LUVs and left to equilibrate overnight. Then,
EGCG (at 5, 10, 20 or 30 mol%) was added to the sample at 303 K and incubated
for 2h before the measurements.
Fluorescence spectroscopy measurements were performed in a Horiba Jobin
Yvon Spex Fluorolog 3-22 spectrofluoremeter (Kyoto, Japan) with excitation at
275 nm (slit width 5 nm) and emission at 353 nm (slit width 5 nm), i.e. at the
maximum of the excitation and emission spectra under our conditions. The fluo-
rescence anisotropy, 〈r〉, was calculated using equation 8.1:
〈r〉 = IVV −GIVH
IVV + 2GIVH
(8.1)
where the fluorescence emission I had subscripts V and H for the vertical and
horizontal orientations of the polarizers. The G–factor is a correction factor for
detector sensitivity and is calculated as G = IHVIHH . A total of seven readings for
each intensity component were taken per sample using an integration time of
0.1 s. For each intensity reading, the background obtained for a DMPC suspen-
sion (without EGCG) was subtracted. All measurements were performed for 3
160
8.2. EXPERIMENTAL
independent samples at 303 K, which was confirmed directly inside the cuvette
using a temperature probe in a thermostated cuvette holder.
To detect the changes in the bilayer dipole potential, the lipid suspensions
were labelled with di-8-ANEPPS (1:500 probe/lipid mole ratio [41]) overnight.
The ratio of the fluorescence intensity at 630 nm of di-8-ANEPPS excited at
420 nm to that excited at 520 nm was used to evaluate the membrane dipole
potential. [58, 59]
8.2.5 Computational Details
8.2.6 Molecular Dynamics
MD simulations were performed with GROMACS 2016.4 [60] and the GROMOS
54A7 force field [61, 62]. Initial parameters for the EGCG molecule were ob-
tained with the Automated Topology Builder (ATB) and Repository [63, 64] and
manually curated. The pairs section were modified to exclude 1-4 interactions in
the aromatic rings. The charge set was obtained from a RESP[65] fitting proto-
col, using the electrostatic potential calculated with Gaussian 09[66], the B3LYP
functional [67, 68, 69] and 6-31G*[70] basis set. We have not explicitly accounted
for the anionic form of EGCG (pKa ∼7.7)[71] since the neutral form is the most
abundant. Additionally, when interacting with lipid bilayers, anionic groups
have their neutral forms stabilized.[43]. Two types of MD simulations were per-
formed: the insertion and the concentration sets. In the insertion simulations,
two EGCG molecules were introduced to a pre-equilibrated 128 lipid DMPC
membrane patch, either outside (in the water phase), or inside the membrane
(Figure 8.2A). These two molecules were not allowed to interact (they are always
at distances larger than 1.0 nm, which is the PME cutoff) and were analyzed as
independent replicates. For the concentration simulations set, we created systems
with 0, 2, 6, 12 and 24 EGCG molecules, corresponding to 0, 1.6, 4.7, 9.4, and
18.8 mol% of EGCG. Note that these molar fractions will slightly differ from the
molar fractions in the experiments. Furthermore, the choice for DMPC was based
on its small size, which leads to faster simulations, while keeping the correct lipid
fluid phase.
The simulations were performed using the v-rescale heat bath [72] at 298 K
with separate couplings for water and solute (DMPC and EGCG), with a relaxation
time of 0.1 ps. A Parrinello-Rahman [73] semi-isotropic pressure couple was used
to keep the pressure at 1 bar with isothermal compressibility of 4.5× 10−5 bar−1,
and a relaxation time of 2.0 ps. All bonds were constrained with the parallel
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version of the LINCS algorithm [74], and the SETTLE algorithm [75] was used
for water (SPC [76]). A time step of 2 fs were used in the integration of the
equations of motion, with the neighbor lists being updated every 10 steps. The
Particle-Mesh Ewald (PME) [77] electrostatics was applied using 0.12 nm for the
maximum grid spacing of the Fast Fourier Transform and a cutoff distance of
1.0 nm for Lennard-Jones and Coulomb interactions. The interpolation order for
PME was 4 (cubic).
Energy minimization of all systems was performed using two steps with the
steepest–descent algorithm, with LINCS constraints turned on in the second step.
The initialization was achieved in a 250 ps MD simulation with harmonic re-
straints in both DMPC and EGCG, followed with 500 ps with restraints only on
DMPC phosphorous atoms, always with a restraint force of 1000 kJ/(mol nm2).
We ran 5 replicate simulations (3 in the insertion set) of 200 ns and all equilibrium
properties were obtained from the last 100 ns. In the insertion set, we doubled
our replicates by following the two EGCG molecules independently.
8.2.7 Analyses and error calculations
The computational analyses were performed using in-house scripts and GRO-
MACS analysis utilities. All simulations and experiments were done with repli-
cates. The error bars represent the standard error of the mean and were deter-
mined with a leave-one-out resampling method.
8.3 Results and discussion
8.3.1 EGCG insertion into DMPC bilayers
We used MD simulations to study the interaction of EGCG with a lipid bilayer
at the molecular level. We setup different systems where EGCG (catechin) was
introduced either in the water phase or at the bilayer hydrophobic region (Fig-
ure 8.2A). Regardless of the starting positions, all EGCG molecules accumulate
in the membrane at ∼10 Å below the average phosphorous atoms positions (Fig-
ure 8.2B-C). There is only a small energy barrier around the phosphate region,
which is easily overcome by the molecules within 100 ns. The preferred position
is in good agreement with the minimum region of the reported potential of mean
force[13], even though completely different force fields were used. In another
separate set of MD simulations, Sirk et al did not observe the complete insertion
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Figure 8.2: Initial (A) and final (B) conformations of the EGCG membrane inser-
tion process. The catechin molecules were added near either the water/membrane
interface (blue sticks) or the membrane center (pink sticks). Even though the cat-
echin molecules started from the water phase, we observe full insertion in all
simulations (B). The membrane is shown as thin grey sticks with the phospho-
rous atoms in spheres to highlight the polar interface. Membrane insertion of all
EGCG molecules over time (C) and the corresponding histograms for the different
molar ratios of the EGCG/DMPC systems (D). The catechin molecules tend to
accumulate within the membrane (in each monolayer), regardless of its original
position. Negative insertion values correspond to positions below the average
phosphorous atoms positions, which were used as reference.
of EGCG into POPC membranes, probably due to the lack of sampling on their
simulations where the catechins were placed at the water region. [4]
The large number of hydrogen bond donor groups in EGCG molecule makes
it ideal to interact with the lipids ester region, where there are plenty of hydrogen
bond acceptors. This feature and the significant hydrophobicity of EGCG explain
its membrane location and the most commonly observed conformations where its
OH groups preferentially interact with the lipid esters (Figure 8.2D).
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8.3.2 Effects of increasing EGCG concentration on DMPC lipid
organization
In the MD simulations, we also built EGCG/DMPC mixtures at different molar
ratios: 0, 1.6, 4.7, 9.4, and 18.8, corresponding to 0, 2, 6, 12, and 24 ∼ EGCG
molecules in 128 ∼DMPC lipids, respectively. The EGCG molecules always re-
mained mainly at the membrane preferred position (∼10 Å below the average
position of the phosphorous atoms). Only for 9.4 and 18.8 molar ratios did we
observe some catechin exchange between solvent and membrane (Figure 8.2D).
The Al values calculated specifically for DMPC indicate significant condensation
with increasing concentrations of EGCG (Figure 8.3A), even though the system is
expanded due to the presence of the catechin (Figure D.1 of Appendix D). The
catechin specific area per molecule was calculated from the MD simulations to
be 82.6, 88.2, 96.8, and 89.6 Å2, for the 1.6, 5, 10, and 20 mol% EGCG mixtures,
respectively. The surface pressure of DMPC Langmuir monolayers displays a
gaseous (100–80 Å2) and a liquid-expanded (LE) phase (molecular areas lower
than 80 Å2), without a well-defined LE/LC transition (Figure 8.3B). The sur-
face pressure increased monotonically up to ∼49 mN/m, reaching values of com-
pressional modulus of ∼96 mN/m (Figure 8.3C). On further compression, the
monolayer collapses to a three-dimensional state at pic ∼49 mN/m.
The Al values from Figure 8.3B are in good agreement with those obtained
from MD simulations (Figure 8.3A). The addition of EGCG to the phospholipid
monolayers caused a shift in the isotherms towards lower Al, a trend similar to
the condensing effect due to the presence of cholesterol in PC membranes at
the air-water interface [81, 82, 83, 84]. As an example, in DMPC monolayers at
30 mN/m, cholesterol concentrations of 4%, 8% and 21% promote molecular area
contractions to 53 Å2, 50 Å2 and 48 Å2, respectively. [85] Therefore, it seems that
EGCG has an even larger condensing effect on DMPC than cholesterol. Interest-
ingly, although EGCG causes condensation of DMPC monolayers, this monotonic
dependence on concentration was not observed in the compressional modulus.
The surface pressure isotherms in Figure 8.3C indicate that small amounts of
EGCG (1.6 and 5 mol%) turn the DMPC membrane more rigid as reflected by the
increased compressional modulus. This agrees with the MD simulations, in par-
ticular with the observed increase in the lipid tail order parameter (Figure 8.4A).
These results are also consistent with the literature where a slight, approximately
linear, decrease of fluidity at the acyl chain level was observed in DMPC LUVs in
the fluid phase with increasing EGCG.[86] In addition, the rigidifying effects of
EGCG are believed to be responsible for the anti-migratory and anti-metastatic
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Figure 8.3: Area per lipid (Al) values of DMPC calculated in the presence of dif-
ferent amounts of EGCG (A). The simulation Al values were calculated using
GridMAT-MD[78], while the experimental details are given in the Experimental
section. The gray shaded region corresponds to the values measured experimen-
tally for pure DMPC in the fluid phase.[79, 80] Surface pressure isotherms for
monolayers of neat DMPC (black), 1.6% (blue), 5% (green), 10% (orange) and 20%
w/w EGCG in DMPC (red) are shown (B). The respective compressional modulus
as a function of surface pressure at the air/water interface are also shown (C).
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effects on lung cancer cells [87, 88, 89, 90, 91]. Rigidification slows down disin-
tegration of drug-loaded liposomes, thus improving stability although compro-
mising drug entrapment efficiency [92]. However, for higher concentrations of
EGCG, the compressional modulus decreases, i.e. the DMPC monolayer becomes
more compressible (membrane fluidization). The latter change was not captured
in the MD simulation, probably because the short time scales used are inadequate
to probe lipid lateral diffusion (several hundreds of nanoseconds are needed[93]
to observe EGCG aggregation). Additionally, the small membrane patch used
(128 lipids) may not capture EGCG-induced phase separation and/or membrane
curvature phenomena. When a large number of EGCG molecules are inserted
into the DMPC monolayer, an anisotropic molecular packing is likely to occur
upon the formation of EGCG aggregates.
The preferred location of the EGCG molecules in the lipid bilayer, as inferred
from the MD simulations (Figure 8.2D), indicates that catechin can have different
concentration-dependent effects on the lipid head and tail groups. The membrane
thickness and the order parameter of lipid aliphatic tails can provide decoupled
information on which region is most affected by the presence of the catechin. In
pure bilayers, these properties are usually highly coupled to the Al values. In
mixtures, however, specific parts of the lipids can be altered while little or no
impact is observed in the overall Al values. The DMPC membrane thickness
can be measured by following the distance between average position of the phos-
phorous atoms in each monolayer. In our simulations, there are no significant
differences in the membrane thickness values, even in the presence of higher
amounts of EGCG (Figure D.2 of Appendix D). A membrane condensation effect,
as suggested by the Al values (Figure 8.3A), is often associated with an increase
in the membrane thickness values, which is not observed. Therefore, these simu-
lations suggest that EGCG could be accommodated in the DMPC bilayer, without
perturbing too much the lipid head groups.
The changes in the DMPC membrane ordering, caused by increasing molar
ratios of EGCG, can be analyzed by calculating the deuterium order parameter on
the lipid tails and by PM-IRRAS spectroscopy of DMPC+EGCG monolayers. The
deuterium order parameter values (−SCD) increase significantly with the molar
fraction of EGCG (Figure D.3 of Appendix D). The −SCD plateau, usually observed
at the 6th methylene group of aliphatic chains, highlights the EGCG induced gain
of order in this membrane region (Figure 8.4A). These results indicate that the
condensing effect observed in the MD simulations can be attributed to a better
packing of the lipid hydrocarbon chains in the presence of EGCG.
In the experiments using Langmuir monolayers, the arrangement of the acyl
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Figure 8.4: Lipid tails order in the presence of different molar ratios of EGCG.
Deuterium order parameter (−SCD) values for the 6th methylene group in DMPC
(A). The 6th positions correspond to a plateau in the −SCD profiles (Figure D.3
of Appendix D). The gray shaded region corresponds to the experimental value
(0.212± 0.005) for pure DMPC in fluid phase[79]. PM-IRRAS measurements for
different EGCG molar fractions in the region of DMPC methylene (CH2) groups
(B), from which the asymmetric/symmetric bands ratios were obtained (C). EGCG
fluorescence anisotropy 〈r〉 in the presence of DMPC vesicles (D). Total fluores-
cence intensity corresponds to the sum of IVV + 2GIVH retrieved from anisotropy
measurements, corrected for inner filter effects[94] and normalized for the max
value in each sample. All values correspond to the average of, at least, 3 indepen-
dent samples. Error bars = ± standard deviation.
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chains was assessed by analyzing the shifts and shape changes of the peaks as-
signed to the CH2 stretching modes. As shown in Figure 8.4B, the positions of the
bands at 2855 cm−1 and 2921 cm−1 assigned to the symmetric and anti-symmetric
stretching of CH2 in the DMPC monolayer, respectively, were not significantly
affected by the incorporation of EGCG. However, the experimental hydrocarbon
ordering parameter (Figure 8.4C), calculated using the ratio between the CH2
anti-symmetric and symmetric stretching bands, revealed that EGCG may have a
disordering effect on the trans-gauche conformational equilibrium of DMPC. In-
deed, even though at lower concentrations we see no significant effect on the CH2
order parameter (the values fall within their error bars), at a larger EGCG concen-
tration (20 mol%) a clear loss of lipid tail ordering is observed in the monolayer.
This disordering effect is not consistent with the −SCD data from the MD simula-
tions, probably due to EGCG aggregation effects, which were not accounted for
in the in silico studies even at higher concentrations.
The EGCG molecules intrinsic fluorescence is environment sensitive, [56]
which allows one to monitor its interaction with the membrane. The fluorescence
anisotropy of the catechin in the presence of DMPC vesicles remains unaltered
at different mol% values (Figure 8.4D). However, the catechin fluorescence in-
tensity increases significantly up to 10 mol%, which indicates that most catechin
molecules are incorporated in the liposomes, since EGCG quantum yield is larger
in the lipid bilayer than in the water phase. [56] This increase is reverted at higher
EGCG concentrations (20 and 30 mol%), probably due to instabilities and the in-
crease of scattering from the suspension associated with catechin and liposome
aggregation (observable with the naked eye after sample preparation) and/or a
change of the catechin microenvironment. These results at high EGCG concen-
trations are consistent with the disordering effect observed in the phospholipid
monolayers, pointing to the role of aggregation in limiting the catechin loading
capacity of DMPC. In fact, from the MD simulations, which exclude the aggrega-
tion effects, one could expect a higher loading capacity according to the increased
−SCD values (Figure 8.4A) and the low catechin exchange from the membrane to
the water phase, which is only present at 18.8 mol% (Figure 8.2D).
8.3.3 Effects of increasing EGCG concentration on DMPC
dipolar properties
Membrane dynamical properties are usually strongly coupled to the electric field
generated by the anisotropic organization of the charged, polar head groups. This
will include the glycerol ester moiety, the first water solvation shells, and even
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Figure 8.5: Surface potential at different Al values for the different EGCG mo-
lar fractions in DMPC monolayers (A). The ratio between the apparent dipole
moment of EGCG and DMPC (µ) and neat DMPC (µ0) when varying the EGCG
molar fractions for different surface pressures (B). DMPC carbonyl and phosphate
hydration degrees (C) obtained from their carbonyl and asymmetric phosphate
bands (see Figure D.4 A-B from Appendix D), respectively. Effect of EGCG con-
centration on the fluorescence ratio reflecting the membrane dipole potential of
DMPC vesicles labeled with di-8-ANEPPS (D). The exponential functions, which
are also shown (black), were fitted to the data points. Error bars = ± standard
deviation of 4 independent samples.
the solution electrolytes, acting as counterions. The transmembrane potential,
the surface potential and the dipole potential are the three types of membrane
electrical potential, which are known to play important roles in the structure and
permeability of biological membranes [59, 95, 96, 97]. A surface potential (∆V) is
generated due to the charge difference that exists between the aqueous interface
(ions in bulk water) and the membrane monolayer surface (charged head groups
of lipids). [95, 98].
We assessed the effect of EGCG on DMPC membrane potential using the lipid
monolayer/bilayer as a model. Figure 8.5 shows the surface potential isotherms.
In pure DMPC, contributions to the surface potential arise from the intrinsic
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dipoles of choline, phosphate and ester (carbonyl) groups, and the interfacial
water molecules in the lipid headgroup region [98, 99]. Surface potential be-
comes non zero at large Al values (∼ 104 Å2) due to the initial assembling of
the lipid molecules in the liquid expanded state, which leads to an increase in
the normal component of the dipole moment (black curve in Figure 8.5A). At Al
of ∼ 58 Å2 the surface potential increases further, probably related to a LE/LC
transition (not completely clear from the isotherm), where dipoles are even more
aligned to the membrane normal. At too small Al values, the monolayer collapses
with the highest surface potential observed of ∼ 530 mV. The Al vs. ∆V curves
for the EGCG/DMPC mixtures have similar profiles to pure DMPC. However,
some differences can be noted, namely, the negative ∆V values at high Al, or the
significantly higher ∆V values observed for 5 and 10% EGCG/DMPC systems
(∼ 610 mV), at monolayer pre-collapsing Al values (Figure 8.5A). It seems that
EGCG contributes with up to 80 mV to the total membrane surface potential.
The potential functions do not exhibit a monotonic behavior due to the distinct
effect of low and large amounts of EGCG in the packing of DMPC phospholipids
molecules, as should be expected from the PM-IRRAS and steady-state fluores-
cence measurements. For the 20% EGCG/DMPC mixture, the membrane surface
potential decreases drastically at small Al, being only ∼ 410 mV near the mono-
layer collapse. This is probably due to the significant increase in the physical
distance between DMPC head groups, promoted by the presence of EGCG, which
surpasses any condensing effect that may have occurred at lower mol% values.
This extra space between the choline/phosphate groups is generated by the pres-
ence of the catechin molecules (Figure D.1 of Appendix D), which are usually
inserted at higher depth (Figure 8.2D), and allows for significant bending of the
head group, leading to a decrease in its total membrane surface potential (Figure
D.5 of Appendix D). This effect is also captured in the apparent dipole ratios
between EGCG/DMPC and neat DMPC at different EGCG molar fractions, for
different surface pressures (Figure 8.5B). Indeed, the predominant effect at small
amounts of EGCG seems to be the lipid monolayer condensation, which is indi-
cated by the compressional modulus (Figure 8.3C) and, to some extent, by the
PM-IRRAS measurements (Figure 8.4C). This seems to be related to an increase in
the apparent dipole moment. However, at larger EGCG mol% fractions, the dipole
moment decreases probably due to the DMPC head group bending, as suggested
above. Shifts in the choline group (N (CH3)
+
3 ) asymmetric stretching band from
978 to 963 cm−1 with 1.6 mol% EGCG in the PM-IRRAS measurements (Figure
D.4C of Appendix D) also suggest a condensation effect, since a shift of this band
to a lower wavenumber indicates a decrease in the choline group bending[100].
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The asymmetric stretching band observed for the 20 mol% fraction (969 cm−1)
suggests a larger choline bending when compared with the 1.6 mol% system, but
still not fully consistent with the pure DMPC measurements. Furthermore, the
head group bending can also explain why the membrane thickness profile does
not change significantly in the MD simulations, even though the Al of DMPC
decreases with increased EGCG concentration. The limitations of our MD simula-
tions to describe the membrane stability are the main reason why these data were
not used further to help interpret the surface potential and PM-IRRAS results.
Considering the relationship between lipid hydration and membrane dipole
potential, the region between 1100-1800 cm−1 in the PM-IRRAS spectra was ana-
lyzed in more detail. This analysis provides information about the spatial arrange-
ment of the water molecules in the vicinity of the ester (carbonyl) and phosphate
groups of lipids, and about its hydrogen bond network (Figures D.4A-B of Ap-
pendix D). The absorption band assigned to the carbonyl group (C=O) was decon-
voluted with two components at 1737 cm−1 and 1746 cm−1 corresponding to the
water-bound ester carbonyl groups and free carbonyl groups, respectively.[101] At
lower concentrations (1.6–5 mol% EGCG) there is a shift to higher wavenumbers,
reflecting a reduction in hydrogen bonding to carbonyl groups. The hydration of
DMPC carbonyl groups decreases in Figure 8.5C, probably due to replacement of
water molecules by EGCG, which can act as hydrogen bond donors to the oxygen
atoms in the DMPC carbonyl groups. Similar results were obtained for the phos-
phate region in Figure 8.5C, where the absorption band assigned to the phosphate
group (P=O) antisymmetric stretching was deconvoluted with two components
at 1232 cm−1 and 1261 cm−1 corresponding to water hydrogen bonding and “free”
phosphate groups, respectively.[102] The hydration level of DMPC phosphate
groups also decreased upon addition of EGCG, following a similar exponential
decay trend.
The dipole potential changes in the presence of EGCG measured in DMPC
monolayers were compared with similar data in DMPC bilayers using fluores-
cence spectroscopy. The DMPC vesicles were labeled with di-8-ANEPPS, a probe
that is very sensitive to the dipole potential changes in the membrane.[58] The
addition of EGCG leads to a decrease of the dipole potential of DMPC vesicles
(Figure 8.5D), following an exponential decrease that is more analogous to the
monolayer dehydration profiles (Figure 8.5C) than to their dipole moment val-
ues (Figure 8.5B). In fact, this decrease in dipole moment is paralleled with the
reduced polarity/hydration at the hydrophilic-hydrophobic interface in DMPC
vesicles assessed through the generalized polarization of Laurdan. [86] This sug-
gests that the displacement of the water molecules by catechin in lipid bilayers is
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a key factor in the dipole moment decrease. Moreover, the addition of EGCG in-
duces DMPC headgroup bending due to increased P–P distances or lipid disorder,
which could be related with liposomes aggregation at higher EGCG concentra-
tions.
8.4 Conclusion
The effects of embedding EGCG into DMPC membranes were studied using Lang-
muir monolayer techniques, lipid vesicles and MD simulations of lipid bilayers.
This interdisciplinary study showed that EGCG accumulates at the lipids ester
region, displacing the water molecules and establishing hydrogen bond interac-
tions with all available hydrogen bond acceptors (phosphate and ester groups) of
DMPC lipids. The presence of EGCG induces changes in several physical prop-
erties of DMPC monolayers/bilayers. The computational data suggests that the
main effect is a condensation, reminiscent of what has been described for choles-
terol. [81, 82, 83, 84] The PM-IRRAS data on lipid monolayers showed that such
an effect appears only at low catechin concentrations, since at higher values the
predominant effect was of increased disorder, which could be confirmed by the
lowering of the dipole moments. The steady-state fluorescence data at higher
EGCG concentrations (> 10 mol%) corroborated that a catechin-induced lipo-
some aggregation process overtakes any condensation effect. Furthermore, the
membrane dipole potential of DMPC vesicles, followed using a di-8-ANEPPS
label, shows that EGCG induces lipid bending in the bilayer and confirms that
catechin loading capacity in DMPC liposomes is ∼10 mol%. This loading capacity
indicates that liposomes are promising as nanocarriers and catechins encapsula-
tion agents. Nonetheless, it may be desirable to develop formulations that stably
retain larger molar fractions of EGCG. From our results we infer that more stable
and organized liposomes (e.g. DPPC),[103] may circumvent the aggregation pro-
cess at larger concentrations of catechin. Finally, this work contributes to better
understanding the extent of molecular interactions between EGCG and PC lipids
and reveal how these interactions influence the loading efficiency and stability
of liposomes. EGCG encapsulation in PC-based liposomes can promote its an-
tioxidant and antimicrobial activities by triggering its sustained and controlled
release over time. Looking ahead, these liposomal systems can be included in:
(1) food packaging – as an active coating that extends the food shelf life by pre-
venting oxidation; (2) cosmetic formulations – with increased EGCG absorption
into human skin; and (3) cancer therapies – as vehicles that provide higher EGCG
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accumulation within tumour cells.
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Cell-based Results
Polycaprolactone/gelatin nanofiber membranes containing
epigallocatechin-3-gallate loaded liposomes and their potential
use for skin regeneration1
Abstract
Polymeric scaffolds incorporating plant-derived compounds, produced by elec-
trospinning, have attracted attention in the field of skin tissue engineering. This
study evaluates the sustained antioxidant activity of polycaprolactone (PCL) /
gelatin nanofibers prepared by electrospinning and incorporating loaded lipo-
somes of epigallocatechin-3-gallate (EGCG), a strong antibacterial and antioxi-
dant molecule found in green tea, that significantly accelerates the wound healing
process. The morphology and the structural properties of the membranes were
characterized by scanning electron microscopy (SEM) and FTIR spectroscopy. Re-
sults revealed that the EGCG released from PCL+Gelatin nanofibers scavenges
the toxic ROS species generated by exposure either to H2O2 or UV radiation and
slows down the oxidation events associated with damage. This study provides
basis for developing new and promising nanofiber formulations containing EGCG
that might enhance repair/regeneration of skin tissue.
1This chapter is based on the following publication in press:
Pires, F., Santos, JF., Bitoque, D., Silva, GA., Marletta, A., Nunes, VA., Ribeiro, PA., Silva, JC.
and Raposo, M..Polycaprolactone/gelatin nanofiber membranes containing epigallocatechin–3–
gallate loaded liposomes and their potential use for skin regeneration. Applied Bio Materials,
2019,DOI:10.1021/acsabm.9b00524
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9.1 Introduction
Skin is a crucial organ of the human body that confers immunologic protec-
tion against pathogenic invasion and provides shielding against harmful phys-
ical and chemical agents such as exposure to ultraviolet radiation (UV), toxic
metals, cigarette smoke, among others.[1, 2, 3] These agents contribute to an
excessive generation and accumulation of highly toxic reactive oxygen species
(ROS), which have been associated to skin aging,[4, 5] cancer progression en-
hancement[6, 7, 8] and delay in the wound healing process.[9] Wound healing
is a complex and highly dynamic process that requires a balance between ROS
species production and detoxification, and involves multiple steps including in-
flammation, proliferation, and tissue remodeling. Remarkably, low levels of ROS
are required to activate cell signaling pathways and angiogenesis that partici-
pate in the elimination of invading pathogens, whereas high ROS levels trigger
oxidative stress that seriously compromises tissue repair, resulting in chronic
non-healing wounds that can be painful and require expensive and long-term
treatments.[10, 11] Fortunately, the advances in the skin tissue engineering field
allowed successful design of new biomaterials and scaffolds, that after surface
functionalization with specific biomolecules (growth factors,[12, 13] vitamins,[14,
15] antibiotics [16, 17]), can prevent infection and promote quick revasculariza-
tion and re-epithelialization, thus significantly improving wound healing. The
biomaterials used should be biocompatible and biodegradable and the scaffolds
should be permeable to moisture and oxygen and able to absorb wound exudate,
avoid infections and mechanical irritations and provide an architecture that sus-
tains cell adhesion, infiltration and proliferation.
One of the approaches used to produce scaffolds for skin tissue engineering is
the electrospinning technique. This technique has been widely used for nanofiber
scaffold production and is gaining more and more interest since the membranes
obtained architecturally resemble the fibrillary structure of the extracellular ma-
trix, thus enhancing cell attachment.[18, 19] Biocompatible scaffolds, with good
mechanical properties for tissue engineering [20, 21, 22, 23, 24, 25], can be pro-
duced by mixing, for instance, the synthetic polyester poly(-caprolactone) (PCL)
with natural polymers such as gelatin. Over the past few decades, the electro-
spinning technology was also used for loading 3D scaffolds with plant-derived
bioactive compounds, molecules that display antimicrobial, antiviral, antioxi-
dant, anti-inflammatory and antitumor activity, thereby offering a great potential
for skin tissue engineering applications ([26] and references therein). Moreover,
the main advantages of this technology over other conventional encapsulating
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methods are its relatively low cost and high production rate without compro-
mising the structural stability/activity of the bioactive molecule. For instance,
the stability of epigallocatechin-3-gallate (EGCG), a natural antioxidant present
in green tea leaves, was greatly increased after encapsulation into PCL/multi-
walled carbon nanotubes (MWCNTs) composite nanofibers produced by electro-
spinning.[27] According to this study, the nanofibers produced were non-toxic
for normal osteoblast cells but markedly inhibited hepatocellular tumor cell pro-
liferation, being the rate of EGCG release strongly influenced by the MWCNTs
content in the nanofibers. In another study, EGCG-loaded PCL nanofibers also
displayed anticancer activity towards gastric cancer cells, through activation of
apoptotic pathways by EGCG.[28] More recently, given the potent angiogenic and
antioxidant activity of EGCG, different sets of nanocomposite membranes carry-
ing EGCG were prepared for wound healing applications.[29, 30, 31] Moreover,
previous studies showed that the encapsulation of EGCG within liposomes, specif-
ically within the lipid bilayer, ensures an optimum antioxidant activity against
UV-induced damage.[32]
In this study, PCL/gelatin nanofibers containing EGCG-loaded liposomes
were produced by electrospinning and their drug release and antioxidant behavior
against oxidative stress induced either by H2O2 or UV radiation was investigated.
The main purpose of this study is to develop a scaffold that sustains cell growth
while at the same time efficiently scavenging ROS species as a novel strategy for
the enhancement of the wound healing process.
9.2 Methodology
9.2.1 Materials
The phospholipid 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was pur-
chased from Avanti Polar Lipids. Polycaprolactone (PCL, Mw = 70–90 kDa),
epigallocatechin-3-gallate (EGCG), hydrogen peroxide solution (H2O2, 30 wt% in
H2O), gelatin from cold water fish skin (Mw = 60 kDa), glutaraldehyde (50 wt%
in H2O) and Dulbecco’s Modified Eagle Medium (DMEM) were obtained from
Sigma-Aldrich. Fetal bovine serum (FBS), streptomycin, penicillin, dichlorofluo-
rescin diacetate (DCFDA) and Hoechst 33342 fluorescent stain were purchased
from ThermoFisher Scientific. All chemicals were used without further purifica-
tion.
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9.2.2 Preparation and characterization of EGCG-loaded
liposomes
The liposomal formulations used in this work are summarized in Table 9.1 . The
liposomal formulation 1 (LF1) consists only of pure 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC) phospholipids. In order to increase the stability of
liposomes,[31, 33] the surfactant Tween 80 was added to DPPC, liposomal formu-
lation 2 (LF2), in a corresponding molar ratio of 10:1 (DPPC:Tween80). As a third
liposomal formulation (LF3), PEG6000 was added to the pre-formed DPPC:Tween
80 liposome vesicles to reach a DPPC:EGCG:Tween80:PEG6000 molar ratio of
10:1:1:0.1, respectively. After incubation at 54◦C for 2 h, PEG chains are an-
chored on the surface of liposomes, which is a useful strategy to increase the in
vivo half-life of liposomes. The PEG chains adsorbed onto liposome’s surface work
as a steric barrier that confers protection against the clearance by serum compo-
nents and, sometimes, can further extend the drug release duration.[34, 35] All
the liposomal formulations were prepared by the thin-film hydration method[36].
Briefly, EGCG was co-dissolved with DPPC, at a molar ratio of 1:10, in a chloro-
form: methanol (4:1) solution. Then, the organic solvents were evaporated under
a stream of nitrogen, being the residual traces removed in a vacuum desiccator
for 4 h in the dark. To maximize the encapsulation efficiency, the mixture was
hydrated by magnesium chloride dissolved in distilled water (in a 5:1 molar ratio
of magnesium/EGCG)[37], stirred at 54◦C until it was dispersed and then cooled
down to 25◦C, resulting in a multilamellar vesicle suspension. This was followed
by sonication (UP50H, Hielscher Ultrasonics, GmbH, Germany) in an ice bath,
where each cycle consisted of 30 s sonication followed by a 1 minute rest. These
cycles were repeated 15 times. The untrapped EGCG was then removed from
DPPC liposomes by dialysis (regenerated cellulose membranes, 8–10 kDa cutoff
size, Spectra/Pro, Biotech USA) at 4 ◦C for 48 h. The concentration of EGCG
entrapped in DPPC liposomes was determined by spectrophotometry (Shimadzu
UV–vis spectrometer, model UV 2101) at 274 nm. The encapsulation efficiency
(EE%) and the drug loading capacity (LC%) of liposomes were calculated by the
following equations 9.1 and 9.2:
EE% =
Cencap
Ctotal
× 100 (9.1)
LC% =
Cencap
Clipid
× 100 (9.2)
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where: Cencap is the amount of EGCG encapsulated in liposomes after dialysis,
Ctotal is the amount of EGCG in liposomes before dialysis and the Clipid is the
total lipid concentration. The size and polydispersity index of the liposome vesi-
cles were determined by dynamic light scattering (DLS) measurements (Zetasizer
Nano ZS Malvern Instrument Ltd, UK).
9.2.3 Immobilization of liposomes onto electrospun fibers
Nanofibers were prepared using a horizontal electrospinning setup as described
in ref.[38] Briefly, PCL was dissolved in glacial acetic acid at a concentration
of 20 wt%. A 40 wt% aqueous gelatin solution was prepared after dissolving
in distilled water (control nanofibers) or in EGCG-liposomal suspension for 12
h, at room temperature, under agitation and in dark conditions. The solutions
were independently loaded in 2 mL syringes connected to 23 G blunt-tip needles,
being pumped at a flow rate of 0.15 mL/h using two syringe pumps. High voltage
DC power supplies were connected to the needle tips and set at 10.0 kV and
12.5 kV for PCL and gelatin solutions, respectively. The resulting nanofibers were
collected on a 6 cm diameter cylindrical rotating collector covered with aluminum
foil placed at a distance of 15 cm from the needle tips. Nanofibers for cell culture
were produced by attaching glass coverslips (12 mm diameter) to the collector.
Nanofibers were vacuum dried at room temperature and were crosslinked with 5
wt% GTA vapor in an oven at 40 ◦C for 5 h. The residual traces of unreacted GTA
were removed by incubation in an oven at 37 ◦C overnight.
9.2.4 In vitro release of EGCG from scaffolds
Samples of PCL/gelatin membranes loaded with EGCG liposomes and weighing
about 25 mg were immersed in 5 mL phosphate buffer saline (pH 7.4) under
magnetic stirring at 37 ◦C. Aliquots of 1 mL were taken at predetermined time
intervals from the release medium. Moreover, 1 mL of fresh medium was added
at each sampling time to keep the release medium volume constant. The amount
of EGCG was quantified at 274 nm using a Shimadzu UV–vis spectrometer. Each
measurement was performed in triplicates (n = 3) and the results obtained are
expressed as mean ± standard deviation (S.D.). The cumulative release of each
nanofiber sampling was calculated by the following equation 9.3:
Q% =
CnV0 +
∑n
i=1Cn−1V
Mt
× 100 (9.3)
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where: Q is the quantity of released EGCG, Cn is the EGCG concentration
measured for the nth time, V0 is the total volume of the release medium, V is
the sampling volume and Mt is the total EGCG content incorporated in each
membrane.
9.2.5 Scaffolds characterization
The surface morphology and size of the nanofibers were evaluated using a Zeiss
Auriga scanning electron microscope (SEM). Samples were sputter-coated with
iridium (Q300T D Quorum sputter coater) before analysis. ATR–FTIR spec-
troscopy analysis was also carried out to study the chemical modifications upon
GTA crosslinking and to detect the presence of EGCG-loaded liposomes at the
fibers surface. The ATR–FTIR measurements were obtained with an ATR–FTIR
spectrometer Nicolet Nexus Continuum in the spectral region from 500 to 4500
cm-1 at a 4 cm-1 resolution.
9.2.6 Cell-based studies
9.2.6.1 Cell culture
Vero cells (monkey kidney epithelial cells) were used for the in vitro cytotoxic-
ity assays of EGCG and of nanofibers extracts. Human fetal foreskin fibroblasts
(HFFF2, European Collection of Authenticated Cell Cultures, UK), were used
in cell survival assays after cell exposure to H2O2 or UV radiation. Cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine
serum (FBS) and streptomycin (100 µg/mL) and penicillin (100 U/mL), in a hu-
midified 5% CO2 atmosphere at 37 ◦C (Sanyo MCO-19AIC-UV).
9.2.6.2 Cytotoxicity assay for antioxidant EGCG screening
The cytotoxicity of EGCG was evaluated following the ISO10993-5 standard test
method.[39] Vero cells were seeded at a concentration of 2× 104 cells/cm2 in a 96
well plate, in standard DMEM culture medium, and allowed to attach for 24 h in
the incubator at 37 ◦C in a 5% CO2 humidified atmosphere. Then, the medium
was aspirated and replaced with fresh medium supplemented with EGCG (10
mM stock solution of EGCG was diluted with PBS) to obtain the desired EGCG
concentration range of 0.1-1000 µM and cells were left exposed to this medium
for 24 h and 48 h. Cells treated with DMEM containing 10% DMSO were used as
positive control. Resazurin dye test was used to assess the viability of cells follow-
ing treatment with EGCG solutions. Resazurin is a non-toxic and stable dye that
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is converted into resorufin due to cellular energy metabolism, leading to a color
change from blue to pink.[40] Cells were incubated with DMEM containing 10%
v/v of the stock solution of resazurin (0.2 mg/mL in PBS) for 3 h. Subsequently,
the absorbance was read at 570 nm and 600 nm on ELX800UV microplate reader
(Biotek Instruments, E.U.A.). The absorbance values of the samples were normal-
ized to control absorbance (Vero cells grown in DMEM medium).
9.2.6.3 Cytotoxicity assay for scaffolds
The cytotoxicity of the electrospun nanofibers was also evaluated following the
ISO10993-5 standard.[39] The extraction media were prepared by immersing
each scaffold (total weight ∼ 25 mg per mL) in serum-free DMEM at 37 ◦C for
24 h. The Vero cells were seeded at a concentration of 2× 104/cm2 in a 96 well
plate, in standard DMEM, and allowed to attach for 24 h prior to the addition of
extraction media. Afterwards, cells were incubated with extraction media for 24
and 72 h, being their viability determined with the resazurin dye test. Vero cells
cultured with DMEM were used as control.
9.2.6.4 Cell attachment on scaffolds
Scaffolds for cell seeding were firstly immersed in 0.1 M glycine aqueous solu-
tion to block unreacted aldehyde groups introduced by GTA crosslinking and
further washed twice with PBS solution. Afterwards, the scaffolds (electrospun
nanofibers covered glass coverslips) were transferred to home-made TeflonRO sup-
ports[22], which have a surface area of 0.5 cm2 for cell adhesion. A density of 2×
104 HFFF2 cells/cm2 were seeded onto scaffolds and maintained in the incubator
at 37 ◦C in a 5% CO2 humidified atmosphere for 7 days. At days 3 and 5, cells
were fixed with 3.7% paraformaldehyde in PBS overnight, washed twice with
ultrapure water for visualization of cell morphology by SEM microscopy.
9.2.6.5 Antioxidant property of extracts from nanofibers against
intracellular ROS production
The antioxidant activity of the scaffolds against intracellular ROS production was
indirectly determined by DCFDA fluorescence-based assay[41, 42]. HFFF2 fibrob-
lasts were seeded in a 96 well culture plate (density of 2× 104/cm2) and, after 1
day of culture, they were treated with the nanofibers’ extracts diluted in DMEM
(1:1, 1:2 and 1:4 v/v) for 24 h. Then, the oxidative stress was induced by exposure
of HFFF2 cells to 50 µM H2O2 in PBS for 30 min. Next, for indirect intracellular
ROS quantification, cells were incubated with the DCFDA dye (10 µM in PBS)
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for 30 min, at 37 ◦C in dark, and the fluorescence was measured at λexcitation =
480 nm and λemission = 530 nm on a Synergy H1 microplate reader (Biotek Instru-
ments, E.U.A.). For fluorescence microscopy studies, the HFFF2 cells were seeded
on glass coverslips (density of 2× 104/cm2) and incubated with the nanofibers’
extracts for 24 h. Then, cells were exposed to 50 µM H2O2 in PBS for 30 min.
Afterwards, cells were washed with PBS and incubated with DCFDA dye (1.5 µM
in PBS) at 37 ◦C for 10 min. Cells were washed twice with PBS, nuclei stained
with Hoechst 33342 dye (2 µM in PBS) and fixed with 3.4% paraformaldehyde
for 15 min. The fluorescence imaging was done on epi-fluorescence microscope
Nikon Ti-S and the images were analyzed using the software ImageJ.
9.2.6.6 Antioxidant property of nanofibers against ROS induced by H2O2
and UV radiation
The antioxidant and cytoprotective properties of the scaffolds were also evaluated
after generating in vitro oxidative stress, by incubating HFFF2 cells with an H2O2
solution or by exposing cells to UV radiation. In both experiments, a density of
2× 104 HFFF2 cells/cm2 were seeded onto scaffolds and the cells were allowed to
attach for 48 h. After this period, the cells were exposed to 50 µM H2O2 for 1 h
to induce ROS production. In UV irradiation experiments, DMEM was replaced
by PBS and the cells were exposed to 220–280 nm radiation from a UVC lamp
at a radiance dose of 2 and 8 J/cm2. After treatment with H2O2 or UV exposure,
cells were cultured with fresh DMEM and incubated with resazurin to assess cell
viability after 4, 24 and 72 h. HFFF2 cells not exposed to H2O2 nor UVC radiation
were used as control.
9.2.6.7 Statistical Analysis
All the experiments were performed in triplicates and all the results are expressed
as mean ± standard deviation of the mean. Microscopy images were analyzed
using the software ImageJ.[43] The statistical differences were analyzed by one or
two-way ANOVA followed by Turkey’s post-hoc analyses using GraphPad Prism
(version 5.0).[44] P values lower than 0.05 (*), 0.01 (**) and 0.001 (***) indicates
that differences are statistically significant.
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9.2.7 Results
9.2.7.1 Cytotoxic activity of EGCG
To screen the in vitro concentration responsible for the antioxidant and prooxi-
dant behavior of EGCG, Vero cells were exposed to a wide range of EGCG con-
centrations (0.1-1000 µM) for 24 and 48h. The dose-response curve shows that
200 µM was the highest EGCG non-toxic concentration for Vero cell metabolism
(Figure 9.1). The LD50 values represent the concentration that causes 50% of
cell death and, in this study, the LD50 values were approximately 800-1000 µM
for 24 h treatment. Furthermore, a marked enhancement of EGCG cytotoxicity
occurred after a prolonged in vitro exposure of Vero cells to high EGCG con-
centrations (400-1000 µM), probably related to inherent instability of EGCG in
culture medium, which generates many secondary metabolites that decrease cell
proliferation and, ultimately, may cause cell death.[45, 46]
Figure 9.1: Dose-dependent cytotoxic effects of EGCG in Vero cells. The cyto-
toxicity of EGCG was evaluated following the ISO10993-5 standard test method
using cells cultured with DMEM and DMEM+10% DMSO (toxic) as negative and
positive control, respectively. Values are presented as the mean ± SD of three in-
dependent experiments. Statistical analysis was performed by repeated measures
two-way ANOVA followed by Tukey’s Multiple Comparison Test and ** p<0.01
and *** p<0.001 indicates significance in relation to negative control.
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9.2.7.2 Characterization of liposomes
In this study, three different liposome drug delivery systems were developed to
avoid EGCG degradation and, at the same time, to control its release to the cell
culture medium. Theoretically, in this way, EGCG secondary metabolite forma-
tion rate is slowed down and the antioxidant activity of EGCG is increased. Table
9.1 shows that all the different liposomal formulations have high encapsulation
efficiencies. The liposome formulations F1, F2 and F3 had encapsulation efficien-
cies of 90.6 ± 2.8, 80.1± 2.1 and 82.4 ± 1.9 and loading capacities of 24.8 ± 1.6, 9.3
± 0.4 and 10.9 ± 0.2, respectively. Regarding the liposome size, the experimental
results showed that the mean particle diameter of F1, F2 and F3 liposomes were
221 ± 21 nm, 97 ± 13 nm and 114 ± 22 nm, respectively, with polydispersity
indices below 0.4 for all the formulations. These findings show that the insertion
of Tween 80 in the liposomal formulation decreased around 10% the EGCG en-
capsulation efficiency and drastically decreased the size of liposomes by two-fold.
Tween 80 monomers have affinity to the DPPC hydrocarbon tail but also to the
liposome surface. The presence of a large amount of the Tween 80 molecules at
the outer surface of liposome is sufficient to increase the degree of liposome cur-
vature, that consequently imply a decrease in particle size (turbidity of liposomal
solution decreased substantially).[47] The decrease in encapsulation efficiency of
EGCG was possibly caused by the accommodation of Tween 80 molecules into the
liposomes, which can lead to some liposomal bilayer’s destruction. Moreover, the
unsaturated alkyl chain of the Tween 80 molecules can loosen the packing of the
hydrocarbon tails of DPPC and thus increase the permeability of liposomes.[48,
49] Additionally, the increase in F3 liposome size confirmed the presence of PEG
coating on the liposomes.
Table 9.1: Composition of liposomal formulations adsorbed on PCL / gelatin
nanofibers.
Liposomal
Formulation
Lipid
Composition
Molar
Ratio
Size
(nm)
Encapsulation
Efficiency
(%)
Loading
Capacity
(%)
F1 DPPC:EGCG 10:1 221±21 90.6±2.8 24.8±1.6
F2
DPPC:EGCG:
T80
10:1:1 97±13 80.1±2.1 9.3±0.4
F3
DPPC:EGCG:
T80:PEG
10:1:1:0.1 114±22 82.4±1.9 10.9±0.2
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9.2.7.3 Fiber morphology of EGCG-containing PCL nanofibers
The morphology of the electrospun nanofibers, before and after the GTA crosslink-
ing process, is shown in Figure 9.2. The SEM images show that randomly oriented
and bead-free nanofibers assembled in highly porous mats were obtained for all
tested conditions. The addition of EGCG-loaded liposomes seems to slightly
increase the average diameter of the nanofibers, which were 398 ± 80 nm for
PCL/gelatin, 415 ± 70 nm for PCL/EGCG, 491 ± 196 nm PCL/EGCG/T80 and
427 ± 50 nm for PCL/EGCG/PEG, respectively (Table 9.2). After GTA crosslink-
ing, the average diameter of the nanofibers was 459 ± 60 nm for PCL/gelatin,
477 ± 220 nm for PCL/EGCG, 672 ± 240 nm PCL/EGCG/T80 and 539 ± 110
nm for PCL/EGCG/PEG, respectively. EGCG contains several hydroxyl groups
attached to its phenol rings that display a tendency for hydrogen bond formation
with gelatin, which might increases the gelatin solution viscosity, thereby raising
the nanofiber diameter.[50, 51] The changes in nanofiber mean diameter suggest
that EGCG-loaded liposomes are present and attached to nanofiber surface. Re-
garding the effect of GTA vapor crosslinking process on nanofiber morphology,
it can be seen that this treatment did not appreciable change the morphology of
PCL/gelatin membranes. In this work, GTA crosslinking process was used not
only to stabilize gelatin and avoid its dissolution but also as a means to immobi-
lize EGCG-loaded liposomes on the scaffolds, since the amino groups of DPPC
liposomes react with the aldehyde groups of GTA molecules. Hence, this inter-
action between GTA and DPPC molecules caused some morphological change in
PCL/EGCG and PCL/EGCG/T80 membranes (Figure 2). However, this change
was not so evident in membranes containing PEG, because the shielding layer of
PEG hindered the attack of GTA molecules to amino groups of DPPC.
Table 9.2: Average nanofiber diameter before and after GTA vapor crosslinking.
Nanofiber
Formulation
Before
Crosslinking
After
Crosslinking
PCL/gelatin 398± 80 459± 60
PCL/EGCG 415± 70 477± 220
PCL/EGCG/T80 491± 196 672± 240
PCL/EGCG/PEG 427± 50 539± 110
Additionally, the SEM images of PCL/gelatin nanofibers containing liposomes
did not show any liposomes possibly because (1) the weight ratio liposome/ge-
latin is low and the liposomes may not be in the focus field-of-view and (2) the
blend electrospinning methodology used to prepare the nanofibers may have dis-
rupted the integrity of the liposomes giving rise to phospholipid bilayers instead
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Figure 9.2: SEM images showing the morphology of PCL+GEL nanofibers con-
taining liposomal formulations with EGCG, EGCG+T80 and EGCG+T80+PEG
before (A, B, C, D) and after (E, F, G, H) GTA crosslinking. This process did not
significantly change the nanofibers morphology, which remained randomly ori-
ented, bead-free and arranged in a highly porous structure. X2000 magnification,
scale bar 2 µm.
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of spherical liposome-structures. The rupture and transformation of liposomes
into phospholipid bilayers influences the rate of EGCG release from nanofibers,
but still a good antioxidant activity of these nanofibers is expected.
9.2.7.4 EGCG immobilization on PCL nanofibers: ATR-FTIR analysis
ATR-FTIR spectroscopy was used to confirm the reaction of GTA with the amino
groups of gelatin and DPPC. The ATR-FTIR spectrum for PCL/gelatin nanofibers
is shown in Figure 9.3. The typical characteristic bands of PCL are observed at
2942 cm-1, 2863 cm-1, 1722 cm-1, 1294 cm-1 and 1240 cm-1 due to asymmetric
CH2 stretching, symmetric CH2 stretching, C=O stretching, C-C stretching and
asymmetric C-O-C stretching, respectively. Additionally, characteristics bands of
gelatin are centered at 3300 cm-1, 1651 cm-1, 1538 cm-1 and 1240 cm-1, which
are attributed to NH stretching, amide I (C=O stretching) and amides II and III
(both originating from CN stretching and NH bending vibrations), respectively.
Regarding the crosslinking process, the intensity ratio (1651 cm-1/1538 cm-1)
increased from 1.1 to 1.5 due to the formation of Schiff bases (aldimine linkages)
showing the efficiency of GTA vapor process in hardening the gelatin fibers. The
increase of the relative peak intensity at 1722 cm-1 is correlated with the pres-
ence of unreacted aldehyde groups, thus increasing the carbonyl content in the
samples.
The GTA vapor process may also crosslink the DPPC liposomes amino groups,
improving their adsorption onto the PCL/gelatin nanofibers as well as the EGCG
release profile from the fibers. The DPPC liposomes[52] exhibited characteristic
peaks at 2920 cm-1, 1730 cm-1, 1220 cm-1 and 1080 cm-1 assigned to asymmetric
CH2 hydrocarbon stretching, C=O stretching, asymmetric and symmetric P=O
stretching, respectively, having the major bands in the fingerprinting region of
PCL. Moreover, typical EGCG peaks[32] were located around 3360 cm-1 (phenyl
OH stretching), 1695 cm-1 (C=O gallic acid stretching), 1519 cm-1 (C=C stretch-
ing) and 1016 cm-1 (CH stretching of aromatic rings). The ATR-FTIR spectra
of PCL/gelatin fibers containing EGCG-loaded liposomes were very similar and
indistinguishable from control sample (PCL/gelatin fibers), firstly because only
a small number of liposomes were incorporated onto these fibers (much smaller
intensity), and secondly, given the overlap of the DPPC absorption bands with
the main bands of PCL/gelatin.
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Figure 9.3: ATR-FTIR spectra of the PCL/gelatin nanofibers before (a) and after
(b) GTA crosslinking process. ATR-FTIR spectra of the PCL/gelatin nanofibers
containing the F1 (c), F2 (d) and F3 (e) liposomal formulation after GTA crosslink-
ing process.
9.2.7.5 EGCG release from liposomes immobilized on PCL nanofibers
The in vitro release profiles of EGCG, obtained from the different liposomal formu-
lations immobilized on PCL/gelatin nanofibers, is shown in Figure 9.4. Despite
the improvements carried out in optimization of liposome design, namely the
addition of PEG and Tween 80, these did not prevent the initial burst release of
EGCG. Release profiles show that all the liposomal formulations are character-
ized by an initial burst during the first hour, releasing on average 30% of their
EGCG cargo, followed by a more sustained release of the encapsulated EGCG. In
addition, it can be observed that the coating of liposomes with PEG results in a
faster release rate and higher total amounts of EGCG released than for conven-
tional DPPC+EGCG liposomes. Indeed, this phenomenon has also been reported
by other authors, showing that PEGylation increases the liposome stability and
plasma circulation time, but also affects the bilayer fluidity in the water interfa-
cial region, which in turn, may influence the drug release kinetics.[53, 54, 55]
According to previous studies, EGCG binds to phosphate and choline groups of
lipid at the interface.[56] At the same time, it is also known that the PEG polymer
chains are tethered to lipids at the air-water interface[57, 58] which, in turn, is
likely to weaken part of the hydrogen bonds between EGCG and DPPC in this
region. So, the addition of PEG can interfere with hydrogen bond network at
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the interface, which compromises the trapping efficiency of liposomes and, thus
increases the burst release as well as EGCG release in the later hours.
Figure 9.4: Release profiles of EGCG from each type of PCL/gelatin membranes
that were immersed in PBS solution (pH = 7.4) at 37 ◦C. All values represent the
mean ± SD (n = 3).
9.2.7.6 Cytotoxicity test of the nanofiber’s extracts
Cytotoxicity assays were performed to determine the biocompatibility of the dif-
ferent types of the PCL/gelatin membranes. As seen in Figure 9.5, all four types
of the membranes displayed cell viabilities above 90% compared to the nega-
tive control (Table 9.3) after both 1 and 3 days of cell exposure to the extracts.
Thus, none of the membranes have cytotoxic effects since the amount of EGCG
released did not disturb Vero cells normal metabolism and are, therefore, suitable
as substrates for cell adhesion.
9.2.7.7 Cell morphology
The changes in cell morphology in response to underling nanofibers topography
was studied by SEM microscopy. As shown in Figure 9.6, HFFF2 cells adhered to
and spread along the nanofibers from day 1 to day 7. At day 3, the images suggest
that HFFF2 cells on PEG-liposomes-containing membranes adhered well, grew
and almost reached confluence by day 7. This finding is consistent with some
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Figure 9.5: Results of the cytotoxicity test using extracts of the PCL/gelatin
nanofibers containing different liposomal formulations. The Vero cells were ex-
posed to the extracts for 24 and 72h. Cell viability was measured with the re-
sazurin method and the results showed that all the extracts are not cytotoxic.
Values are presented as the mean ± SD of three independent experiments.
Table 9.3: VERO cells viability relative to the negative control after 1 and 3 days
of culture with nanofibers-extracted media. Values are presented as the mean ±
SD of three or more independent experiments.
Nanofiber
Formulation
Day 1 Day3
PCL/gelatin 108.7± 2.1 97.6± 7.9
PCL/EGCG 117.7± 5.1 95.5± 3.3
PCL/EGCG/T80 115.6± 3.2 110.9± 4.3
PCL/EGCG/PEG 120.5± 3.3 104.1± 3.1
previous studies, which found that the presence of PEG in PCL/gelatin mem-
branes increased porosity and hydrophilicity, resulting in a significant increase
in cell attachment and proliferation[59, 60, 61]. Overall, the results evidence the
good biocompatibility of all membranes that provide a high surface area for cell
adhesion.
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Figure 9.6: SEM micrographs of HFFF2 cells seeded over PCL/gelatin membranes
containing liposomal formulations with EGCG, EGCG+T80 and EGCG+T80+PEG
after 3 (A, B, C, D) and 7 (E, F, G, H) days of culture, respectively. x 500 magnifi-
cation, scale bar 10 µm.
9.2.7.8 In vitro antioxidant effect of the nanofibers against H2O2
9.2.7.8.1 Cell viability after damage The antioxidant activity of each type of
membrane was tested following 50 µM H2O2 exposure for 1 h; the results for
cell survival are shown in Figure 9.7. After 4 h of H2O2 exposure, a significant
reduction in cell viability on conventional PCL/gelatin membranes (∼ 37% of
viable cells) was observed, whereas the changes in cell viability were not so dras-
tic on EGCG-loaded PCL/gelatin membranes (∼ 60% of viable cells). Indeed,
all the antioxidant functionalized nanofibers showed an improvement in cell vi-
ability, where their antioxidant efficiency was seen to be increased in the order
PCL/EGCG < PCL/EGCG/T80 < PCL/EGCG/PEG. After 24 h of H2O2 treat-
ment, a time sufficient for cells to metabolize H2O2, the percentage of viable
cells was again calculated to further elucidate if the damage caused by H2O2 is
201
CHAPTER 9. CELL-BASED RESULTS
too severe to be repaired or if damage was completely repaired. The viable cell
population in PCL/gelatin membranes drops to ∼ 20% as compared to ∼ 45%
in PCL/gelatin membranes containing PEG-liposomes. Indeed, a significantly
higher number of viable cells (p < 0.05) was always observed in PCL/EGCG/T80
and PCL/EGCG/PEG membranes for each day of culture. Nonetheless, the results
also showed that from day 1 to day 3 after H2O2 exposure, the cells continued
dying regardless of EGCG presence in cell culture medium. The dose-response
for H2O2 toxicity in eukaryotic cells is discontinuous, specifically, several studies
reported that a micromolar concentration of H2O2 is much more severe than a
millimolar concentration, because of the difference in the association of Fe2+ with
DNA [62, 63]. So, in this study, we may suggest that the cell damage caused by
50 µM H2O2 exposure was enough to disrupt cell membrane integrity and affect
the cellular respiratory pathways, hampering the DNA repair and cell renewal.
Hence, the results showed that the liposome-coated PCL/gelatin membranes con-
tinuously deliver EGCG reducing H2O2-induced damage in HFFF2 cells but did
not completely block the oxidant action of this compound.
Figure 9.7: Cell viability of HFFF2 cells cultured on PCL/gelatin nanofibers con-
taining different liposomal formulations after 4, 24 and 72 h of oxidative stress
induced by 50 µM H2O2 treatment. Values are presented as the mean ± SD of the
three independent experiments. * p<0.05, ** p<0.01 and *** p<0.001 indicates
significance in relation to conventional PCL+GEL nanofibers treated with 50 µM
H2O2.
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9.2.7.8.2 Detection of intracellular ROS production According to previous
results, a higher percentage of viable cells is achieved in PCL/gelatin membranes
containing EGCG-loaded liposomes under stress conditions, which may be corre-
lated with a decrease in ROS species production. We studied this correlation by
using the DCFDA fluorescence assay that detects the generation of intracellular
ROS in cells. H2DCFDA is a non-fluorescent molecule that is readily cleaved to
2’,7’-dichlorofluorescein (DCF, a fluorescent molecule) by intracellular esterases
or following oxidation, being used for evaluation of changes in the intracellular
redox state. HFFF2 cells were exposed to 50 µM H2O2 for 30 min and treated
with the extracts from the unloaded and from each liposome containing PCL/ge-
latin nanofibers. Results are shown in Figure 9.8. After 50 µM H2O2 exposure,
treatment with the extracts from all the nanofibers containing EGCG caused a sig-
nificantly decrease in fluorescence intensity compared to the control PCL/gelatin
group, which is indicative of the potent antioxidant activity of these nanofibers
against H2O2-induced damage (Figure 9.8).
Figure 9.8: Assessment of ROS formation in HFFF2 cells following incubation
with 50 µM H2O2 (30min) based on the fluorescence intensity of DCFDA dye.
Values are presented as the mean ± SD of three independent experiments. ** (p
< 0.01) and *** (p < 0.001) indicates significance in comparison to PCL/gelatin
(control).
Fluorescence microscopy images show a strong and bright green signal in
HFFF2 cells cultured with the extracts from PCL/gelatin scaffolds, associated
with the enhancement of the endogenous ROS species, as can be seen in Figure 9.9.
Cells treated with the extracts from EGCG-containing nanofibers displayed low
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green fluorescence intensities, more specifically, the number of green fluorescent
cells decreases in the order PCL/EGCG/PEG ≤ PCL/EGCG/T80 < PCL/EGCG.
Also, the reduction in the observed fluorescence intensity can be directly related to
radical-scavenging activity of EGCG that reduced the presence of ROS species and
delayed the oxidation. These results corroborate the findings of cell viability assay
(Figure 9.7, indicating that the inclusion of EGCG into PCL/gelatin nanofibers
was effective in decreasing the H2O2-induced overproduction of ROS in HFF2
cells.
Figure 9.9: Fluorescence images of HFFF2 cells seeded on unloaded PCL/gelatin
(A), PCL/EGCG (B), PCL/EGCG/T80 (C) and PCL/EGCG/PEG (D) membranes.
The HFFF2 cells were stained with DCFDA (ROS sensitive dye, green color) and
Hoechst (cell nuclei dye, blue color) to check formation of intracellular ROS after
oxidative stress. Scale bar = 100 µM.
9.2.7.9 In vitro antioxidant effect against UV radiation
In UV irradiation experiments, the HFFF2 cells were exposed to two UV doses
(2 and 8 J/cm2), triggering a distinct rate of ROS generation, that allows to infer
about the relationship between ROS concentration and antioxidant potential of
EGCG containing nanofibers. Figure 9.10 shows that upon exposure to a low
UV-dose (2 J/cm2), the cell survival percentage was approximately 76.9%, 84.7%
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and 96.1% in EGCG, EGCG+T80, EGCG+PEG formulations, respectively, con-
trasting with the 52.9% in the PCL/gelatin control nanofibers. According to these
results, the cell survival percentages were higher in the nanofibers containing the
antioxidant EGCG, being significantly different from that in PCL/gelatin control
nanofibers, demonstrating that EGCG confers cell resistance and can effectively
reduce the UVC induced-oxidative stress.
Figure 9.10: Cell viability of HFFF2 cells cultured on PCL/gelatin nanofibers
containing different liposomal formulations after oxidative stress induced by UVC
light exposure at a dose of 2 or 8 J/cm2. Values are presented as the mean ± SD
of three independent experiments. * p<0.05 and ** p<0.01 indicates significance
in relation to conventional PCL+GEL nanofibers exposed to UVC light.
At high-UV-dose (8 J/cm2), cell viability percentages reduced to 16.7%, 12.5%,
25.4%, contrasting with the 8.3% of the control. A higher radiation dose may
impair the DNA integrity and also decline the activity of the DNA repair machin-
ery and the cellular antioxidant defense system, leading to much lower survival
percentages.[64] For instance, after the 8 J/cm2 dose, the cell survival percentage
in PCL/EGCG/PEG nanofibers was still significantly higher than in the control
group, but is much lower (almost 4 fold) when compared to the one obtained
at 2 J/cm2. Therefore, these results suggest that high UV doses could photode-
grade EGCG [65, 66] and the others fiber components resulting in oxidant and
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toxic sub-products that may lead to additional cell damage. After UV irradia-
tion, an increased number of ROS, matrix metalloproteinases (MMPs) and proin-
flammatory cytokines are produced contributing to the development of chronic
inflammation that is the main reason for failure/delay of wound healing.[67,
68, 69] Numerous studies have incorporated natural antioxidant molecules in
PCL-based scaffolds to suppress chronic inflammation and to facilitate skin re-
epithelization/tissue regeneration.[70, 71, 72, 73] Curiously, in spite of the well-
known anti-inflammatory and anti-bacterial properties of EGCG only a few stud-
ies immobilized this molecule into scaffolds. In a recent study, collagen scaffolds
incorporating EGCG were synthetized that have ability to decrease the production
of pro-inflammatory cytokines (such as IL-8, IL-1 and TNF-α) and proteolytic en-
zymes. Further, these scaffolds also controlled the macrophage recruitment into
wounds that accelerates the tissue remodeling.[74] Regarding the photoprotective
role of EGCG against UV damage, some studies showed that EGCG inhibits the
UVA/UVB radiation induced-apoptosis in vitro in human HaCaT keratinocytes
by preventing the activation of caspase pathway, which significantly reduces the
degree of DNA fragmentation.[75, 76, 77, 78] Huang et al. also found that EGCG
(1-100 µM) treatment prior to UVA irradiation renders high cell survival rates
due to a reduction in intracellular H2O2 production and through blockage of the
ERK signalling pathway, which prevents cell matrix degradation.[79] So, there is a
remarkable agreement between our results and these published studies, showing
that EGCG treatment improves the ability of human fibroblasts to survive UV
damage and also support the appreciation that our scaffolds can be used for skin
wound healing.
9.3 Conclusion
In this study, DPPC liposomes carrying EGCG were designed to be immobilized
in PCL/gelatin nanofibers mats through a blend electrospinning technique. The
SEM images of PCL/gelatin nanofibers containing DPPC+EGCG liposomes did
not show any intact liposomes suggesting that the blend electrospinning method-
ology used to prepare the nanofibers disrupts the integrity of the liposomes and
leads to a premature EGCG leakage. Nevertheless, this technique successfully
gave rise to PCL/gelatin nanofiber supported DPPC+EGCG phospholipid bilay-
ers, that are highly biocompatible and have a cellular antioxidant capacity supe-
rior to that of raw PCL/gelatin nanofibers. The EGCG released from the DPPC
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phospholipid bilayers immobilized at the surface of PCL+GEL nanofibers guar-
antees higher cell survival rates after oxidative stress induced either by H2O2
(induced ±2.3 fold increase in cell survival over control within 72 h) or UV radi-
ation (up to ±3 fold increased in cell survival over control after high-UV-dose).
Therefore, the results showed that the EGCG-containing nanofibers slows down
oxidative-stress related cell damage and could be used for wound healing and skin
tissue engineering. Looking ahead, the coaxial electrospinning technique may be
used in future studies since it conserves the integrity of liposomes rendering a
better performance of the nanofibers against oxidative damage.
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Concluding Remarks
In this section one intends to summarize the main conclusions of this doctoral
thesis. 1
This work thesis focused on the development of a liposome-based carrier
for topical/transdermal delivery of EGCG, firstly, to overcome the issue of poor
bioavailability of EGCG and, secondly, to offer an adequate skin protection against
oxidative stress induced either by blue or UV radiation. Although it was common
knowledge the antioxidant/radical scavenging activity of EGCG, the molecular
mechanisms underlying its mode of action in cell membrane are not fully under-
stood. Understanding these molecular interactions can reveals the localization
of EGCG on cell membrane and lead to a better understanding of the antioxi-
dant action of EGCG, through the analysis of correlation between the structural
changes in membrane caused by EGCG and the resistance to radiation damage.
Considering this and, to the best of our knowledge, here are encompassed the
first Langmuir studies performed to identify the molecular interactions between
EGCG and different lipidic monolayers, and as to determine how blue radiation
affects these interactions and therefore compromises the monolayer integrity.
Concerning the molecular interactions of EGCG with DPPG monolayer in dif-
ferent molar ratios at the air–water interface, Chapter 5 , it was observed that
as the amount of EGCG was increased, the surface pressure–area isotherms sig-
nificantly shifted to lower areas in relation to DPPG monolayer, indicating a
1The introductory Chapters 1, 2, 3 and the experimental Chapter 4 are excluded from the
discussion, because they do not contain new experimental findings.
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condensation of the monolayer triggered by EGCG. Furthermore, the accommo-
dation of EGCG in lipidic monolayer induced conformational changes in DPPG
headgroups, in particular, significantly reduced the hydration status of phosphate
and carbonyl groups of DPPG, which promoted variations in membrane poten-
tial. Blue irradiation experiments demonstrated the antioxidant effect of EGCG
since the hydration sites of DPPG lipids (carbonyl and phosphate groups) become
relatively less vulnerable to radiation damage. The main findings of this study
suggest that EGCG displace water molecules at phosphate and carbonyl groups of
lipids, triggering a condensing effect in lipid monolayer, which can hamper ROS
diffusion across the monolayer and thus, prevent the oxidizing events.
The antioxidant action of EGCG in DPPC and DPPS Langmuir monolayers
spread at the air-buffer interface rather than in air-water interface was analyzed
to check whether the protonation state of EGCG and the surface charge of lipid
modulate the EGCG partitioning to lipidic membrane and, which implications
that this entails for the prevention of oxidative damage (Chapter 6). The results
indicated that EGCG interacts with both lipids, irrespective of their charge state,
perturbing the monolayer structure and morphology. Nonetheless, the affinity
and insertion of EGCG was higher for DPPC since the degree of monolayer con-
densation was larger and the hydrocarbon chains were more ordered in compar-
ison to those obtained in DPPS/EGCG system. So, the results stated that the
molecular organization of the lipid ( differences in substituents at the headgroup,
compaction and hydration regime) dictate EGCG insertion or adsorption in lipid
membrane. Moreover, the anionic and neutral forms of EGCG arising from its
deprotonation due to subphase pH, efficiently protected both lipid monolayers
from blue radiation, indicating that the electron-donating ability was the main
mechanism of its radical scavenging action.
The encapsulation rate of the EGCG in DPPG liposomes was investigate as well
as the molecular mechanisms underlying the radical scavenging activity of EGCG
responsible for conferring liposome-resistance against UV damage (Chapter 7).
The liposomal formulation showed good encapsulation efficiency of about ∼ 67%
indicating that EGCG was well loaded in liposomes and so, certainly, this system
have potential to improving the trandermal EGCG bioavailability. The irradiation
experiments demonstrated that EGCG and DPPG are co-helpers against oxidative
stress-induced by UV radiation, such that the mixed DPPG + EGCG system is
significantly less photodegraded than the empty DPPG liposomes and the EGCG
in aqueous solution. Additionally, the results also showed that the impairment
in the pyrogallol ring of the EGCG caused by UV light significantly reduced the
ability of EGCG to protect liposomal lipids against oxidative stress-induced by
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The interactions of EGCG with the DMPC membranes were studied by using
MD simulations, Langmuir monolayer film experiments and fluorescence tech-
niques (Chapter 8 ). The Langmuir monolayer results and the MD simulations
indicated that the EGCG penetrates at the lipid ester region and promotes the con-
densation of the membrane. Also, the steady-state fluorescence results showed
that EGCG changes the membrane dipole potential and that 10 % in EGCG-to-
lipid molar ratio is the maximum EGCG loading capacity of the DMPC liposomes,
which guarantees a better stability since the liposomes do not suffer leakage, ag-
gregation and fusion.
Finally, the idea of encapsulating EGCG inside DPPC liposomes, which are
more stable and organized than the obtained DMPC liposomes and embedding
them in PCL/Gelatin nanofibers to enhance human fibroblast cells resistance
against oxidative stress induced either by H2O2 or UV radiation was tested. Also,
in this approach Tween 80 and PEG were added to liposomal formulations for en-
hance elasticity and stability, respectively. The resulting PCL/Gelatin nanofibers
containing DPPC + EGCG liposomes showed good biocompatibility, supported
human fibroblasts adhesion and delivered EGCG in a controlled and sustained
manner, which guaranteed a higher cell survival after oxidative stress to that in
raw PCL/Gelatin nanofibers.
In summary, the work presented in this doctoral thesis strengthens the idea
that Langmuir monolayer films and liposomes can be used as artificial mem-
brane models that mimic the cell plasma membrane for the understanding of the
molecular mechanisms underlying the antioxidant activity of EGCG against blue
and UV light. Lastly, DPPC liposomes are suitable and biocompatible nanocarri-
ers for the encapsulation of EGCG that, after being immobilized in PCL/Gelatin
nanofibers and applied in human skin cells, efficiently attenuated the UV-induced
oxidative stress.
Directions for Future Work
Looking ahead, more studies are needed to fully understand the antioxidant
mechanism triggered by EGCG in lipid membranes, since those will ultimately
help to further optimize the delivery rate and the therapeutic efficacy of liposomes
against skin cancer.
Regarding the Langmuir monolayer film experiments some suggestions for
future research are:
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• Study the effect of the spreading procedure (co-spread or separately spread
at the interface) on the formation of EGCG/lipid monolayer;
• Study the influence of temperature, pH, and physical state of monolayer on
the adsorption of EGCG;
• Compare the stability and vulnerability of a monolayer maintained at dif-
ferent surfaces pressures to the radiation damage;
• Incorporate EGCG in mixed monolayer of saturated and polyunsaturated
phospholipids and perform irradiation experiments for assessment of an-
tioxidant/prooxidant effect of EGCG in this system;
• Considering that piperine is a natural bioenhancer that increases bioavailabil-
ity and therapeutic index of EGCG, the interaction between both molecules
in lipid monolayer should be analyzed to envisage a liposome carrying
both molecules for synergistic tumor treatment (experiments currently in
progress in our laboratory 2).
Concerning the experiments carried out in liposomes and considering the
outcomes of cellular studies some guidelines for future work are:
• Irradiation experiments in DPPG liposomes, the type of by-products photo-
generated in presence and absence of EGCG should be identified by high
performance liquid chromatography (HPLC) or mass spectrometry;
• The UV–Vis absorption spectra obtained after irradiation should be com-
bined with theoretical calculations (such as density functional theory) for un-
derstanding better the photochemical reaction mechanism of the lipid and
EGCG molecules (experiments and theoretical studies currently in progress
in our laboratory in a collaboration with a Danish and Greek groups)3
• DPPC liposomes composed of different amounts of Tween 80 and PEG
should be prepared and characterized by various techniques such as FTIR,
differential scanning calorimetry and fluorescence, to better study the influ-
ence of the Tween 80 and PEG on the loading efficiency and release behavior
of liposomes;
2 Publication in preparation for submission: Pires, F., Magalhães-Mota, G., Geraldo, V. P.,
Ribeiro, P.A., Oliveira Jr, O. N., and Raposo, M. Exploring the effect of co-administration of EGCG
and piperine on DPPC monolayer structure: Implications for drug delivery.
3 Publication in preparation for submission: Pires, F., Hoffmann, S., Jones, N. C., Tzeli, D. and
Raposo, M. Probing the Electronic States of Epigallocatechin-3-gallate in the 4 to 9 eV Energy
Range.
220
• Considering that DPPG is a skin penetration enhancer, a liposomal formu-
lation composed of DPPC:DPPG:EGCG should be designed and tested as
another alternative to improve skin resistance against oxidative stress;
• Co-encapsulation of EGCG with other phytochemicals (such as curcumin,
piperine, quercetin) and vitamins (tocopherol and ascorbic acid) in lipo-
somes is another alternative that can provide a synergistic antioxidant ef-
fect;
• Study the antioxidant and prooxidant behavior of EGCG on DNA 4 as well as
the synergistic interaction between EGCG and lomustine (anticancer drug)
to kill the skin cancer cells (experiments currently in progress in our labo-
ratory).
4Pivetta,T.P., Pires, F. and Raposo.M. Effect of EGCG on the DNA in presence of UV ra-
diation.Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2018)
Proceedings
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Effect of blue light on the stability
of lipid molecules in the presence of
EGCG
Since the insertion of EGCG into the phospholipid membrane will occupy a spe-
cific area and contribute to the total molecular area, we decided to apply a weight-
ing factor to the experimental isotherms obtained. As the values of A, c and NA
do not change, the weighting factor consisted in the following ratio (equation A.1:
Weightingf actor =
MMA×Vlipid
Mlipid ×Vmixture (A.1)
where MMA is the average molar mass using the molar fractions of EGCG
and DPPG, Mlipid is the molecular weight of lipid, Vmixture is the solution volume
spread and Vlipid is the volume of the lipid spread.
When the representation area per lipid is adopted, the isotherms normally
shift to the right, to larger areas per lipid as guest molecules are incorporated at
the subphase and occupy a given area. The effect is expected to increase with the
concentration of guest molecules in case further molecules are incorporated with
increasing concentration. Shifts to the left can only happen if the guest molecules
induce condensation of the monolayer or disrupts it causing lipid molecules to be
removed from the interface.
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APPENDIX A. EFFECT OF BLUE LIGHT ON THE STABILITY OF LIPID
MOLECULES IN THE PRESENCE OF EGCG
Figure A.1: A) Surface Pressure for DPPG monolayers with different contents
of EGCG at water interface. B) Compressional modulus vs surface pressure for
DPPG and DPPG + EGCG monolayers at the air/water interface. C) Surface
Potential isotherms of DPPG + EGCG monolayers at various concentrations. The
top-right inset in Figure 1C shows the ratio between the apparent dipole moment
of DPPG + EGCG (µ) and pure DPPG (µ0) vs. EGCG concentration at 1 mN/m
and 30 mN/m. The solid lines in the graph are only to guide the eyes.
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Figure A.2: A. Compression-decompression cycles of DPPG+13% EGCG mono-
layer irradiated with blue light over 1h at a surface pressure of 30 mN/m. B.
Area-time relaxation isotherms of DPPG+EGCG at the three concentrations taken
at a constant pressure of 30 mN/m. The almost horizontal lines for the areas after
the monolayers were compressed to 30 mN/m do indicate stability.
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The impact of blue light in
tumorigenic and nontumorigenic
monolayers containing EGCG
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APPENDIX B. THE IMPACT OF BLUE LIGHT IN TUMORIGENIC AND
NONTUMORIGENIC MONOLAYERS CONTAINING EGCG
Figure B.1: PM-IRRAS spectra for neat DPPC (A) and mixed EGCG/DPPC mono-
layer (B) monolayer in the CH2 methylene deformation region before and after
blue light irradiation.
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Figure B.2: Surface pressure-area isotherms for neat DPPC (A) and DPPC con-
taining EGCG (B) monolayers before and after blue light irradiation.
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APPENDIX B. THE IMPACT OF BLUE LIGHT IN TUMORIGENIC AND
NONTUMORIGENIC MONOLAYERS CONTAINING EGCG
Figure B.3: Surface pressure-area isotherms for neat DPPS (A) and DPPS contain-
ing EGCG (B) monolayers before and after blue light irradiation.
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On the role of EGCG in protecting
phospholipid molecules against UV
irradiation
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APPENDIX C. ON THE ROLE OF EGCG IN PROTECTING
PHOSPHOLIPID MOLECULES AGAINST UV IRRADIATION
Figure C.1: EGCG seems to protect the phosphate and carbonyl groups of DPPG
phospholipids against UV irradiation.
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Evaluation of EGCG loading
capacity in DMPC membranes
Figure D.1: A1 values of DMPC head groups calculated in the presence of different
amounts of EGCG and assuming that the catechin molecules are in the tails and
not in the head group region. These were calculated ignoring the specific area
occupied by EGCG. The grey shaded region corresponds to the values measured
experimentally for pure DMPC in fluid phase.
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APPENDIX D. EVALUATION OF EGCG LOADING CAPACITY IN DMPC
MEMBRANES
Figure D.2: Membrane thickness values in the presence of different EGCG molar
fractions. The thickness is calculated from the distance between the phosphorous
atoms average positions in each monolayer. The gray shaded region corresponds
to the values measured experimentally for pure DMPC in fluid phase.
Figure D.3: Deuterium order parameter (SCD) values along the aliphatic chain for
the different molar ratios of the EGCG/DMPC systems. The experimental profile
presented is for pure DMPC in fluid phase.
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Figure D.4: PM IRRAS measurements for different EGCG molar fractions in
DMPC. The PM IRRAS data on DMPC ester C=O (A), phosphate P=O groups (B),
and choline N-CH3 (C) are also shown.
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APPENDIX D. EVALUATION OF EGCG LOADING CAPACITY IN DMPC
MEMBRANES
Figure D.5: Top (left) and side-view (right) of DMPC headgroup bending in
the presence of EGCG. This figure highlights how the choline (N atom in blue
spheres) and phosphate (P atom in orange spheres) groups of DMPC bilayer oc-
cupy the space created with EGCG (grey spheres) insertion. The remaining DMPC
atoms are shown as transparent grey sticks.
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